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ABSTRACT
Chemokine and chemokine receptor expression have been investigated in the gastric 
mucosa in association with H. pylori infection and gastritis.
The AGS and MKN45 gastric epithelial cell lines were cultured in the presence of 
the pro-inflammatory cytokines IL-la, TNF-a and IFN-y added alone or in 
combination up to 48 hours and were investigated for the expression of IL-8/CXCL8 
and RANTES/CCL5 mRNA by Northern analysis. The cytokine-stimulated cell lines 
were found by RT-PCR to express ‘CXC’ and ‘CC’ chemokines including EL- 
8/CXCL8 , MIG/CXCL9, IP-10/CXCL10, SDF-lcc/CXCL12, BCA-1/CXCL13, 
MCP-1/CCL2, MIP-la/CCL3, RANTES/CCL5, MCP-3/CCL7 and LARC/CCL20. 
The AGS and MKN45 cell lines were found to express IL-8/CXCL8 , MIG/CXCL9 
and LARC/CCL20 constitutively.
The regulation of IL-8/CXCL8 and RANTES/CCL5 by IL-4 and IL-13 were 
investigated by Northern analysis and ELISA. Neither IL-4 nor IL-13 modulated the 
IL-8/CXCL8 production in the AGS and MKN45 cells but both cytokines down- 
regulated the RANTES/CCL5 secretion in the MKN45 cells.
Chemokine expression was also investigated by RT-PCR in gastric biopsies from 
patients with H. py/on-associated gastritis, non-//, py/on-associated gastritis and 
normal controls. Many ‘CXC’ chemokines including IL-8/CXCL8 , MIG/CXCL9, IP- 
10/CXCL10, SDF-loc/CXCL12 and BCA-1/CXCL13 and ‘CC’ chemokines MCP- 
1/CCL2, MIP-la/CCL3, RANTES/CCL5 and LARC/CCL20 were expressed at 
higher levels in patients with gastritis. The chemokine expression was not totally 
dependent on the presence of H. pylori infection but seemed to be an inflammatory 
response. Chemokines detected in the gastric biopsies from the normal patients were 
MCP-1/CCL2 and SDF-la/CXCL12.
Chemokine receptors were investigated in the AGS and MKN45 cell lines by RT- 
PCR. MKN45 cells expressed CXCR4 and CXCR5. CCR2 were found to be 
expressed in both cell lines. The AGS cells also expressed CCR1 and CXCR1.
Immunohistochemical experiments performed on histology slides demonstrated that 
epithelial cells from normal patients expressed low levels of BCA-1/CXCL13 while 
patients with H. /?y/ori-associated gastritis demonstrated very intense staining for 
BCA-1/CXCL13 in the epithelial cells.
CXCR4, the SDF-la/CXCL12 receptor was found to be expressed constitutively by 
gastric epithelial cells although staining was more dense in epithelial cells from H. 
pylori-infected patients.
These chemokines and their receptors may be important in immunosurveillance and 
epithelial cell behaviour.
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11.0 INTRODUCTION
1.1 BACKGROUND
The stomach is a digestive organ, hence foreign substances including food and 
microbial pathogens are introduced into the stomach daily. As a result of this, the 
stomach has a role in food digestion and elimination of the microbial pathogens. 
Elimination of pathogens is important in order to prevent diseases and pathological 
states that these organisms may cause. Various types of barriers are found in the 
stomach to achieve the goal of bacterial elimination, these include the mucus gel 
barrier, the epithelial cell barrier and the immune barrier (Holzer, 2000).
The bacteria Helicobacter pylori (H. pylori) was discovered by Marshall and Warren 
in 1982. It is now well-known that the bacteria is responsible for the pathogenesis of 
various types of gastrointestinal diseases such as gastritis, peptic ulcers, duodenal 
ulcers, gastric adenocarcinomas and gastric B cell mucosa-associated lymphoid 
tissue (MALT) lymphomas (Crabtree, 1996). H. pylori infections are very common 
worldwide, although prevalence in the developed world is now decreasing.
The stomach secretes hydrochloric acid which aids food digestion and creates a 
region of low pH (pH 1) and it also secretes enzyme containing mucus which make 
the stomach inhospitable to foreign organisms. However, H. pylori can survive 
beneath the mucus layer on gastric epithelial cells, where it is protected from the 
gastric acidity. Pro-inflammatory cytokines and ‘chemokines’ which are 
chemoattractant cytokines are expressed by the host in an attempt to recruit immune 
cells which can eliminate the bacteria.
Chemokines are pro-inflammatory mediators typically secreted by leukocytes 
responsible for various processes such as the recruitment of other white blood cells, 
lymphoid trafficking, lymphoid organ development, inflammation, Thl and Th2 
development, wound healing, angiogenesis and angiostasis as well as metastasis 
(Rossi et al., 2000). Subsequently, it was discovered that other types of ‘non- 
immune’ cells such as endothelial cells, mesangial cells and fibroblasts could also
2express chemokines when stimulated with pro-inflammatory cytokines or bacteria. 
As a result of that, interest in the epithelial cells as a source of chemokines also grew 
as the epithelial cells were the cells which separated the host from its external 
environment and were responsible in host protection.
The cytokines and chemokines which are secreted by the gastric epithelial cells are 
secreted via the T helper 1 (Thl) type of reactions (D’Elios et al., 1997). As a result 
of the expression of the pro-inflammatory IL-2, IL-12, TNF-p and IFN-y cytokines, 
inflammatory cells such as neutrophils, basophils, T and B lymphocytes, 
macrophages and natural killer cells are attracted to the site of the bacterial infection. 
This demonstrates the important communication between gastric epithelial cells and 
mucosal immune and inflammatory cells in the normal host mucosal defense. Once 
the bacterial infection is eliminated, the inflammation will resolve, however, if  this 
bacteria is not eliminated, persistent inflammatory cell recruitment leading to chronic 
inflammation will occur (Bamford, 1999). Interestingly, a Thl type of reaction is not 
very effective in eliminating extracellular infections such as the H. pylori infection 
and is more suitable for eliminating intracellular bacterial infections. Therefore, anti- 
secretory and antimicrobial drugs need to be used to assist the immune response to 
eliminate H. pylori effectively from the host.
This study aims to determine if chemokines and their receptors play a role in the 
maintenance of gastric epithelial cell physiology. Another aspect which will also be 
of interest would be to examine the regulation and expression of chemokines 
secreted in inflammatory states in the gastric mucosa and their relationship to H. 
pylori with a view to the possibility of developing novel therapies using 
antichemokines to treat H. pylori infections. This would overcome the problem of the 
development of antimicrobial resistance which can occur with the common usage of 
antibiotics.
31.2 ANATOMY OF THE STOMACH
1.2.1 The stomach
The stomach is located in between the oesophagus and the small intestine and is used 
for storing and digesting food. Food is churned and mixed with gastric juices 
consisting of hydrochloric acid, pepsin, intrinsic factor and gastric lipase in the 
stomach and mucus is secreted to lubricate the process. The digested food is then 
moved to the small intestine by peristaltic waves achieved by contraction of smooth 
muscles in the stomach wall. The stomach also is involved in the elimination of 
pathogens by the secretion of hydrochloric acid, the absorption of vitamin B12 by the 
secretion of intrinsic factor and the limited absorption of water, alcohol and drugs 
(Thibodeau et al., 1993; Tortora et al., 2000). The stomach also secretes the gastrin 
hormone which regulates the digestive processes.
The stomach has two curvatures, the lesser curvature and the greater curvature 
(Fig.l). The greater curvature is 4-5 times longer than the lesser curvature. The 
stomach can be divided into 4 distinct regions, which are the cardia, fundus, body 
(corpus) and pylorus. The pylorus can be subdivided into the pyloric antrum (antrum) 
which connects the pylorus to the gastric body and the pyloric canal which connects 
the pylorus to the duodenum. The cardia is found on the superior opening of the 
stomach. The fundus is above the level of the cardiac orifice which is the opening 
from the oesophagus into the stomach. The body is the large central portion of the 
stomach below the fundus and the pylorus is a muscle controlled opening that 
separates the stomach from the small intestine (Williams et al., 1993; Tortora et al., 
2000).
1.2.2 The structure of the gastric mucosa
The gastric mucosa which is next to the lumen, consists of the three layers, 
epithelium, lamina propria and the muscularis mucosa (Fig.2). The epithelial layer is 
made up of gastric pits which contain gastric glands while the lamina propria
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Schematic representation o f a stomach wall (adapted from Freeman et al., 1980)
6contains reticular, lymphoid connective tissue which functions immunologically and 
also supports the mucosa. The muscularis mucosa is made up of smooth muscles and 
is the boundary of the mucosa. Beneath the muscularis mucosa is the submucosa 
layer which contains arteries, veins, nerves and lymphatics. Under the submucosa 
layer, there lies the smooth muscle layer made up of the oblique, circular and 
longitudinal layers of muscularis followed by the serosa layer.
Gastric epithelial cells
The epithelial cells lining mucosal surfaces provide a mechanical barrier which 
separates the host internal milieu from the external environment (Kagnoff et al., 
1997) which may include pathogenic and non-pathogenic micro-organisms. 
Previously, epithelial cells were assumed to be a passive barrier towards pathogenic 
organisms and only being a cellular target for such organisms in the worse case. 
However, in recent years, studies have found that epithelial cells act as sensitive 
sensors of infection or injury which subsequently initiate defence mechanisms in the 
form of cytokine or chemokine secretion. Epithelial cells are in an ideal position for 
this function (Stadnyk, 1994).
The gastric epithelium forms a highly organised layer which covers the free surfaces 
of the body. The apical surface is the free surface of the cell and the basal surface 
rests on a basement membrane (Stadnyk, 1994). Therefore, gastric epithelial cells 
play a major role in providing protection to gastric tissues from external irritants, 
secrete hormones and enzymes which aid in digestion, act as detectors of foreign 
particle invasion and trigger the immune system to combat the infection or 
inflammation. Sometimes the responses may become excessive and this leads to 
inflammatory conditions which provide the basis for various pathological diseases in 
the stomach.
Gastric pits which consist of gastric glands (Fig.3), occupy the luminal surface of the 
mucosa. The main gastric glands are located in the fundus and body parts of the 
stomach and consist of highly differentiated cells with at least 4 cell types and 
undifferentiated cells (Williams et al., 1989).











8The cells in the main gastric glands are:




v) undifferentiated columnar cells
i) Mucus neck cells
These cells are found at the necks of the gastric glands. Their role is to secrete mucus 
which aids in food lubrication, transports hydrogen and bicarbonate ions and 
prevents mechanical damage to the surface of the gastric mucosa (Ye et al., 1997).
ii) Parietal/oxyntic cells
These cells are large, round, eosinophilic and have a characteristic ‘fried egg’ 
appearance. They are mostly found on the side walls of the gastric glands and near 
their ducts. Parietal cells have a large, round, central nucleus and very dense 
mitochondria packed closely together in the cytoplasm. The function of the parietal 
cells are to secrete chloride and hydrogen ions in the acid secretions of the stomach 
as well as a protein called intrinsic factor which is needed for vitamin B12 absorption.
ii) Chief/peptic/zymogenic cells
These cells are mostly found in the basal part of the gastric gland and appear 
cuboidal in shape. Unlike the parietal cells, they contain many secretory vacuoles 
and have a lot of granular endoplasmic reticulum and a distinct Golgi complex. 
These cells function to produce gastric digestive enzymes such as pepsinogen which 
digests protein.
9iv) Entero-endocrine/argentaffin/enterochromaffm cells
These cells are found in all types of gastric glands but more so in the body and 
fundus. They can usually be found in the deeper parts of the gastric gland between 
the chief cells and the basal lamina or lamina propria into which they discharge their 
products. They have irregular nuclei with a granular cytoplasm and a well-developed 
rough endoplasmic reticulum and Golgi membranes. These cells produce peptide 
hormones and vasoactive amines in addition to the peptides gastrin and somatostatin. 
Gastric motility is increased by gastrin which also increases the secretion of 
hydrochloric acid and pepsinogen. Somatostatin can inhibit the function of gastrin 
and other hormones. Insulin and glucagon producing cells are also found in the 
stomach which are directly involved in the regulation of insulin. Histamine, which 
stimulates gastric secretions and increases vascular permeability is also secreted by 
the entero-endocrine cells together with a hormone serotonin which can inhibit the 
role of histamine.
v) Undifferentiated columnar cells
The low number of undifferentiated cells appear to be the stem cells which undergo 
cell division and differentiation which replace the other cell types in the gastric 
glands.
The gastric glands differ slightly in their composition depending on their position, 
whether they are in the cardiac, main or pyloric parts of the stomach. In different 
locations in the stomach, the gastric gland differs slightly in its cellular composition. 
At the proximal and distal ends of the stomach, there are mostly mucus cells. The 
gastric pits and glands in the cardiac region are short, tubular glands whereas in the 
pyloric region, the glands are longer, coiled and more branched. No parietal or chief 
cells are present in the cardiac or pyloric regions of the stomach. The entero- 
endocrine cells are mostly found in the pyloric region (Borysenko et al., 1989; 
Williams et al., 1993).




The cardia is located in the first part of the stomach below the part where the 
oesophagus joins the stomach. It is made up of simple tubular or cystic glands lined 
by mucus secreting cells. There are also many endocrine cells which secrete 
hormones and a few scattered parietal and chief cells (Dixon, 1996).
• Body mucosa
The part of the stomach defined histologically as the body mucosa occupies the 
proximal two-thirds of the stomach and is made up of tightly-packed tubular glands. 
The upper parts of the glands comprise of parietal cells and the lower parts of the 
gland are made up of chief cells. There are also mucus neck cells at the bases of the 
gastric pits and endocrine cells which are also called enterochromaffin cells (Dixon,
1996).
• Antral mucosa
Antral mucosa is found in a triangular part proximal to the pylorus in the last part of 
the stomach. The glands in the antral mucosa are more branched, tortuous and less 
tightly packed than the body mucosa. There are mucus-secreting cells, endocrine 
cells and parietal cells lining the glands. The endocrine cells secrete several types of 
hormones. The G cells secrete gastrin, the D cells secrete somatostatin, the EC 
(enterochromaffin) cells secrete 5-hydroxytryptamine, 5-HT, the P cells secrete 
bombesin and the S cells secrete secretin (Dixon, 1996; Calam, 1999).
1.3 GASTRIC SECRETIONS
The mucus secreted by the columnar mucus-secreting cells on the surface of the 
gastric mucosa and its pits, together with the mucus from the antral mucus glands 
create a viscid gel called the gastric mucus barrier which covers the gastric mucosa. 
The surface epithelial cells also secrete bicarbonate and sodium ions which diffuse 
into the gel, buffering the hydrogen ions which enter from the luminal part of the
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stomach. As a result of this, a pH gradient is achieved, whereby the pH is 1 or 2 at 
the luminal surface of the barrier and neutral at the epithelial plasma membrane 
(Dixon, 1996).
Food digestion is achieved by the release of hydrochloric acid and pepsin from the 
parietal and chief cells respectively. These gastric secretions are regulated by the 
hormones gastrin and somatostatin as well as the vagal nerve system. Gastrin, 
released from the antral G cells stimulates the parietal cells directly to release gastric 
acid and indirectly by stimulating the enterochromaffin cells in the gastric body, near 
the parietal cells to release histamine (Kandel, 2000). Conversely, somatostatin 
released by the D cells in the gastric antrum antagonises the effect of the gastrin 
hormone. An overproduction of gastrin, due to the presence of H. pylori or the 
Zollinger-Ellison disease results in an overproduction of gastric acid resulting in 
gastric ulcers.
Other hormones secreted by the gastric cells are 5-hydroxytryptamine, 5-HT which is 
secreted by the enterochromaffin cells, bombesin which is secreted by the P cells and 
secretin which is secreted by the S cells (Dixon, 1996).
1.4 THE IMMUNE SYSTEM
When a foreign bacteria or particle invades the body, the body‘s immune system is 
triggered into action to dispose of the foreign bacteria or particle. The immune 
mechanisms can be divided into:
a) the innate/natural/native immunity and
b) the specific/adaptive immunity
a) The native/innate/natural immunity
The native immunity is the first line of defence against microbes and recognizes 
particles which are foreign to the host. Subsequently, it launches an attack against the 
invader. This type of immunity is limited in diversity and functions in the same way 
against most microbes without distinguishing one microbe from the other. It is very
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efficient, however, some organisms have developed mechanisms to evade the innate 
immunity. Therefore, the innate immunity can also induce the specific immune 
responses to eliminate the microbes. The components of the innate immunity are:
i) physical and chemical barriers such as epithelia and antimicrobial substances 
produced at the epithelial surfaces such as defensins
ii) blood proteins including the complement system and mediators of 
inflammation
iii) phagocytic cells such as neutrophils, macrophages and other leukocytes such 
as natural killer cells
(Abbas et al., 1997; Eales, 1997; Staines et al., 1993).
b) The specific/adaptive immunity
The specific/adaptive immunity is more highly evolved and is triggered by exposure 
to infectious agents. The magnitude and defensive capabilities of the specific 
immunity increases with each exposure to a particular microbe. This is called an 
immunologic memory.
The specific immune system is made up of B lymphocytes, T lymphocytes and 
antibodies which are the products of B lymphocytes. The T lymphocytes can be 
subclassed into helper T lymphocytes, cytotoxic lymphocytes and natural killer cells.
B lymphocytes produce antibodies for the humoral immunity. T helper lymphocytes 
stimulate B cell growth and differentiation and activate macrophages by secreted 
cytokines.
Helper T lymphocytes can be subdivided again into Thl and Th2 cells depending on 
the types of cytokines produced by the activated Th cells (Wells et al., 1998). T 
suppressor cells suppress immune responses whereas Th2 cells help B cells to make 
antibodies by synthesising and secreting cytokines which activate the growth and
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differentiation of B cells. Thl produce cytokines such as interleukin-2 (IL-2), tumour 
necrosis factor alpha (TNF-a), interferon-gamma (IFN-y) and interleukin-12 (IL-12). 
Th2 cells secrete interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-10 (IL-10) and 
interleukin-13 (IL-13) (Wells et al., 1998). Thl cytokines are implicated in 
rheumatoid arthritis and delayed-type hypersensitivity reactions while Th2 cytokines 
are involved in allergic inflammatory diseases such as asthma and atopic dermatitis.
1.5 CYTOKINES
Cytokines are a group of highly potent, low molecular weight (8-25 kDa) proteins 
which can mediate the growth of cells, inflammation, immunity, differentiation and 
repair. Most cytokines are secreted soluble and bind to specific receptors (Stadnyk, 
1994). Cytokines usually act locally but may have autocrine and paracrine roles. 
Cytokines usually have cascade and network effects on the expression of other 
cytokines, therefore, even low concentrations of cytokines may result in amplified 
results and effects. Cytokines can be classed into different groups:
i) interleukins
ii) colony stimulating factors
iii) tumour necrosis factors
iv) chemokines
v) others
Cytokines are produced briefly during the activation and effector phases of innate 
and specific immunity and mediate and regulate immune and inflammatory 
responses. They are produced by diverse cell types such as by immune cells 
including lymphocytes, B cells, macrophages, natural killer cells, T cells, monocytes 
and non immune cells such as fibroblasts, endothelial cells, astrocytes and epithelial 
cells. They act on many cell types (pleotropic) but may also have different effects on 
the same cell. IL-1 and TNF-a are examples of pleiotropic cytokines which have 
many similarities in the biological activities which they induce. Many cytokines 
usually have redundant and overlapping actions (Staines et al., 1993).
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The expression of cytokines by gastric epithelial cells during inflammatory 
conditions and in disease such as in patients infected with the bacteria H. pylori, 
suggests that there is an interaction between epithelial cells and the immune system 
and that cytokines act as communication molecules between these cells. Therefore, 
there is interest in controlling the expression of cytokines and chemokines by the 
epithelial cells in order to control inflammatory diseases.
1.5.1 Interleukin-1 (IL-1)
Interleukin-1 (IL-1) is a mediator of the host inflammatory response in innate 
immunity. The activated mononuclear phagocyte (monocyte) is the major cellular 
source of IL-1. Bacterial lipopolysaccharide (LPS), macrophage-derived cytokines 
such as IL-1 or TNF-a and CD4+ T cells can trigger the production of IL-1. IL-1 can 
also be produced by many types of cells such as epithelial cells, fibroblasts, 
astrocytes, B cells and endothelial cells, although most of it is produced by 
macrophages (Kolios et al., 1995) and lymphocytes (Stadnyk, 1994). There are 2 
forms of IL-1 which are IL-1 a  and IL-1 p. Both of them are 17 kDa polypeptides but 
share very little homology with each other, although they both have identical 
biological activities. This is since they both bind to the same IL-1 receptor types 
(Stadnyk, 1994). IL-1 does not activate inflammatory neutrophils directly but 
stimulates the synthesis of chemokines by mononuclear phagocytes and endothelial 
cells which activate leukocytes. In larger quantities, the expression of IL-1 can exert 
endocrine effects such as fevers, the synthesis of acute phase plasma proteins by the 
liver and induce metabolic wasting/cachexia.
1.5.2 Tumour necrosis factor (TNF-a)
Tumour necrosis factor-a (TNF-a) is the main mediator of the response to gram- 
negative bacteria and other infectious organisms. TNF-a is secreted by a number of 
cell types including monocytes, antigen stimulated T cells, activated natural killer 
(NK) cells, normal B cells, B-lymphoblastoid cells and activated mast cells. Other 
‘non-immune’ cells that produce TNF-a are fibroblasts, smooth muscle cells, 
astrocytes, osteoblasts, retinal pigment epithelial cells, gastric epithelial cells
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(Nakachi et al., 2000) and others (Aggarwal et al., 1996). TNF-a mediates the innate 
and specific immunity and links the specific immune responses with acute 
inflammation. TNF-a is 17 kDa cytokine (Van Deventer, 1998) and in small 
quantities, it can act as a paracrine and autocrine regulator of leukocytes and 
endothelial cells. Inducers of TNF-a include gram-positive and negative bacteria, 
cytokines (IL-1, IL-2, IFN-y) and others (Le et al., 1987; Larrick et al., 1988). TNF-a 
can be down-regulated by cytokines such as interferon-a and p (IFN-a/p), IL-4, IL- 
6 , IL-10, transforming growth factor-p and granulocyte colony stimulating factor. 
TNF-a is also down-regulated by viruses such as the Epstein-Barr virus, and 
adenovirus proteins and drugs such as cyclosporin A and dexamethasone among 
others. Some of the functions of TNF-a are to stimulate mononuclear phagocytes 
and other cells to secrete chemokines which recruit leukocytes, to activate the killing 
of microbes by inflammatory leukocytes and to stimulate the secretion of IL-1 and 
IL-6  into the circulation by mononuclear phagocytes and vascular endothelial cells.
TNF-a has been demonstrated to play a role in normal physiological processes such 
as haematopoiesis, inflammation, reproduction and protection against infection. It 
also has a clinical role in cancer chemotherapy, when used in conjunction with 
interferon-y (IFN-y) and chemotherapeutic drugs (Aggarwal et al., 1996). However, 
most of its actions are proinflammatory (Ebert, 1998). TNF-a increases the 
inflammation by inducing IL-1 production (Le et al., 1987).
In patients with H. pylori infection, TNF-a levels were higher in the gastric mucosa 
than in patients who were H. pylori negative (Yamaoka et al., 1996; Yamaoka et al.,
1997). CagA+ strains of H. pylori induced more cytokines compared to the CagA' 
strain (Peek et al., 1995).
1.5.3 Interferon
Interferon (IFN) is a group of polypeptides of 18 kDa. IFN is mostly produced by 
mononuclear phagocytes (Abbas et al., 1997) and activated Thl lymphocytes 
(Warhurst et al., 1998), B cells, epithelia, fibroblasts as well as natural killer cells 
(Kolios et al., 1995). There are three forms of interferons which are IFN-a, IFN-p
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and IFN-y although IFN-y does not show significant homology to the other two IFNs. 
IFN-y synthesis is inhibited by vitamin D3, dexamethasone and Cyclosporin A, 
conversely IL-2, basic fibroblast growth factor (BFGF) and endothelial growth-factor 
(EGF) induce the synthesis of IFN-y (De Maeyer et al., 1992; Farrar et al., 1993). 
IFN-y acts in synergy with other pro-inflammatory cytokines for example, TNF-a to 
stimulate the secretion of chemokines in various systems (Warhurst et al., 1998). 
IFN-y has antiviral and antiparasitic properties while also inhibiting the proliferation 
of some normal and transformed cells. However, immunomodulation seems to be the 
main biological activity of IFN-y. It is moderately useful when used in conjunction 
with other IFNs and chemotherapy to treat cancer since it inhibits cell proliferation 
(Kardamakis, 1991; Emstoff et al., 1992; Schiller et al.,1992). This cytokine is used 
to regulate the Thl and Th2 responses in activating mononuclear cells (Sawai et al., 
1999) which control infections in the long-term. IFN-y is not secreted by epithelial 
cells during infections. During an infection, pathogens stimulate epithelial cells to 
secrete cytokines, chemokines and stress proteins that attract neutrophils. The stress 
proteins stimulate the lymphocytes to secrete IFN-y, IL-2, IL-4, IL-9 and IL-13 
around the epithelial cells which stimulate the expression of adhesion molecules on 
the epithelial cell. The neutrophils then bind to the adhesion molecules on the 
epithelial cells and ingest the foreign organisms (Strober, 1998). IFN-y is involved in 
gastric inflammation caused by H. pylori infection although it might also have a role 
in protection from H. pylori. The suggested protective mechanism of IFN-y is to 
increase the intensity of the antigen-presenting cell function of gastric epithelial cells 
(Sawai et al., 1999) possibly through the up-regulation of the class II major 
histocompatibility complex (Ye et al., 1997).
1.5.4 Interleukin-4 (IL-4!
IL-4 is a 20kDa cytokine and is a member of the 4-a-helical cytokine family. It 
regulates the IgE and mast cell/eosinophil-mediated immune reactions. IL-4 is 
produced by CD4+T lymphocytes specifically of the Th2 subset, mast cells, basophils 
and CD8+ T cells.
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The actions of IL-4 are:
a) to aid in the production of IgE and is the main cytokine that stimulates the 
switching of B cells to this heavy chain isotype
b) as a factor for growth and differentiation for T cells, especially for the Th2 subset
c) to stimulate the expression of vascular cell adhesion molecule-1 (VCAM-1) on 
endothelial cells increasing the binding of lymphocytes, monocytes and 
eosinophils
d) as a growth factor for mast cells and to stimulate mast cell proliferation together 
with IL-3
IL-4 inhibits the production of inflammatory cytokines such as IL-1, IL-6  and TNF-a 
by monocytes and TNF-a by T cells. Therefore, it is useful in the regulation of 
inflammatory diseases and autoimmune diseases. EL-4 also inhibits the growth of 
colon and mammary tumours, hence it may also be used in the treatment of solid 
tumours (Dullens et al., 1991, Toi et al., 1992).
1.5.5 Interleukin-13 (IL-13)
Interleukin-13(IL-13) is a recent addition to the T helper (Th2) family of cytokines. 
IL-13 is distantly related to IL-4 as they both belong to the a-helix family of proteins 
and they both share some similar structural characteristics (Brombacher, 2000). IL- 
13 is produced by activated T lymphocytes, mainly Th2 cells, mast cells, basophils, 
dendritic cells and natural killer cells (Zurawski et al., 1994). It is not expressed in 
the heart, brain, placenta, lung, liver and skeletal muscle tissues. IL-13 has 
immunomodulatory effects on a variety of different types of cells such as monocytes, 
macrophages, natural killer cells, fibroblasts, eosinophils, airway smooth muscle 
cells and endothelial cells. IL-13 could potently suppress the cytokine and 
chemokine generation by activated monocytes and macrophages (Minty et al., 1993; 
Zurawski et al., 1994) and endothelial cells (Marfaing-Koka et al.,1995). It has also 
been shown to up-regulate some of the integrin superantigen family (adhesion 
molecules) which induce the trafficking of these cells. EL-13 has both 
immunosuppressive and anti-inflammatory properties (Minty et al., 1993). Some of
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the cytokines that IL-13 are known to inhibit include IL-1, IL-6 , IL-8 , IL-10, IL-12, 
TNF-a, GM-CSF, G-CSF and chemokines such as IL-8/CXCL8 , MCP-1/CCL2, 
MIP-la/CCL3, RANTES/CCL5, MCP-3/CCL7 and eotaxin/CCLl 1 in response to 
IFN-y or bacterial lipopolysaccharides. Due to their immunomodulatory and anti­
inflammatory properties, IL-13 and IL-4 show great promise to be used in the 
treatment of chronic inflammatory diseases.
1.5.6 The effect of IL-4 and IL-13 on cytokines secreted by cell lines
It has been suggested that IL-4 and IL-13 are anti-inflammatory cytokines. The 
inhibitory effect of IL-13 could be a result of enhancement of the IL-1 receptor 
antagonist (IL-lra) and soluble receptors and a direct inhibition of chemokine 
transcription (Muzio et al., 1994). However, the converse was found to be true in 
some types of cells. Therefore, IL-13 has a bifunctional role depending on the stimuli 
and chemokines being investigated (Kolios et al., 1996).
1.6 CHEMOKINES
Chemoattractant cytokines, collectively known as chemokines are a family of low- 
molecular weight proteins (8-14 kDa), consisting of 70-100 amino acids (Baggiolini 
et al., 1994; Horuk et al., 1994; Rollins, 1997; Balkwill, 1998, Nagasawa et al., 1998; 
Pelchen-Matthews, 1999). Traditionally, the main known role of chemokines was to 
attract the migration of many types of leukocytes including neutrophils, T cells, 
monocytes, natural killer cells, basophils, eosinophils and mast cells to the sites of 
inflammation or infection. This was achieved by the activation of cell adhesion 
molecules which regulate the activation and movement of leukocytes (Zack Howard 
et al., 1996). Leukocyte migration is important for immune surveillance of the tissues 
of the body and for focusing immune cells to the site of the antigenic challenge. 
Leukocyte migration is dependent on the actions of various adhesion molecules, 
chemokines and their receptors (Qin et al., 1997; Sallusto et al., 1998).
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Different chemokines attract different leukocytes. Leukocytes travel to the site of 
infection or injury in the blood. Leukocytes roll along the endothelial cells which 
make up the walls of the blood vessels (Fig.4). When the leukocytes reach the site of 
infection or injury, intercellular adhesion molecules (ICAM-1/CD54) are expressed 
on the surface of the endothelial cells as well as the leukocytes which enable the 
leukocytes to attach themselves to the endothelial cells. Following this, the 
leukocytes migrate or enter the site of injury or infection by squeezing in between the 
endothelial cells. These leukocytes then attach themselves via the adhesion 
molecules(ICAM-l/CD54) expressed on the gastric epithelial cells and cause 
inflammatory processes to occur at the gastric mucosa (Crowe et al., 1995).
Some examples of specific chemokines which attract leukocytes are SDF- 
la/CXCL12 which attracts most peripheral blood lymphocytes and LARC/CCL20 
attracts memory CD4+ T cells (Campbell et al., 2000). Apart from inducing 
inflammatory conditions by attracting leukocytes, chemokines may also have other 
basic functions in the immune system which are not directly related to the 
inflammatory processes. These other functions include regulation in the trafficking of 
immature blood cells and naive lymphocytes (Chang et al., 1999; Kim et al., 1999).
It is now known that chemokines are not only expressed by ‘immune’ cells such as 
monocytes, macrophages, dendritic cells but can be expressed by other types of ‘non- 
immune’ cells such as fibroblasts, epithelial cells, stromal cells from many sources, 
keratinocytes, chondrocytes, mesangial cells, endothelial cells and smooth muscle 
cells (Baggiolini et al., 1994; Luster, 1998; Kim et al., 1999). These cells produce 
chemokines when they are subjected to the appropriate conditions and stimulations 
and these chemokines are expressed constitutively or in an inducible manner. 
Constitutively expressed chemokines are important for cell homing and the 
trafficking of leukocytes under normal conditions, whereas inducible chemokines 
mediate inflammatory and immune responses (Sallusto et al., 1998; Sozzani et al., 
1999).
More recently, it has been realised that chemokines had effects on cells other than 
leukocytes. Chemokines may affect the migration and proliferation of endothelial 
cells which is important in angiogenesis and angiostasis and may also affect the
Fig.4 A d ia g ram  o f leukocyte m ig ra tion  to the site o f in ju rv /in fec tio n
Leukocyte
A) Leukocyte rolling along the endothelial cells B) Adhesion C) M igration/Extravasation
ENDOTHELIAL CELL ■
Adhesion molecule
Release of inflammatory chemokines




B: Adhesion molecules (eg. ICAM-1, VCAM-1) tether the leukocytes to the endothelial walls 
C: Leukocytes migrate to the site o f injury/infection
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migration of smooth muscle cells which may be important in atherosclerosis 
(Stemme & Hansson, 1994). The responses induced by the chemokines include 
chemotaxis, release of enzymes from intracellular stores, formation of oxygen 
radicals, a change of shape through cytoskeletal rearrangements, generation of lipid 
mediators and adhesion to endothelium or extracellular matrix protein.
The main biological activities of chemokines include directing the movement of 
leukocytes, angiogenesis and angiostasis, Thl/Th2 development, wound healing, cell 
recruitment, lymphoid organ development and haematopoiesis. Apart from a role in 
immunoregulation, chemokines are also involved in inflammatory and disease states 
(Schall et al., 1994) such as in inflammation and tumour metastasis. Examples of 
inflammatory diseases that are associated with the expression of chemokines are 
glomerulonephritis (Brown et al., 1996), rheumatoid arthritis (Koch et al., 1992), 
asthma (Teran et al., 1996) and inflammatory bowel disease (Grimm et al., 1996). 
During inflammation, chemokines have been detected in most organs and in many 
types of cells. Therefore, many types of cells can secrete the chemokines in response 
to the appropriate stimuli such as pro-inflammatory cytokines including IL-1 and 
TNF, bacterial lipopolysaccharides (LPS) and viral infections, IFN, IL-4 and Thl 
and Th2 products (Strieter, 1996; Luster, 1998). Conversely, chemokine expression 
can be down-regulated by anti-inflammatory cytokines such as IL-10 (Karakurum et 
al., 1994), IL-4 and IL-13 (Kolios et al., 1999).
IL-8/CXCL8 and DMO/CXCLIO modulate the proliferation and migration of smooth 
muscle cells, on the contrary, MCP-1/CCL2 increases the proliferation of smooth 
muscle cells (Xu et al., 1996) and upregulates intercellular adhesion molecules 
(ICAM-1). MCP-1/CCL2 also encourages coagulation activities which stimulate the 
formation of thrombosis in atherosclerotic plaques (Yla-Herttuala et al., 1991). SDF- 
la/CXCL12 also is a chemoattractant in glial and endothelial cells (Murdoch, 2000).
There are 4 main chemokine subfamilies which are the ‘CXC’ (a), ‘CC’ (P), ‘C’ (y) 
and ‘CX3C’ (5) families (Shimada et al., 1998; Sato et al., 1999). This distribution of 
chemokines into the various families is based on the 4 cysteines (represented by the 
letter ‘C’) in the terminal amino section of the chemokine molecule which are linked
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by disulphide bonds (Bliss et al., 1998) to the more structured core of the molecule 
(Mantovani, 1999). The exception to this rule is the chemokine which belongs to the 
‘C’ family which is called lymphotactin which only has 2 cysteines. The letter ‘X’ 
represents an amino acid (Fig.5).
1.6.1 CXC chemokines
These chemokines have 4 cysteine residues which are separated by a single amino 
acid (Schrum et al., 1995; Van Deventer, 1997). The ‘CXC’ (a) chemokines can be 
further subdivided into those which contain the glutamic acid-leucine-arginine 
(‘ELR’) sequence between the N-terminus and the first cysteine and those which do 
not (Rollins, 1997; Zlotnik et al., 2000). The ‘ELR’-containing ‘CXC’ chemokines 
exert angiogenic effects while the non-‘ELR’ ‘CXC’ chemokines exert angiostatic 
effects (Strieter et al., 1995). However, there is an exception to this rule, whereby 
SDF-la/CXCL12, a non-‘ELR’ ‘CXC’ chemokine exhibits angiogenic activity 
(Schnyder-Candryan et al., 1995; Romagnani et al., 2001). The ‘ELR’ ‘CXC’ 
chemokines have an ability to bind to a shared chemokine receptor, CXCR2, (Schall 
et al., 1994) conversely the ‘CXC’ chemokines without the ‘ELR’ motif bind to the 
receptors CXCR3, CXCR4 and CXCR5 (Zlotnik et al., 1999). These chemokines are 
produced by activated mononuclear phagocytes, tissue cells such as endothelial cells, 
fibroblasts and megakaryocytes and typically attract neutrophils (Baggiolini et al., 
1994; Shimoyama et al., 1994; Raport et al., 1996) in acute inflammatory conditions. 
The ‘CXC’ chemokines without the ‘ELR’ motif attract T lymphocytes (Mantovani, 
1999). ‘CXC’ chemokines are associated with acute inflammatory states such as 
acute respiratory distress syndrome and septic shock (Wells et al., 1998). IL- 
8/CXCL8 is the “prototype” CXC chemokine and was the first one to be identified. 
Many studies have been performed to study this chemokine.
Fig.5 Schematic diagrams of chemokine families
I) CC chemokine family
NH CC
C = cysteine 
X = any amino acid 
E = glutamic acid (specific amino acid) 
L = leucine (specific amino acid)
R = arginine (specific amino acid)
NH2 = amino 
H = hydrogen 
O = oxygen
C C COOH
II) CXC chemokine family
NH ELRCXC —C C COOH
NH- CXC € C COOH tou>
III) C chemokine family
NH C COOH
IV) CX3C chemokine family
Long stalk
NH CXXXC c c
'^-C O O H
24
1.6.2 CC chemokines
In the ‘CC’ (p) chemokine family, the cysteine residues are adjacent to one another 
(Schrum et al., 1995; Van Deventer, 1997). The ‘CC’ chemokines are produced by T 
cells which have been activated and they stimulate eosinophils, basophils, 
monocytes, dendritic cells, natural killer cells and T cells (Raport et al., 1996; 
Mantovani, 1999). The ‘CC’ chemokines do not act upon neutrophils. These 
chemokines are associated with chronic inflammatory diseases such as asthma, 
arthritis and atherosclerosis (Wells et al., 1998).
Recently, novel ‘CC’ chemokines such as TARC/CCL17 and LARC/CCL20 have 
been discovered. They have features which distinguish them from the traditional 
‘CC’ chemokines which are their constitutive expression in some tissues, specificity 
for lymphocytes, interaction with receptors highly specific for each chemokine and 
the chromosomal gene loci different from the traditional ‘CC’ chemokine gene 
cluster (Yoshie et al., 1997).
1.6.3 C chemokines
This subfamily of chemokines is also known as the y family (Gale et al., 1999). This 
family lacks the first and third cysteines in the typical chemokine structure and has 
only 2 cysteine residues (Rossi et al., 2000). It has two members which are 
lymphotactin (XCL1) and SCM-lp (XCL2). Lymphotactin is chemotactic for 
lymphocytes (Shimoyama et al., 1999), B and T cells and natural killer cells but it 
does not attract neutrophils or monocytes (Schall et al., 1994).
1.6.4 CX^C chemokines
The fourth chemokine subfamily is the ‘CX3C’ (8) family which has 3 amino acids in 
between the 2 cysteines in the amino terminal. An example of the chemokine in this 
family is fractalkine, also called neurotactin. This chemokine attracts monocytes,
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natural killer cells and T cells (Bazan, 1997; Mantovani, 1999). Fractalkine is the 
only chemokine to be attached to the membrane by a mucin-like stalk (Mahalingam 
et al., 1999; Zlotnik et al., 2000).
1.7 CHEMOKINE NOMENCLATURE
Recently, a new nomenclature system for chemokines was proposed by Dr Osamu 
Yoshie (Kinki University, Japan) at the 1999 Keystone Conference. This has now 
been agreed by the other international chemokine experts (Zlotnik et al., 2000). This 
nomenclature was proposed to minimise the confusion associated when a chemokine 
was given a variety of different names. This new nomenclature is based on the 
previous chemokine receptor nomenclature except where ‘L’ (for ligand) is used 
instead of ‘R’ (for receptor). The numbering system used in the new nomenclature is 
the same one as that presently used to specify the genes encoding each chemokine. 
This new nomenclature system also shows the subfamily where each chemokine 
belongs.
In this section, the chemokines which have been studied in the reverse-transcription 
polymerase chain reaction (RT-PCR) experiments are explained in more detail. The 
expression of these chemokines were examined in the AGS and MKN45 gastric 
epithelial cell lines as well as in human gastric biopsies taken from patients with 
different pathological states.
26













CXCL1 GRO-a/MGSA-a CXCR1 ,CXCR2 Neutrophils
CXCL2 GRO-P, MGSA-p CXCR2 Neutrophils
CXCL3 GRO-y/MGSA-y CXCR2 Neutrophils
CXCL4 PF4 unknown Fibroblasts
CXCL5 ENA-78 CXCR2 Neutrophils
CXCL6 GCP-2 CXCR1, CXCR2 Neutrophils
CXCL7 NAP-2 CXCR2 Neutrophils
CXCL8 IL-8 CXCR1, CXCR2 Neutrophils
CXCL9 Mig CXCR3 Activated T cells, 
natural killer cells
CXCL10 IP-10 CXCR3 Activated T cells, 
natural killer cells
CXCL11 I-TAC CXCR3 Activated T cells, 
natural killer cells
CXCL12 SDF-la/p CXCR4 Resting T cells, 
dendritic cells, 
monocytes, B cells
CXCL13 BLC/BCA-1 CXCR5 B cells
CXCL14 BRAK/Bolekine unknown unknown
CXCL15 unknown unknown unknown
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CCL1 1-309 CCR8 T cells
CCL2 MCP-1/MCAF CCR2 Dendritic cells, 
basophils, 
monocytes, 
activated T cells 
and natural killer 
cells
CCL3 MIP-l(x/LD78a CCR1, CCR5 Monocytes, natural 
killer cells, 
activated T cells, 
dendritic cells
CCL4 MIP-lp CCR5 Monocytes, 
activated T cells , 
dendritic cells, 
natural killer cells





activated T cells, 
dendritic cells, 
natural killer cells
CCL6 Unknown unknown unknown





activated T cells, 
natural killer cells
28












CCL8 MCP-2 CCR3 Basophils, 
monocytes, 
activated T cells, 
dendritic cells, 
natural killer cells
CCL9/CCL10 Unknown unknown unknown
CCL11 Eotaxin CCR3 Eosinophils, 
basophils, dendritic 
cells
CCL12 Unknown CCR2 unknown
CCL13 MCP-4 CCR2, CCR3 Eosinophils, 
basophils, 
monocytes, 
activated T cells, 
dendritic cells, 
natural killer cells
CCL14 HCC-1 CCR1 Monocytes
CCL15 HCC-2, LKN-1, 
MIP-15
CCR1, CCR3 unknown
CCL16 HCC-4, LEC CCR1 Monocytes,
lymphocytes
CCL17 TARC CCR4 T cells
CCL18 DC-CK1,PARC,
AMAC-1
unknown Naive T cells
CCL19 MIP-3p/ ELC/ 
Exodus-3
CCR7 Naive T cells, 
dendritic cells
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CCR7, CXCR3 T cells, B cells
CCL22 MDC/STCP-1 CCR4 Dendritic cells, T 
cells
CCL23 MPIF-1 CCR1 Monocytes, resting 
T cells, neutrophils
CCL24 MPIF-2/Eotaxin-2 CCR3 Basophils
CCL25 TECK CCR9 Macrophages, 
thymocytes, 
dendritic cells
CCL26 Eotaxin-3 CCR3 unknown





XCL2 SCM-lp XCR1 unknown
CX3C chemokine
CX3CL1 Fractalkine CX3CR1 unknown
Abbreviations: 6 Ckine (CCL21) = Six-cysteine chemokine; BCA-1(CCL13) = B- 
cell-attracting chemokine 1; BLC(CXCL13) = B lymphocyte chemoattractant; 
ELC(CCL19) = EBV-induced genel-ligand chemokine; DC-CK1(CCL18) = 
dendritic cell chemokine; ENA-78 (CXCL5) = 78-amino acid epithelial cell-derived 
neutrophil activator; ELC(CCL19) = EBI1-ligand chemokine; FLK(CX3CL1) = 
fractalkine; GCP-2(CXCL6) = granulocyte chemoattractant protein 2; GCP- 
2(CXCL6) = granulocyte chemotactic protein-2; GRO(CXCL 1,2,3 for a,p,y ) =
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growth-related oncogene; HCC-1(CCL14) = haemofiltrate CC chemokine 1; 
I309(CCL1) = inducible 309; IL-8 (CXCL8) = Interleukin-8 ; IP-IO(CXCLIO) = 
interferon y-inducible protein 10; IT AC = interferon-inducible T cell a  
chemoattractant; LARC(CCL20) = liver and activation-regulated chemokine; 
LEC(CCL16) = liver-expressed chemokine; LKN-1(CCL15) = leukotactin-1; 
LT(XCLl) = lymphotactin; MCP(CCL2,CCL7, CCL8 , CCL13 for MCP-1,2,3 and 4 
respectively) = monocyte chemotactic protein; MDC(CCL22) = macrophage-derived 
chemokine; MGSA(CXCL1,2,3) = melanoma growth-stimulatory activity protein; 
MIG(CXCL9) = monokine induced by interferon-y; MIP(CCL3 and CCL4 for a  and 
P respectively) = macrophage inflammatory protein; MIPF-1,2(CCL23/CCL24) = 
myeloid inhibitory factor 1,2; NAP-2(CXCL7) = neutrophil-activating peptide 2; 
PARC(CCL18) = pulmonary and activation-regulated chemokine; PF-4 (CXCL4) = 
platelet factor-4; RANTES(CCL5) = regulated on activation normal T-cell expressed 
and secreted; SDF-1(CXCL12) = stromal cell-derived factor; SLC(CCL12) = 
secondary lymphoid tissue chemokine; TARC(CCL17) = thymus-and activation- 
regulated chemokine; TECK(CCL25) = thymus-expressed chemokine.
1.7.1 IL-8/CXCL8
CXCL8 was formerly known as Interleukin-8 (IL-8). The predominant form of IL- 
8/CXCL8 has 72 amino acids. It has 4 cysteines forming 2 intrachain disulphide 
bridges which link Cys-7 to Cys-34 and Cys-9 to Cys-50 (Baggiolini et al., 1992). 
IL-8/CXCL8 is expressed by ‘immune’ cells such as mononuclear phagocytes, 
monocytes, T lymphocytes, neutrophils as well as many types of ‘non-immune’ cells 
such as endothelial cells, fibroblasts, keratinocytes, synovial cells, chondrocytes, 
epithelial cells and tumour cells which secrete IL-8/CXCL8 in response to 
stimulation with pro-inflammatory cytokines including IL-1 a, IL-ip and TNF-a 
(Rollins, 1997; Baggiolini et al., 1992). IL-8/CXCL8 has been shown to recruit 
neutrophils in several pathological conditions such as in psoriasis, rheumatoid 
arthritis and adult respiratory stress syndrome. ‘ELR’ positive ‘CXC’ chemokines 
such as IL-8/CXCL8 contributes to tumorigenesis as a result of angiogenesis by 
causing migration and proliferation of endothelial cells (Moore et al., 1998; Moore et
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al., 1999; Strieter et al., 1995). The expression of IL-8/CXCL8 receptors on 
endothelial cells is controversial and some evidence indicate that IL-8/CXCL8 may 
have a direct role in angiogenesis (Salcedo et al., 2000).
IL-8/CXCL8 is one of the initial chemokines to be released by epithelial cells, 
mainly by parietal cells (Martin-Guerrero et al., 2000) when in contact with 
microorganisms, hence IL-8/CXCL8 was expressed by gastric epithelial cells which 
were infected by H. pylori (Kusugami et al., 1997; Suzuki et al., 1998; Yamaoka et 
al., 1998; Eck et al., 2000; Rieder et al., 2001). Following its release, IL-8/CXCL8 
induces an acute inflammatory response in the gastric epithelial cells by attracting 
neutrophils (Eckmann et al., 1993; Takagi et al., 1997). Gastric epithelial cell have 
also been shown to express IL-8 /CXCL8 when stimulated with pro-inflammatory 
cytokines (Sharma et al., 1995) or viable H. pylori (Aihara et al., 1997)
1.7.2 MIG/CXCL9 and IP-10/CXCL10
Both of these chemokines are expressed by monocytes, fibroblasts, endothelial cells 
and T cells. They do not have the ‘ELR’ structural motif in the N-terminal regions, 
and are angiostatic. This angiostatic property of these two chemokines renders them 
suitable for use in anti-tumour chemotherapy (Strieter et al., 1995). IP-10/CXCL10 
was found in higher levels in non-small cell lung cancer compared to 
adenocarcinoma and this resulted in angiostatic effects on the non-small-cell lung 
cancer (Arenberg et al., 1996, Keane et al., 1998). IP-10/CXCL10 is induced by IFN- 
y and TNF-a and is expressed by monocytes, endothelial cells, keratinocytes and 
fibroblasts. In H. pylori infected gastric mucosa, MIG/CXCL9 and IP-10/CXCL10 
have been shown to be expressed by the endothelial cells in the small gastric blood 
vessels and mononuclear cells at the sites of T cell infiltration (Eck et al., 2000). The 
receptor for MIG/CXCL9 and IP-10/CXCL10 is found on Thl cells, therefore these 
chemokines selectively recruit Thl cells at sites of inflammation with high 
production of IFN-y (Sallusto et al., 1998) and the Thl response contributes to 
gastric mucosal damage. MIG/CXCL9 and IP-10/CXCL10 were also expressed by 
untreated HT-29 colonic epithelial cells and HT-29 cells when they were stimulated
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with a combination of IL-la, TNF-a and IFN-y. In normal colonic biopsies, 
MIG/CXCL9 and IP-10/CXCL10 were also expressed (Jordan et al., 1999).
IP-10/CXCL10 is found in high levels in psoriatic plaques and areas of chronic 
inflammation (Zack Howard et al.,1996). It also plays an important role in delayed- 
type hypersensitivity reactions.
1.7.3 CXCL12/ SD F-la
SDF-la/CXCL12 is the only known ligand for the chemokine receptor CXCR4 and 
is expressed constitutively in many organs (Nagasawa et al., 1998; Mantovani, 
1999). In some cell types, SDF-la/CXCL12 secretion appears to be independent 
from the effects of pro-inflammatory cytokines (Bleul et al., 1996). SDF- 
la/CXCL12 stimulates the migration of endothelial cells and angiogenesis by 
CXCR4 despite SDF-la/CXCL12 not having the ‘ELR’ motif. It is an important 
chemokine involved in the development of an embryo as SDF-la/CXCL12 is 
responsible for haematopoiesis (B lymphopoiesis) and cardiogenesis (Nagasawa et 
al., 1998). A deficiency of SDF-la/CXCL12 has been shown to result in defects in 
the cardiac ventricular septum and red and white blood cells in embryos (Horuk,
1998). SDF-la/CXCL12 is normally expressed by fibroblasts, therefore it is widely 
found in various organs such as the brain, heart, lung, kidneys, thymus, spleen and 
liver. Although expressed constitutively in many tissues (Bleul et al., 1996; Sozzani 
et al., 1999; Murdoch, 2000), it was demonstrated that SDF-la/CXCL12 was 
decreased in hepatocellular carcinoma (HCC) and other gastrointestinal cancer 
tissues. It was also absent in pre-malignant colonic adenomas (Begumet et al., 1996). 
SDF-la/CXCL12 might have an immune surveillance role as it attracts resting T 
lymphocytes, monocytes and intraepithelial T cells. It also stimulates pre-B cell 
growth and encourages migration of B cells. SDF-la/CXCL12 is the ligand for the 
CXCR4/fusin chemokine receptor which is also a co-receptor for the HIV-1 virus, 
therefore it can inhibit the infection of the cells by the T-tropic strains of HIV 
(Zlotnik et al. 1999). SDF-la/CXCL12 is expressed on mucosal tissues which are 
highly relevant for the transmission and propagation of HIV (Agace et al., 2000).
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The involvement of CXCR4 in HIV-1 infection meant that therapy could be aimed at 
blocking CXCR4 using peptides or other agents or at regulating the expression of 
CXCR4 or SDF-loc/CXCL12 (Nagasawa et al., 1999).
1.7.4 BCA-1/ BLC/CXCL13
This chemokine was formerly known as B-cell attracting chemokine (BCA-1) and 
BLC (B lymphocyte chemoattractant) and is mostly found in the liver, spleen, 
Peyer’s Patches, mesenteric lymph nodes followed by lower levels in the lymph 
node, appendix, stomach, salivary gland and mammary gland (Barella et al., 1995; 
Legler et al., 1998). Possible sources of BCA-1/CXCL13 are dendritic cells and B 
lymphocytes. BCA-1/CXCL13 is highly expressed in primary and secondary 
lymphoid follicles and MALT lymphomas. BCA-1/CXCL13 attracts mature B cells 
that express its receptor, CXCR5 (Legler et al., 1998; Schaerli et al., 2000). Not 
many studies have been conducted on BCA-1/CXCL13, but BCA-1/CXCL13 is 
thought to act constitutively as a homing chemokine directing leukocyte trafficking 
in normal lymphoid tissue, however it is also induced by chronic H. pylori gastritis 
and in mucosal-associated lymphoid tissue (MALT) lymphomas in the stomach 
(Mazzucchelli et al., 1999). Therefore, BCA-1/CXCL13 has both a homeostatic and 
an inflammatory role.
1.7.5 MCP-1/CCL2
MCP-1/CCL2 (monocyte-chemotactic protein) is predominantly expressed by 
monocytes, vascular endothelial cells, smooth muscle cells, glomerular mesangial 
cells (Rovin et al., 1992), osteoblastic cells (Williams et al., 1992), fibroblasts, 
pulmonary epithelial cells (Standiford et al., 1991) and T cells. It is found in a variety 
of diseases such as granulomatous diseases, rheumatoid arthritis, inflammatory heart 
disease of the smooth muscle, endothelial and myocardial tissue, asthma, bone 
trauma and host responses to bacteria. MCP-1/CCL2 attracts monocytes in 
atherosclerosis which forms the basis of atherosclerotic plaques (Hayes et al., 1997). 
MCP-1/CCL2 in synergy with lipopolysaccharide may confer anti-tumour effects to
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melanoma cells (Singh et al.,1993) but MCP-1/CCL2 on its own does not have any 
anti-tumour effects (Zack Howard et al., 1996).
MCP-1/CCL2 mRNA was expressed in unstimulated HT-29, colonic epithelial cells 
as well as in HT-29 cells stimulated with a combination of IL-la, TNF-a and IFN-y. 
MCP-1/CCL2 mRNA was also found in normal colonic biopsies (Jordan et al., 
1999). In some gastrointestinal disease states such as Crohn’s disease and ulcerative 
colitis, MCP-1/CCL2 has been shown to be increased and is thought to be 
responsible for inducing macrophages and eosinophils to the site of disease (Van 
Coillie et al., 1999).
1.7.6 MIP-lct/CCL3
MIP-la/CCL3 mRNA was found in patients with H. pylori gastritis and there was 
positive correlation between the MIP-la/CCL3 levels and the influx of mononuclear 
cells (Yamaoka et al., 1998). There was hardly any expression of MIP-la/CCL3 in 
normal tissues. In contrast, HT-29 colonic epithelial cell line expressed constitutive 
MIP-la/CCL3 (Jordan et al., 1999). Patients with duodenal ulcer (DU) expressed 
higher levels of MIP-la/CCL3 in the antrum compared to the gastric body and vice 
versa for patients with gastric ulcer. Eradication of H. pylori decreased the levels of 
MIP-la/CCL3 to normal levels (Yamaoka et al., 1998; Sato et al., 1999), hence 
MIP-la/CCL3 maybe induced by H. pylori infection.
1.7.7 RANTES/CCL5
Most of RANTES/CCL5 is induced by IL -la  or TNF-a, RANTES/CCL5 is 
produced by T cells and it stimulates the chemotaxis of T cells, eosinophils, 
basophils, and mast cells. Histamine in allergic reactions can be induced by 
RANTES/CCL5, MCP-3/CCL7 and MCP-2/CCL8, although RANTES/CCL5 is 
expressed earlier.
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RANTES/CCL5 is often associated with diseases such as asthma, allergic rhinitis 
(Alam et al., 1993) and rheumatoid arthritis (Rathanaswami et al., 1993) In 
rheumatoid arthritis, it is expressed by human synovial fibroblasts. Interestingly, 
RANTES/CCL5 was also expressed in normal colonic biopsies (Jordan et al., 1999).
The role of RANTES/CCL5 in the gastric mucosa is confusing with conflicting 
reports. RANTES/CCL5 was present in H. />y/on-infected stomach mucosa 
compared to H. pylori negative mucosa (Kikuchi et al., 2000). However, Yamaoka et 
al. (1998) found that RANTES/CCL5 mRNA but not RANTES protein was 
associated with H. pylori infection. In patients infected with H. pylori gastritis, 
immunoinflammatory cells such mononuclear cells demonstrated strong 
RANTES/CCL5 expression (Eck et al., 2000; Kikuchi et al., 2000). However, there 
was no in vivo expression of RANTES/CCL5 in the control tissue mucosa and in the 
gastric epithelial cells (Eck et al., 2000). There are no differences between the 
expression of RANTES/CCL5 in patients with duodenal ulcer or gastric ulcer and 
RANTES/CCL5 was not associated with polymorphonuclear cells. RANTES/CCL5 
levels also did not decrease when H. pylori was eliminated (Sato et al., 1999). 
Therefore, more studies would have to be carried out to determine the role that 
RANTES/CCL5 plays in H. /?y/on-infected gastric mucosa.
1.7.8 MCP-3/CCL7
MCP-3/CCL7 is also known as monocyte-chemoattractant protein-3. It is produced 
by many tumour cell lines and regulates the secretion of protease by macrophages. It 
is important in the invasion and metastasis of cancer cells (VanDamme et al., 1992). 
MCP-3/CCL7 was also expressed by the HT-29 colonic epithelial cell line 
irrespective whether it was unstimulated or stimulated with a combination of IL -la, 
TNF-a and IFN-y. It was also found in normal colonic biopsies (Jordan et al., 1999).
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1.7.9 TARC/CCL17
The former name of CCL17 was thymus and activation-regulated chemokine 
(TARC). TARC is constitutively expressed in the thymus at high levels therefore it 
may be involved in the development of the thymus. However, it can also be detected 
in the lungs, colon and small intestine (Imai et al., 1996) but nothing is known about 
its role in the stomach. TARC/CCL17 has been shown to be important in the 
chemotaxis of T cells (Andrew et al., 1999).
1.7.10 LARC/ MIP-3a/CCL20
LARC/CCL20 was formerly known as macrophage inflammatory protein-3a, liver 
and activation-regulated chemokine (LARC) and Exodus (Tanaka et al., 1999). 
LARC/CCL20 is expressed by the liver, thymus, lymph nodes, appendix, tonsil, 
lungs and peripheral blood lymphocytes (Rossi et al., 1997; Hromas et al., 1997; 
Power et al., 1997). It is also expressed by foetal liver and lungs (Rossi et al., 1997). 
LARC/CCL20 can induce chemotaxis of the peripheral blood mononuclear cells, 
lymphocytes and dendritic cells (Hromas et al., 1997; Power et al., 1997.). 
LARC/CCL20 can also inhibit the haematopoietic progenitor cell proliferation 
(Hromas et al., 1997) and according to Campbell et al., (1998), it can also stimulate 
the adhesion of a subset of memory T cells. Some LARC/CCL20 is expressed 
constitutively to direct the flow of leukocytes under physiological conditions, some 
LARC/CCL20 is expressed in neoplasia and some LARC/CCL20 is expressed in 
response to microbial infections, inflammatory conditions and immune signals 
(Mantovani, 1999).
In normal mice, murine LARC/CCL20 mRNA was expressed in the colon and small 
intestine and in humans LARC/CCL20 mRNA was expressed in the appendix 
(Tanaka et al., 1999) and the intestine (Hieshima et al., 1997). LARC/CCL20 has 
been shown to attract lymphocytes and dendritic cells towards the intestinal epithelial 




Chemokine receptors, with the exception of the Duffy antigen receptor for 
chemokines (DARC), are G-protein-coupled, 7-transmembrane spanning-helical 
proteins (Fig.6 ) and are found predominantly on leukocytes but are also expressed by 
‘non-immune’ tissue cells, although less is known about this (Zack Howard et al., 
1996; Rollins, 1997; Ward et al., 1998; Tachibana et al., 1998; Wells et al., 1998; 
Gale et al., 1999; Mahalingam et al., 1999; Rossi et al., 2000). Chemokine receptors 
are made up of 339-373 amino acids (Baldwin, 1993; Schertierer et al., 1993). These 
receptors have an extracellular N terminus tail and a cytoplasmic C terminal 
(Pelchen-Matthews et al., 1999). All chemokine receptors have 2 conserved cysteines 
situated in the NH2 terminal domain and in the third extracellular loop which form a 
disulfide bond important for the confirmation of the ligand-binding pocket 
(Baggiolini et al., 1997). Chemokine receptors have the amino acid sequence 
DRYLAIV in the second intracellular loop domain which makes them unique from 
the other 7-transmembrane receptors (Rollins, 1997; Rottman, 1999). The two main 
sites of chemokine-chemokine receptor interaction involves the N-terminal region of 
the chemokine and also within the exposed loop of the chemokine backbone which 
extends between the second and third cysteine (Clark-Lewis et al., 1995).
The nomenclature for chemokine receptors can be classified as CXCR1-5 for the 
‘CXC’ chemokines, CCR1-10 for the ‘CC’ chemokines, XCR1 for the ‘C’ 
chemokines and CX3CRI for the CX3C chemokine. Most receptors are found on T 
cells and their expression depend on the activation state of the T cell, the activating 
stimuli and the growth stage. The chemokine receptors activate large GTP-binding 
proteins which initiates signal transduction processes via the production of second 
messengers such as cyclic AMP(cAMP), inositol triphosphate(IP3), calcium ions and 
activated small G proteins (Goldsby et al., 2000).
Recently ‘non-immune’ cell types have been shown to express chemokine receptors. 
CXCR1, CXCR2, CXCR3 and CXCR4 were found to be expressed by endothelial 
cells, CCR1 and CCR2 were expressed by smooth muscle cells and the colonic 
epithelial cell line HT-29 expressed CXCR4 (Jordan et al, 1999; Dwinell et al.,




A simplified diagram o f a 7-transmembrane-G-protein-coupled chemokine receptor in a cell membrane lipid bilayer. The receptor 
has an extracellular N-terminus marked “NH2” and an intracellular C-terminus marked “COOH” . The hydrophobic transmembrane 
regions are shown as numbered cylinders embedded between the lipid bilayer.
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1999). The types of chemokine receptors expressed by gastric epithelial cells were 
still largely unknown.
There are 4 general classes of chemokine receptors which are promiscuous receptors, 
shared receptors, specific receptors and virally encoded receptors (Schall et al., 1994; 
Rollins, 1997). Some chemokine receptors are constitutively expressed, some are 
inducible and some can be down-regulated. Most ‘CXC’ chemokines have affinities 
for a single receptor, whereas the ‘CC’ chemokines generally bind to 2 or more 
receptors.
Promiscuous receptors
This type of receptor will bind to both ‘CXC’ or ‘CC’ chemokines (Gale et al.,
1999). Erythrocyte chemokine receptor (ECKR/DARC) is an example of a 
promiscuous receptor and is found on red blood cells (erythrocytes). However, the 
receptor has also been found on other non-erythroid cells implying it might have 
other regulatory roles. The tissues that express ECKR/DARC are the spleen, lungs, 
liver, kidneys and to endothelial cells of post-capillary venules (Horuk et al., 1993). 
The ECKR/DARC is thought to bind the malarial parasite Plasmodium vivax to red 
blood cells.
Shared receptors
A shared receptor will bind to more than one chemokine within the same ‘CXC’ or 
‘CC’ class. Examples of shared receptors are the CXCR1 receptor which binds to IL- 
8/CXCL8 and any other ‘CXC’ chemokine with an ‘ELR’ protein group, CXCR3 
which binds MIG/CXCL9 and IP-10/CXCL10, and also the CCR1 receptor which 
binds the ‘CC’ chemokines MIP-la/CCL3, RANTES/CCL5, MCP-3/CCL7 and 
HCC-1/CCL14.
CXCR1 and CXCR2 are expressed on neutrophils, monocytes, basophils and 
eosinophils but all of these cells with the exception of neutrophils have a weak 
response to IL-8/CXCL8 (Baggiolini et al., 1994). CXCR2 has a high affinity for IL- 
8/CXCL8 and all ‘ELR’ containing ‘CXC’ chemokines which attract neutrophils
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such as GRO-cx/CXCLl, GRO-P/CXCL2, GRO-y/CXCL3, ENA-7 8/CXCL5, GCP- 
2/CXCL6 and NAP-2/CXCL7.
CXCR3 has been found in circulating T and B lymphocytes (Qin et al., 1998) and in 
activated T lymphocytes and natural killer cells (Loetscher et al., 1996).
Specific receptors
This receptor only binds to one chemokine. Examples of this type of receptor are the 
CCR6 , CXCR4 and CXCR5 receptors. CCR6  is the receptor for the chemokine 
LARC/CCL20 (Greaves et al., 1997). CCR6  mRNA has been shown to be expressed 
in the spleen, lymph nodes, thymus and appendix (Greaves, et al., 1997; Liao et al.,
1999). It is also expressed in CD34+ bone marrow cell-derived dendritic cells, in B 
cells CD4+ and CD8+ T cells (Power et al., 1997). CCR6 , which is the receptor for 
LARC/CCL20 was found abundantly in normal human colonic epithelial cells 
(Izadpanah et al., 2001) and in other human intestinal epithelial cell lines. 
LARC/CCL20 may mediate autocrine and paracrine effects on the intestinal 
epithelium.
CXCR5 is expressed on B lymphocytes and attracts BCA-1/CXCL13 (Legler et al.,
1998). This receptor is involved in the migration of B cells and memory T cells 
(Zlotnik, et al., 1999). The CXCR5 receptor is found mostly in the liver, spleen, 
lymph node, appendix, stomach, salivary gland and lower numbers of this receptor is 
expressed in the mammary gland (Gunn et al., 1998).
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Table 2. A list of chemokines and chemokine receptors relevant to this study
CHEMOKINE RECEPTORS LIGAND(S)
CCR1 MIP-la/CCL3, RANTES/CCL5, MCP- 
1/CCL2
CCR2 MCP-1/CCL2, RANTES/CCL5, MCP- 
3/CCL7













CXCR4 was formerly known as ‘fusin’ or LESTR (Loetscher et al., 1994). This 
chemokine receptor is expressed throughout the body, predominantly on naive, 
inactive T cells (Bleul et al., 1997) and together with SDF-la/CXCL12, CXCR4 is 
important in the development of the heart, blood cells as well as in the development 
of the neuronal networks in the central nervous system and the blood vessels in the 
gastrointestinal tract (Tachibana et al., 1998). CXCR4 and SDF-lcx/CXCL12, its 
only ligand (Bleul et a l, 1996; Tanabe et al., 1997) are also instrumental in the 
processes of embryogenesis, haematopoiesis, activation of T cells, activation of 
endothelial and epithelial cells, brain development and pathogenesis of 
HIV(Murdoch, 2000).
42
The formation of a mature vascular system for supplying the gastrointestinal tract is 
dependent on the CXCR4/SDF-la(CXCL12) pair (Tachibana et al., 1998). This is 
achieved by vascular branching regulation and remodelling processes in endothelial 
cells. CXCR4 may also help in the apoptotic elimination of cells that have migrated 
incorrectly in the central nervous system (Zou et al., 1998). Mitra et al. (1999) found 
that the CXCR4 mRNA was expressed equally in the colon, squamous oesophageal 
and gastric cancers in the adjacent normal tissues.. CXCR4 can be upregulated by IL- 
2 or phytohaematoagglutinin (PHA) stimulation o f  the T cells (Bleul et al., 1997) and 
CXCR4 can also be up-regulated by IL-4 (Jourdan, 1998; Murdoch, 2000). 
Conversely, IL-10 can down-regulate the expression of CXCR4 (Jinquan et al., 2000; 
Murdoch, 2000). When SDF-lcc/CXCL12 binds to CXCR4, CXCR4 is rapidly 
internalised but relocates to the cell surface within minutes (Agace et al., 2000).
CXCR4 is expressed constitutively in the HT-29 colonic epithelial cell line (Jordan 
et al., 1999) and in inflamed and non-inflamed colonic mucosa. It has been shown by 
immunohistochemistry experiments that epithelial cells at the bottom of intestinal 
crypts or glands express CXCR4. The cells at the bottom of the glands are dividing, 
therefore it was believed that CXCR4 was important to stimulate cell division 
(Jordan et al., 1999). CXCR4 has also been shown to be expressed by endothelial 
cells on blood vessels. Since it is expressed constitutively by many cells, CXCR4 
may have some important roles to play in cell homeostasis.
1.9 GASTRIC DISEASES (GASTRITIS!
Gastritis means inflammation of the gastric mucosa and it is the host’s response to 
damage caused in part of the tissues. The damaged tissues release chemoattractants 
which attract inflammatory cells to the site of damage.
Recently, there has been great interest in gastritis Ibecause
a) it is an immunological disease associated with H. pylori
b) it is associated with the occurrence of gastric cancer 
(Ishihara et al., 1996)
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The Sydney system has been created to classify the various types of gastritis in a 
systematic way. According to this system, there are three categories of gastritis 
which are acute gastritis, chronic gastritis and gastritis of special forms (Price, 1991).
H. /Ty/on'-associated gastritis can be characterized by increased polymorphonuclear 
neutrophils, chronic inflammatory mononuclear cells including macrophages and 
lymphocytes in the gastric mucosa (Kusugami et al., 1999).
I.9.1 Acute gastritis
Acute gastritis is known to occur in the early stages of infection with the bacterium
H. pylori. This is characterised by an intense polymorphonuclear inflammation of the 
gastric antrum and body of the stomach, mainly the gastric body. The mucosal gland 
layer is severely damaged (epidemic achlorhydric gastritis) but heals within days or 
weeks (Sobala et al., 1991). Sometimes the acute gastritis can develop into chronic 
gastritis (Dixon, 1996).
I.9.2 Chronic gastritis
Chronic gastritis includes non-atrophic gastritis and atrophic gastritis whereby the 
normal gastric glands are lost, this leads to other functional consequences which vary 
in type and severity depending on the site of gastritis. If atrophy occurs in the 
antrum, there is a decrease of gastrin secretion by the G cells. Conversely, if it occurs 
in the body of the stomach, there will be a decrease of parietal cells (Sipponen et al.,
1991). Usually atrophic gastritis can lead to intestinal metaplasia and gastric ulcers. 
Risk factors for acquiring atrophic gastritis are a high salt intake, intragastric bile 
(Sobala et al., 1993) and low dietary supply of vitamins and micronutrients (Correa,
1992). Non-atrophic gastritis usually occurs in the antrum and body, but the 
inflammation is mostly in the antrum (Bayerdoffer et al., 1992). Infection with the 
bacterium H. pylori is implicated in active chronic gastritis. This bacterium invokes 
an acute inflammatory response mediated by complement components, low- 
molecular weight chemotactic factors shed by the bacterium and the chemotactic 
cytokine IL-8/CXCL8 expressed by epithelial cells, macrophages and endothelial
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cells in response to bacterial infection. Chronic gastritis is marked by infiltration of 
lymphocytes, plasma cells and neutrophils with lymphoid follicles and surface 
epithelium damage which begins in the antrum and proceeds to the gastric body 
(Hirai et al., 1999).
1.9.3 Special forms of gastritis
This category includes lesions which have special clinical disorders with specific 
pathogenesis and histological features such as eosinophilic, granulomatous or 
lymphocytic gastritis, reactive gastritis whereby the gastric mucosa has been 
subjected to noxious stimuli such as non-steroidal anti-inflammatory drugs, bile and 
corrosives (Sipponen et al., 1991), drugs and alcohol (Dixon, 1996). These irritants 
exfoliate the surface epithelial cells and decrease the secretion of mucous, causing 
the gastric mucosa to be prone to acid attacks. The acid attacks cause the gastric 
mucosa to develop vasodilation, become oedematous, form erosions and 
haemorrhages. If the haemorrhages are not very serious, they heal up 24-48 hours 
post-bleeding (Dixon, 1996).
1.10 HELICOBACTER PYLORI (H. PYLORI)
1.10.1 Epidemiology
H. pylori has been implicated in a number of gastrointestinal disease states such as 
gastric ulcers (Crowe, et al., 1995; Huang et al., 1995; Malfertheiner, 1997; 
Yamaoka et al., 1998; Zarilli et al., 1999; Shimizu et al., 2000), duodenal ulcers, 
chronic active antral gastritis (Crowe et al., 1995; Huang et al., 1995; Haeberle et al., 
1997; Yamaoka et al., 1998; Zarilli et al., 1999; Martin-Guerrero et al., 2000; Lohoff 
et al., 2000; Shimizu et al., 2000), gastric carcinomas (Parsonnet et al., 1991; Crowe 
et al., 1995; Huang et al., 1995) and mucosal-associated lymphoid tissue (MALT) 
lymphomas (Hunt, 1996; Zarilli et al., 1999; Martin-Guerrero et al., 2000; Joo et al.,
2000). Peptic/gastric ulcers are a major cause of death and distal gastric 
adenocarcinoma is the second biggest cancer killer worldwide (Atherton, 1997;
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Vandenplas, 2000). H. pylori infection are very common worldwide although 
prevalence in the developed world is now decreasing (Tytgat et al., 2000). It mostly 
occurs in lower socio-economic patients as it is associated with poor hygiene, 
crowded living conditions, sharing of beds in childhood and poor domestic water 
supply (Marshall, 1994). Human beings are natural hosts of H. pylori. There is still 
uncertainty over the mode of transmission of H. pylon  (Axon, 1996). It has been 
suggested that in the developed world, oral-oral contact, especially from children was 
the major mode of transmission, whereas in the developing world, faecal-oral was 
the major mode of transmission (Feldman et al., 1998).
1.10.2 The structure, microbiology and location of infection
H. pylori is a gram-negative (Yamaoka et al., 1998) spiral-shaped, microaerophillic 
bacillus which is 3-5 pm in length and 0.5 pm in diameter. It becomes rod-shaped 
when cultured in solid medium (Goodwin et al., 1990) and the bacteria converts to a 
coccoidal shape during unfavourable culture conditions. It has 5-6 unipolar sheathed 
flagella which enables it to move in the mucous layer covering the epithelial cells of 
the gastric mucosa (Marais et al., 1999).
H. pylori is a non-invasive bacteria and colonizes the mucous layer above the gastric 
epithelial cells (Bodger et al., 1998). This bacteria can only live in gastric-type 
epithelium and is not found in any other part of the gastrointestinal tract which does 
not have gastric mucosa (Harris et al., 1996).
The location of the H. pylori infection within the stomach determines the clinical 
manifestation of the disease. Generally, after ingestion, the bacterium colonises 
predominantly the gastric antrum (Hunt, 1996). In individuals who have low acid 
secretion, the bacteria will colonise both the gastric antrum and body. This leads to 
gastric ulcer and gastric body mucosal atrophy with increased risk of gastric cancer. 
In individuals with increased production of acid in the stomach, this can lead to 
gastric metaplasia in the duodenal bulb and there will be a greater risk of H. pylori 
colonising the duodenum which results in duodenal ulcers (Harris et al., 1996).
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1.10.3 Physical adaptations
H. pylori bacteria produce the enzyme urease which aids it to survive the acidic 
conditions in the stomach because it does not tolerate strong acids. However, it can 
withstand mildly acidic conditions and when urea is present, it can tolerate pH as low 
as 1.5 (Hirai et al., 1999). The urease enzyme hydrolyses urea into alkaline ammonia 
which increases the pH of the microenvironment where the bacteria live. However, 
although the urease on the surface of H. pylori plays a very important role in the 
bacterial colonization of the stomach, it can also damage the epithelial cells. This is 
because urease attracts human leukocytes which recruits monocytes and neutrophils 
to induce gastric mucosal injury (Craig et al., 1992; Harris et al., 1996). The 
ammonia combines with water to yield ammonium hydroxide which is also directly 
toxic to the gastric mucosal cells and results in the formation of gastric ulcers (Smoot 
et al., 1990). The high concentration of ammonia also increases the permeability of 
hydrogen ions leading to gastric ulcers (Desai et al., 1993).
1.10.4 Virulence factors
i) Vacuolating cytotoxin (VacA)
Approximately 50% H. pylori strains secrete the vacuolating cytotoxin (VacA) which 
is an 87 kD protein that induces vacuolation and cell damage in epithelial cells in the 
stomach. It is only present in H. pylori strains which have a pathogenicity island 
(Axon, 1999). There are three signal sequence types, sla, sib  and s2, which are 
situated at the 5' end of the gene with two mid-region types m l and m2 in the VacA 
allele. The toxicity of the bacteria strain depends on the final structure of the VacA 
allele. The sla/m l strain is more toxigenic than the slb/m l allele (Atherton, 1998; 
Axon, 1999), In fact, the strains with the sla/m l gene are the most toxic (Shimoyama 
et al., 1998; Vandenplas, 2000). Possible mechanisms by which VacA can be toxic to 
cells are interference with the cell protective immunity (Wilson et al., 1999), affects 
with the antigen processing and presentation mediated by the newly made major 
histocompatibility complex (MHC) class II (Molinari et al., 1998) and inhibits the 
epidermal-growth factor mediated cell repair which leads to mucosal injury (Wilson
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et al., 1999). One of the mechanisms by which expression of VacA gene increases 
the virulence of the bacteria is by inducing the secretion of the chemokine IL- 
8/CXCL8 from the gastric epithelial cells. The increase in IL-8/CXCL8 secretion can 
also stimulate the release of gastrin from antral G cells (Harris et al., 1996) which in 
turn results in increased levels of gastric acid production and the formation of ulcers.
ii) The pathogenicity island (PAI) and cytotoxin associated antigen (CagA)
This pathogenicity island (PAI) contains about 40 genes and is thought to be 
important in the transfer of macromolecules in the host-bacteria interaction (Axon,
1999). CagA+ is one of the genes in the PAI which encodes for the 120-140kD CagA 
protein (Tummura et al., 1993). It consists of the pic A  and picB  genomic regions 
(Martin-Guerrero et al., 2000). CagA+ strains of H. pylori is associated with more 
severe gastritis, increased occurrence and intensity of atrophy of the antrum, peptic 
ulcer, intestinal metaplasia (Wilson et al., 1999), duodenal ulceration and gastric 
cancer (Audibert et al., 2001). The presence of the bacterial CagPAI is associated 
with the induction of IL-8/CXCL8 and other ‘CXC’ chemokines secretion which is 
responsible for the inflammatory processes (Audibert et al., 2001; Crabtree, 1998). 
This phenomenon is seen in gastric epithelial cell lines (Shimada et al., 1998). IL- 
8/CXCL8 attracts neutrophils to the site of infection and also acts as a pro- 
inflammatory cytokine which attracts other leukocytes (Hirai et al., 1999). This 
increases the inflammation that occurs on site. Interestingly, CagA protein is not 
involved directly with the IL-8/CXCL8 response (Shimada et al., 1998), instead, 
many genes in the CagPAI are needed to induce the IL-8/CXCL8 response (Censini 
et al., 1996). However, CagA+ infections may not always lead to serious 
complications as it has been shown that CagA+ is protective against adenocarcinoma 
of the oesophagus and oesophagogastric junction (Chow et al., 1998).
The picB  (promote the induction of cytokines B) and picA  gene in the PAI increase 
the virulence of the bacteria as these components are involved in increasing the 
production of IL-8/CXCL8 by gastric epithelial cells (Sharma et al., 1995; Tummuru 
et al., 1995; van Doom et al., 1998). Another gene which has been identified is 
'induced by contact with epithelium' (ice A) of which there are two types, ice A l and 
ice h i .  IceAl is a marker for peptic ulcer disease.
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iii) Lipopolysaccharide (LPS)
Lipopolysaccharides (LPS), also known as endotoxins, are carbohydrate components 
on the bacterial surface. Generally, the H. pylori LPS has low endotoxic and 
immunostimulatory activities compared to the LPS from other bacteria (Bliss et al., 
1998; Kelly et al., 1998). H. pylori LPS has not been associated with high mitogenic 
and endotoxic activity in mice, but it can stimulate the expression of IL-6  in human 
peripheral blood mononuclear cells which can induce inflammation reactions 
(Ogawa et al., 1997). It has been hypothesised that having a less inflammatory LPS 
allows H. pylori to infect its host chronically (Bliss et al., 1998) and leads to gastric 
damage. LPS may also cause an autoimmune reaction from the host leading to 
gastric mucosal injury (Appelmelk et al., 1997; Bliss et al., 1998). Piotrowski et al. 
(1997) have shown that H. pylori LPS weakens the interactions between the mucosal 
cells and proteins of the extracellular matrix which leads to apoptosis (programmed 
cell death) of the gastric epithelial cells.
iv) Effects on gastric secretions
H. pylori infection increases the basal, post-prandial and GRP (gastrin releasing 
peptide)-stimulated serum gastrin levels. This in turn stimulates the parietal cells to 
secrete more gastric acid. Cytokines such as IL-2, TNF-a and IFN-y also can induce 
the expression of gastrin (Lehmann et al., 1998). The levels of somatostatin, which 
inhibits acid secretion, is decreased during H. pylori infection, hence acid levels 
increase. In patients suffering from H. py/on'-induced duodenal ulcers, histamine 
synthesis was found to be reduced, leading to low antral histamine content. This in 
turn decreases somatostatin in the antral D cells and leads to an increase in gastrin 
production (Harris et al., 1996).
I.10.5 Pathological effects
It is widely believed that H . pylori causes gastric mucosal inflammation by several 
possible mechanisms including the release of the IL-8/CXCL8 chemokine by the 
gastric epithelial cells when they come into contact with the bacteria. The release of
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chemotaxic substances by the bacteria such as urease also attracts inflammatory cells 
(Smoot et al., 1997; Kandel et al., 2000).
The incidence of adenocarcinoma of the oesophagus and upper stomach as well as 
Barratt’s oesophagus have also been observed to be inversely proportional to the 
prevalence of H. pylori. This was because infection with the bacteria resulted in a 
decrease of acid secretion. Eradication of CagPAI-positive H. pylori infection of the 
gastric body increased the acid secretion resulting in a worsening of the severity of 
gastro-oesophageal reflux disease and its’ complications.
CagA+VacAsla strain of H. pylori attracts macrophages and T cells during chronic 
inflammatory reactions which releases proinflammatory cytokine migration 
inhibitory factor. This factor inactivates the transcription of p53 tumour suppressor 
resulting in formation of cancers (Hudson et al., 1999; Ibraghimov et al., 2000).
H. pylori has also been suggested to be involved in non-gastrointestinal diseases such 
as ischaemic heart disease, acute myocardial infarction, angina, hypertension or 
electrocardiographic abnormalities, although the evidence for these claims is not 
conclusive (Strachan, 1998). The suggested mechanisms for these coronary events 
are due to the induction of pro-inflammatory cytokines such as TNF-a, IL-6  and IL-8  
in the H. pylori stimulated gastric mucosa. However, many factors play a role in 
causing inflammation apart from the virulence of the infecting H. pylori, these 
include the host response to the infection and environmental factors (Takagi et al., 
1997).
I.11 H. PYLORI AND CYTOKINES
Infection with H. pylori leads to inflammation either due to the direct injury as a 
result of bacterial adhesion to the cells or to the subsequent release of vacuolating 
cytotoxin, phospholipases, urease, cytokines and chemokines. Yamaoka et al. (1995 
& 1996) found that H. pylori infection induced the secretion of various cytokines 
such as IL-6 , IL-7, IL-8 , IL-10 and TNF-a which contributed to the gastric 
inflammation associated with the infection. Gastric epithelial cells may be the cells
50
expressing IL-8/CXCL8 (Crabtree et al., 1994; Crowe et al., 1995) but it is not 
known which cells express the other cytokines although activated macrophages may 
secrete IL-lp and TNF-a (Sartor, 1994) and T lymphocytes or natural killer cells 
may secrete IFN-y and IL-2 (Karttunen et al., 1995). Activated T lymphocytes with 
Thl type characteristics have been implicated in H. pylori infections (D’Elios et al., 
1997; Crabtree, 1998; Zarilli et al., 1999). Thl cells boost cell-mediated immunity to 
cancers and intracellular infections, therefore it is paradoxical that it should be 
implicated in responses to H. pylori infection which is an extracellular/non-invasive 
type (Ernst et al., 1997). The Thl response to the H. pylori infection is not 
necessarily sufficient to clear the infection, despite inducing inflammatory reactions. 
Mucosal and systemic antibody responses towards the bacterial antigens are also not 
sufficient to eradicate the infection (Blanchard et al., 1999). However, Thl reactions 
could damage the gastric mucosa directly by inducing the epithelial cells to express 
immunogenic peptides or epitopes that could be recognised by antibodies and the 
overwhelming Thl response. Additional factors including host genetics and 
environmental factors and the strain of the bacteria in combination could lead to 
epithelial damage and eventually ulcerogenesis (Ernst et al. 1997). Additionally, Thl 
reactions could also cause damage indirectly when bacteria are phagocytosed.
Thl pro-inflammatory cytokines IL-ip, TNF (Crowe et al., 1995; Yamaoka et al., 
1996; Katagiri et al., 1997; Martin-Guerrero et al., 2000), IL-8/CXCL8 (Noach et al., 
1994; Crowe et al., 1995; Huang et al., 1995; Yamaoka et al., 1996; Sharma et al., 
1995; Ando et al., 1996; Katagiri et al., 1997; Bliss et al., 1998, Martin-Guerrero et 
al., 2000) and IL-6  (Crowe et al., 1995; Huang et al., 1995, Yamaoka et al., 1996; 
Martin-Guerrero et al., 2000) induce the expression of neutrophil or macrophage- 
attracting chemokines which in turn release cytotoxic material to eliminate the 
bacteria (Ernst et al., 1997) which also damage the host. Hida et al. (1999) extended 
this study and have shown that IL-10 and IL-12 mRNA were both increased in the 
gastric antrum and gastric body biopsies of patients infected with the CagA+ H. 
pylori. IL-12 was thought to polarise the T cells into active Thl cells (O’Garra et al., 
1995; Scott et al., 1995; Crabtree, 1998) and promote cell mediated responses and is 
known to cause gastritis (Karttunen et al., 1997) whilst the anti-inflammatory
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cytokine IL-10 down-regulated the proinflammatory responses to protect the cells 
against excessive ‘CXC’ and Thl responses.
1.12 CHEMOKINE PRODUCTION IN RESPONSE TO H. PYLORI 
INFECTION
Investigations have shown that there appears to be a link between H. pylori infection 
and chemokine expression, mainly GRO-a/CXCLl and IL-8/CXCL8 (Gionchetti et 
al., 1994; Noach et al., 1994; Moss et al., 1994; Fan et al., 1995; Peek et al., 1995; 
Yamaoka et al., 1995; Yamaoka et al., 1996; Ando et al., 1996). So far, only a few 
‘CXC’ and ‘CC’ chemokines had been studied. There is longstanding evidence of 
non-immune cell production of chemokines and it has been shown that certain 
chemokines are expressed constitutively by the epithelial cells in the gastric mucosa, 
such as IL-8/CXCL8 (Crabtree et al., 1994) and SDF-loc/CXCL12 in the colonic 
epithelial cells (Jordan et al., 1999), which may have homeostatic roles to play. 
Chemokine expression may also be induced in normal gastric cells as a result of 
exposure to various stimuli such as dietary components (Yamaoka et al., 1998). Most 
of the studies to date have been carried out to look for IL-8/CXCL8 and there is less 
information available regarding the newer chemokines.
Infection of the gastric epithelial cell lines and gastric mucosa by H. pylori induces 
the production of chemokines. Neutrophils are recruited to the site of inflammation 
by IL-1 and TNFa, the pro-inflammatory cytokines which are released from 
macrophages as a result of the infection. Neutrophils release chemokines which 
amplify the inflammatory response to the infection (Crabtree, 1997). ‘CXC’ 
chemokines play a more important role than ‘CC’ chemokines in recruiting the 
neutrophils and T lymphocytes to the sites of inflammation (Shimoyama et al., 1998; 
Yamaoka et al., 1998).
KATO III and AGS gastric epithelial cell lines have been shown to express IL- 
8/CXCL8 mRNA constitutively (Sharma et al., 1995). IL-8/CXCL8 has an important 
role to recruit and activate inflammatory immune cells and gastric epithelial cells
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(Eck et al., 2000). KATO III and MKN45 cell lines also expressed IL-8/CXCL8 in 
response to pro-inflammatory cytokines such as IL -la  and TNF-a (Yasumoto et al.,
1992).
It has been shown that different strains of H. pylori induce different quantities of IL- 
8 /CXCL8 secretion by epithelial cells, CagA+ H. pylori induce more IL-8/CXCL8 
than the CagA' strain (Crabtree et al., 1994; Ernst et al., 1997). Stimulation of the 
KATO III and MKN45 gastric epithelial cell lines were more successful in producing 
IL-8/CXCL8 when live H. pylori was used rather than killed H. pylori, cell-free 
supernatants from H. pylori cultures or bacterial lipopolysaccharides (Aihara et al., 
1997). Similarly, stimulation with sonicated or freeze-thawed viable H. pylori 
resulted in the expression of GRO-a/CXCLl, IL-8/CXCL8 , MCAF/CCL2, MIP- 
la/CCL3 and MIP-ip/CCL4 by KATO III and MKN45 cells (Yamaoka et al., 
1997). When the AGS gastric epithelial cell line was stimulated with viable H. 
pylori, IL-8 /CXCL8 mRNA peaked early post-stimulation, but ENA-78/CXCL5 
peaked later around 90 minutes post-stimulation (Rieder et al., 2001). Due to its 
delayed and long-lasting effects, ENA-78/CXCL5 could be involved in the 
recruitment of granulocytes in acute and chronic infections. Other chemokines 
released by KATO III cells such as GRO-a/CXCLl, IL-8 /CXCL8 , MCP-1/CCL2 
and MIP-la/CCL3 decreased when H. pylori was eradicated. KATO III cells 
expressed intercellular adhesion molecule-1 (ICAM-1), the adhesion molecule for 
leukocytes when these cells were stimulated with pro-inflammatory cytokines such 
as IL-1, TNF-a and IFN-y (Sharma et al., 1995). However, stimulation of the KATO 
III cells with H. pylori did not result in the expression of ICAM-1.
In a study performed upon antral biopsy cultures from patients with and without H. 
pylori infection, the chemokines GRO-a/CXCLl (Kusugami et al., 1997; Suzuki et 
al., 1998), IL-8/CXCL8 (Kusugami et al. 1997; Ando et al., 1998; Suzuki et al., 
1998; Rieder et al., 2001), MIP-la/CCL3 (Ando et al., 1998) and ENA-78/CXCL5 
(Rieder et al., 2001) were elevated in H. pylori positive patients. In H. py/on'-infected 
gastric mucosa, macrophages expressed mainly GRO-a/CXCLl (Ando et al., 1996; 
Kusugami et al., 1997), IL-8/CXCL8 (Ando et al., 1996; Kusugami et al., 1997) and 
MIP-la/CCL3 (Suzuki et al., 1999).
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The expression of four chemokines mainly GRO-a/CXCLl, IL-8/CXCL8 , MCP- 
1/CCL2 and MDMa/CCL3 were studied in patients with H. py/on-associated gastric 
ulcers and H. py/on-associated duodenal ulcers (Sato et al., 1999). As expected, 
GRO-a/CXCLl and IL-8/CXCL8 expression were associated with increased 
myeloperoxidase which is synonymous with the numbers of neutrophils.
Antral biopsies from patients with duodenal ulcers and gastric ulcers are also known 
to express higher levels of GRO-a/CXCLl and IL-8/CXCL8 compared to patients 
with gastritis or normal patients (Ohsuga et al., 2000). The expression of IL- 
8/CXCL8 and MDMa/CCL3 in the antrum and at the gastric ulcer sites of patients 
with and without H. pylori infection was studied. As expected, there were higher 
levels of expressed IL-8/CXCL8 , MIP-lot/CCL3 and inflammatory cells in the 
antrum and ulcer sites of patients positive for H. pylori infection compared to 
patients negative for H. pylori. However, the ulcer sites expressed more IL- 
8/CXCL8 , MIP-la/CCL3 and inflammatory exudate than the antrum (Shimizu et al., 
2000).
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2.0 AIMS OF THE STUDY
The bacteria Helicobacter pylori have been implicated in various diseases in the 
stomach which can lead to complications such as gastric ulcers, particularly duodenal 
ulcers, gastric cancers and mucosa-associated lymphoid tissue lymphomas. This 
study, has focused on gastritis, as this is a precursor of various complications.
It is now known that some chemokines, especially IL-8/CXCL8 , which are proteins 
involved in attracting leukocytes to the site of infection are responsible for the 
inflammation associated with the H. pylori infection.
This study aims to investigate the role of gastric epithelial cells and their chemokine 
production in the initiation and propagation of inflammatory events in the gastric 
mucosa and the role of chemokines and receptors in normal gastric epithelial cell 
function.
1) Gastric epithelial cell lines have been used as a model to investigate the 
expression of members of the chemokine families, especially recently identified 
chemokines like BCA-1/CXCL13 and LARC/CCL20.
2) To investigate the regulation of IL-8/CXCL8 and RANTES/CCL5 chemokine 
expression by the cytokines IL-4 and IL-13.
3) To determine using RT-PCR and immunohistochemistry whether the chemokine 
expression in gastric biopsies is associated with inflammation or H. pylori 
infection, with an emphasis on recently identified chemokines.
4) To determine by RT-PCR which chemokine receptors are expressed by gastric 
epithelial cells
Although the aetiology of gastric diseases as a result of H. pylori infection is still not 
fully understood, it is hoped that we might gain some useful insight as to the possible 
mechanisms involved in causing gastric damage. Increasing our understanding of 
chemokine production by gastric epithelial cells may provide leads for the
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development of novel therapeutic strategies targetting chemokines or chemokine 
receptors to decrease inflammation associated with H. pylori infection.
3.0 MATERIALS AND METHODS
METHODS
3.1 CELL CULTURE
3.1.1 MKN45 and AGS gastric epithelial cell lines
Two human gastric epithelial cell lines were used in these studies, MKN45 and AGS. 
The MKN45 cells were obtained from the Japanese Collection of Research 
Bioresources (JCRB) and had been isolated from a poorly differentiated 
adenocarcinoma in the stomach of a 62 year old female. The MKN45 cells grow in a 
monolayer with clusters of cells containing oval and spindle shaped cells.
The AGS cells were obtained from the European Collection of Animal Cell Cultures 
(ECACC) and had been isolated from a stomach adenocarcinoma in a 54 year old 
Caucasian female. Both cell lines have been frequently used as models of the gastric 
epithelial mucosa in other previous studies of AGS (Rieder et al., 2001) and MKN45 
(Mori et a l . , 2001; Ohsuga et al., 2000).
Two other human cell lines, HT-29 and U937 were used as positive controls for the 
reverse-transcriptase polymerase chain reaction (RT-PCR) experiments (section 2.6). 
The HT-29 and U937 cell lines were used by colleagues within our laboratory, and 
had been obtained from the European Collection of Animal Cell Culture (ECACC). 
The HT-29 cells had been isolated from a colorectal adenocarcinoma in a 78 year old 
female and had an epithelial cell morphology. The HT-29 cells grow in an adherent 
monolayer. The U937 cell line is a myeloid leukaemia cell line obtained from a 37 
year old Caucasian male. These cells grow in suspension.
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3.1.2 Cell culture
MKN45 cells were cultured in 80cm2 tissue culture flasks in RPMI 1640 medium 
containing 2mM glutamine supplemented with penicillin (lOU/ml), streptomycin 
(lOpg/ml), amphotericin B/Fungizone® (0.5pg/ml) and 10% heat-inactivated foetal 
bovine serum (referred to as a complete medium). The U937 cells were cultured in 
the same conditions.
AGS cells were cultured in 80cm tissue culture flasks in Ham’s F I2 Nutnent 
medium containing 2mM glutamine supplemented with penicillin (lOU/ml), 
streptomycin (lOpg/ml), amphotericin B/Fungizone® (0.5pg/ml) and 10% foetal 
bovine serum (referred to as a complete medium).
HT-29 cells were cultured in 80cm tissue culture flasks in McCoy’s 5A medium 
containing 2mM glutamine supplemented with penicillin (lOU/ml), streptomycin 
(10pg/ml), amphotericin B/Fungizone (0.5pg/ml) and 10% foetal bovine serum 
(referred to as complete medium).
Cultures of the MKN45, AGS, HT-29 and U937 were maintained at 37°C in a 
humidified incubator in an atmosphere of 5% CO2 and 95% air. The medium was 
changed every 2-3 days.
To subculture the cells, the medium was removed and the cells were washed twice 
with phosphate buffered saline solution (PBS) without calcium and magnesium. The 
excess solution was removed and 3 ml of trypsin/EDTA mixture containing 0.05% 
(w/v) trypsin and 0.02% (w/v) EDTA were added. The cells were incubated for 5 
minutes at 37°C until they had detached from the flask. Ten ml of complete medium 
were added to the cell mixture to inhibit the reaction of the trypsin/EDTA solution. 
Cells were centrifuged at 200g for 5 minutes. After centrifugation, the supernatant 
was removed and the cell pellet was resuspended in complete medium. A count of 
viable cells was carried out by mixing a small volume of cells with an equal volume 
of 0.02% trypan blue in PBS. The cells were counted using a Neubauer 
haemocytometer. Dead cells absorbed trypan blue into the cells and stained blue.
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Cell viability was generally more than 95%. Cells were counted and seeded for 
further culture at 2xl04cells/ml of medium into 80cm2 tissue culture flasks. For 
experimental protocols, cells were seeded at the same density into 24 well plates or 
25cm2 tissue culture flasks. AGS, MKN45 and HT-29 cells reached confluency after 
approximately 7 days when 1ml of resuspended AGS or MKN45 or HT-29 cells 
were seeded together with 10ml of complete medium in a 80cm flask. The U937 cell 
line reached the appropriate density to be harvested after approximately 5 days in 
culture.
For storage, cells were resuspended in 4xl06 cells/ml of freeze medium which 
contained 10% dimethylsulphoxide (DMSO) and 90% foetal bovine serum. The cell 
suspension was transferred to cryovials (Nunc) at 1 ml/tube which were cooled 
gradually overnight in the vapour phase of liquid nitrogen and then stored in liquid 
nitrogen. When the cells were required again, the cryovials were rapidly defrosted at 
37°C in a water bath, washed in the appropriate tissue culture medium and cells from 
1 cryovial were resuspended in complete medium and plated out as usual.
3.1.3 Experimental protocol
MKN45 cells were grown in 25cm flasks or 24 well plates until confluent, while 
AGS cells were grown until confluent in 80cm2 flasks or 24 well plates until 
confluent, depending on the experiments to be carried out. MKN45 and AGS cells 
were seeded into 24 well plates for ELISA experiments and in 25cm2 and 80cm2 
flasks for Northern analysis and reverse-transcriptase polymerase chain reactions 
(RT-PCR) experiments respectively. The HT-29 and U937 cell lines were seeded 
into 80cm flasks for RT-PCR experiments. The freshly isolated human white blood 
cells (refer to section 3.4.1) were seeded into small 5ml petri dishes and incubated 
with a combination of medium and phytohaemagglutinin (PHA) or medium and 
lipopolysaccharide(LPS) for a short period (2-4 hours) to be used in the RT-PCR 
experiments.
Twenty four hours before an experiment, these cells were usually ‘serum starved’, 
that is were cultured in their respective media without foetal bovine serum. The
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absence of serum ensured that all cells were growth-arrested. These growth-arrested 
cells were then treated with fresh serum-free medium and treated with the specific 
doses of cytokines or vehicle controls for the stated times described in the results 
section. For ELISAs, the supernatants were collected, centrifuged to remove cellular 
debris and stored at -70°C until assayed for extracellular chemokines. Total RNA 
and cellular proteins were extracted from the cells as described in the section below.
3.2 NORTHERN ANALYSIS
Total cellular RNA was extracted from MKN45, AGS cells or biopsy samples using 
a commercial solution containing guanidinium thiocyanate (RNAzol B@), with a 
modification of the method described by Chomszynski and Sacchi (1987). Buffers 
and solutions used for Northern analysis are detailed in section 3.8.2 and all solvents 
were high performance liquid choromatography (HPLC) grade.
3.2.1 RNA isolation
Monolayers of MKN45 cells in 25cm2 tissue culture flasks and AGS cells in 80cm2 
tissue culture flasks were lysed by adding 1 ml of RNAzol B® per 80 cm2 flask. The 
cells were removed with a sterile cell scraper and transferred to sterile 1.5ml 
centrifuge tubes by plastic pipettes. To extract total RNA, lOOpl of chloroform was 
added to each 1ml of homogenate, vortexed and kept on ice for 5 minutes. Then the 
homogenates were centrifuged at 12000g for 15 minutes at 4°C. Using a sterile 
pipette, 0.5ml of the upper, clear layer was transferred to a fresh sterile 1.5ml 
centrifuge tube and 0.5ml of propan-2-ol was added to it. The mixture was left on ice 
for 15 minutes before it was centrifuged again at 12000g for 15 minutes. After 
centrifugation, the supernatant was discarded and the white RNA pellet at the bottom 
of the tube was washed with 1ml 75% cold ethanol and centrifuged again at 12000g 
rpm for 8 minutes at 4°C. The contents of the centrifuge tube was frozen at -70°C. 
The sample was used directly for Northern analysis or purified further for PCR.
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3.2.2 RNA measurement and sample preparation
After overnight storage at -70°C, the 75% ethanol was discarded, the pellet was 
rewashed in 1 ml of fresh 75% cold ethanol, vortexed and centrifuged at 12000 g for 
8 minutes. Then the ethanol was removed and the RNA pellet was air dried in a fume 
cupboard for an hour. When the pellet was dry, it was solubilised in 20-40 pi of 
DEPC-treated water and kept on ice.
Total RNA was measured using a Gene Quant spectrophotometer. Two pi of RNA 
was diluted into 100 pi of DEPC-treated water in a cuvette and its absorbance was 
read at 260nm. Optical density readings were also obtained at 230nm or 280nm to 
assess the purity of the RNA pellet. Low protein contamination was shown by a ratio 
of less than 1.7 for the OD:260nm:OD280nm and a low OD230nm:OD260nm ratio 
indicated low guanidine contamination.
For Northern analysis, 30pl of sample buffer containing ethidium bromide, was 
added to 5-7 pg of sample and the samples were vortexed mixed before they were 
heated for 15-30 minutes at 80°C in a heating block. The samples were then cooled 
on ice and stained with 2.5 pi bromophenol blue solution. The samples were vortex 
mixed and briefly centrifuged before they were loaded onto 1% agarose gels.
3.2.3 Gel preparation and transblotting
One percent agarose gel was prepared by dissolving 3.6g of agarose (Roche) into 
280ml sterile MilliQ water. Eighteen ml of 20xMOPS and 65 ml of formaldehyde 
were added to the dissolved agarose and the gel was cooled to about 60°C before 
pouring. The gel was set in a 15x25 cm gel tray with two 15 lane combs purchased 
from Bio-Rad.
After the gel had set in the gel tank, it was transferred to a Bio-Rad submarine tank 
which was filled with cold lxMOPS running buffer. RNA (5-7 pg calculated from
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the spectrophotometer readings) was loaded per lane and the gel was run at a current 
of 100mA until the bromophenol blue had migrated about 5cm. The gel was placed 
on a ultra-violet transilluminator and the ethidium bromide stained 18S and 28S 
ribosomal RNA bands were examined for equal loading. The gel was then 
photographed using a Polaroid CU5 88-46 land camera (Genetic Research 
Instrumentation Ltd.) and type 55 Polaroid film (Sigma). The gel was rinsed gently 
in sterile MilliQ water for 30-60 minutes to remove the formaldehyde, prior to 
transblotting, as the formaldehyde would interfere with the transfer of RNA onto the 
nylon membrane.
The blotting tank consisted of a glass plate suspended in a plastic container which 
was partially filled with 20xSSC buffer (made up of sodium citrate and sodium 
chloride). A strip of Whatman filter paper was placed on the glass plate with its ends 
reaching into the buffer solution acting as a wick to draw up the 20xSSC buffer. The 
gel was placed upside down on the filter paper and covered with a positively charged 
nylon membrane and 3 pieces of filter paper cut a similar size as the nylon 
membrane, which had all been wet with the 20xSSC buffer. A stack of paper towels 
were then placed on top of the filter papers, followed by a weight of 500g on top. 
This was left overnight at room temperature to allow the RNA to transfer from the 
agarose gel onto the nylon membrane by capillary transfer. The RNA was baked in 
an oven at 120°C for 20 minutes to allow the RNA to be fixed onto the membrane. 
The nylon membrane was then sealed in a polythene bag at room temperature before 
it was hybridised.
3.2.4 Hybridisation with Dig-labelled oligonucleotide probes
Nylon membranes were hybridised with Digoxigenin labelled oligonucleotide probes 
and the probes which were bound to the mRNA were detected following the method 
described in the Digoxigenin(DIG) chemiluminescent detection kit for Northern 
blotting from Roche. A steroid hapten, digoxigenin, was used to label the nucleic 
acid probes, this enabled an alkaline phosphatase anti-conjugated DIG antibody to be 
used in the detection system. The 100cm2 membrane was prehybridised with 20ml 
hybridisation solution in a bag for an hour at 42°C. The prehybridisation solution 
was discarded and 1ml of lOng/ml IL-8/CXCL8 or RANTES/CCL5 RNA probe
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diluted in hybridization solution was added to the membrane and the plastic bag was 
sealed, ensuring air bubbles were not trapped, and left at 42°C overnight. The 
following day, the membrane was washed twice at 42°C with 2xSSC containing 
0.1% SDS for 5 minutes followed by two washes with O.lxSSC containing 0.1% 
SDS for 5 minutes per wash. The membrane was then washed for 5 minutes at room 
temperature in washing buffer on a rocking platform followed by a 30 minute wash 
with buffer 2 to block any non-specific binding of probes to the membrane. The 
membrane was incubated for 30 minutes on a rocking platform with a Dig-labelled 
antibody diluted 1 :1 0 0 0 0  in buffer 2  followed by 2  washes with a wash buffer for a 
duration of 15 minutes per wash. The membrane was then equilibrated with buffer 3 
for 5 minutes and then drained and incubated for 5 minutes in between 2 pieces of 
plastic sheet with 1ml of CSPD substrate diluted 1:100 in buffer 3. After the 
membrane was drained again, it was sealed inside a plastic bag and incubated in a 
dark place at 37°C for 10-15 minutes. The membrane was then exposed to a Kodak 
X-Omat AR5 X-ray film (Sigma) for about 2 hours at room temperature in the dark 
room. The film was then developed using an automatic RGII Fuji X-ray film 
developer.
3.2.5 Stripping membranes for B-actin analysis
The nylon membranes which were tested for IL-8 /CXCL8 and RANTES/CCL5 
mRNA expression were subsequently stripped of the chemokine probes in order to 
probe them for the housekeeping gene, p-actin. This step was important to prove that 
equal loading of cellular mRNA was performed for each well.
SDS(0.1%) solution was made up using sterile MilliQ water. About 100ml was
•> * 
prepared per 100cm membrane. The SDS solution was microwaved in a glass
beaker until it was boiling. Following this, the nylon membranes were taken out of
their sealed polythene bags and put into the beaker containing the boiling SDS
solution. The membranes were swirled around in the beaker to ensure they were
evenly exposed to the SDS solution and left until the SDS solution cooled to room
temperature. This was repeated IX in freshly prepared boiling SDS. The nylon
membranes were removed from the SDS solution, prehybridised in hybridisation
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solution and hybridised overnight (as described in section 3.2.4) with DIG-labelled 
p-actin probes. The following day, these membranes were washed and developed as 
in section 3.2.4.
3.3 ENZYME-LINKED IMMUNOABSORBENT ASSAY (ELISA)
The sandwich ELISA technique was used to quantitate antigenic chemokine 
secretion into cell culture media supernatants. All ELISA samples were measured in 
duplicate. All the recipes for buffers and solutions can be found in section 3.8.3.
3.3.1 IL-8/CXCL8 and RANTES/CCL5 ELISA
The monoclonal capture anti IL-8/CXCL8 and RANTES/CCL5 antibodies were 
diluted in coating buffer to a concentration of 2pg/ml in PBS (pH 7.4) buffer. 
Immediately 50pl were added per well of 96 well microtitre plates and the plates 
were covered and left overnight at room temperature. The wells were aspirated and 
washed three times with wash buffer and lOOpl of blocking buffer was added to each 
well and incubated for 1 hour at room temperature. Following this, the plates were 
washed three times with wash buffer and the IL-8/CXCL8 or RANTES/CCL5 
standards and culture supernatants diluted in a dilution buffer were loaded into the 
wells in duplicates and were incubated at room temperature for 2 hours. The same 
standard concentration range of 0.02-2ng/ml was used for both the IL-8/CXCL8 and 
RANTES/CCL5 standard curves. The plates were washed three times with wash 
buffer and lOOpl of 20ng/ml of biotinylated anti-human IL-8/CXCL8 detecting 
antibody or 5ng/ml of biotinylated anti-human RANTES/CCL5 detecting antibody 
was added onto each well and the plates were incubated at 37°C for 1 hour.
The plates were then washed three times with wash buffer and 50pl/well of 
streptavidin peroxidase (0 .2 pg/ml) was added to each well on the plates and they 
were incubated at 37°C for 30 minutes. The plates were washed another three times 
with wash buffer. Fifty ml of substrate solution was prepared, containing hydrogen 
peroxide and a lOmg OPD tablet. This was added to each well at a volume of lOOpl.
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The plates were incubated in the dark for 30 minutes for IL-8 /CXCL8 and 45 
minutes for RANTES/CCL5 to allow for colour development. After this time, the 
reaction was quenched by adding 150pl of 1M H2SO4 to each well. The optical 
density of the plates was determined at 490nm on Dynatech MR500.
3.4 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION (RT- 
PCR)
Polymerase chain reaction is a technique which is used to amplify regions of known 
size in chemokine and housekeeping mRNA of interest using specific primers. All 
recipes for buffers and solutions are found in section 3.8.4.
3.4.1 Preparation of white blood cells as positive controls for PCR
About 20ml of blood was taken from a donor using a needle and syringe containing 
50pl heparin. Blood was centrifuged in a sterile Falcon tube at 450g for 10 minutes. 
The plasma layer was discarded and an equal volume of RPMI medium was added to 
the packed cell volume at the bottom of the tube. The RPMI medium did not contain 
any added antibiotics, anti-fimgals or foetal bovine serum.
Four ml of 6 % dextran at room temperature was added to the packed cells in RPMI 
medium. The contents were inverted and mixed well and the mixture was left at 
room temperature for 30 minutes.
After 30 minutes, the contents of the Falcon tube had separated into 2 layers. The 
supernatant containing white blood cells was transferred to another sterile Falcon 
tube and washed with a large volume of RPMI medium and centrifuged at 45Og for 
10 minutes. After centrifugation, a pellet of cells was obtained and the supernatant 
was discarded. Two ml of cold sterile MilliQ water was added to the pellet of cells to 
lyse the erythrocytes (red blood cells) present in the cell pellet. The cells were gently 
mixed with the cold water and after 1 minute, RPMI medium was added to the cells 
which were washed by centrifugation for 10 minutes at 450g. If the pellet of cells
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still appeared red in colour, the erythrocytes were lysed again using 2ml of cold 
sterile MilliQ water. The white blood cells obtained were used in the RT-PCR 
experiments as a control.
If?)If unstimulated white blood cells were needed, 1ml of RNAzol B was added 
immediately to the white blood cells, the cells were pipetted, mixed well and lysed 
before they were stored in the -80°C freezer until future use.
If stimulated white blood cells were needed as positive controls, the white blood cells 
were added to about 4ml of complete RPMI medium, and seeded into a little culture 
dish. It was then stimulated with either 50ng/ml leucoagglutinin (PHA-L) or 50ng/ml 
phorbol 13-myristate 12-acetate (PMA) for 2-4 hours.
3.4.2 Total RNA isolation
Total RNA was isolated from AGS and MKN45 cells as described in 3.2.1. The same 
total RNA isolation method as described in section 3.2.1 was also performed on the 
HT-29, U937 and white blood cells which were used as positive controls in the PCR 
experiments. Total RNA was also extracted from gastric mucosa biopsies using 4-5 
pieces of gastric biopsies from the antrum or body of the stomach homogenised on 
ice with a glass homogeniser using 1ml of RNAzol B® solution.
3.4.3 Sample preparation
The total purified RNA pellets derived from AGS, MKN45, HT-29, U937, white 
blood cells and gastric mucosa biopsies were solubilised in 40pl sterile MilliQ water 
and the quantity of nucleic acid was measured by measuring the absorbance at 
260nm (section 3.2.2).
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3.4.4 DNAse treatment of RNA preparations
A DNAse treatment step was included to destroy any genomic DNA contaminants 
which might exist in the sample and give a false positive result in the reaction. The 
DNA is destroyed by using a DNAse I enzyme which works optimally in the 
presence of DNAse I reaction buffer provided in the kit. One pg of total RNA from 
each sample was made up to a volume of 8pl with DNAse/RNAse free water 
(nuclease free water). This was done in duplicate tubes enabling a negative control to 
be included in the PCR for each sample. One pi of lOxDNAse reaction buffer was 
added to each PCR tube followed by 1 pi of DNAse I enzyme. This mixture was left 
at room temperature for 15 minutes. One pi of 25mM EDTA was added to each tube 
to inactivate the DNAse reaction and the sample was heated for 10 minutes at 65°C 
in the Perkin Elmer Gene Amp 2400 thermocycler machine (Warrington, UK.)
3.4.5 Reverse-transcription
This step enabled the synthesis of complementary DNA (cDNA) from the RNA 
present in the sample, which is the template used in the PCR step. Following the 
DNAse treatment, 2 pi of oligo(dT)i2-i8 (5pM) primer were added to each tube and 
the samples were denatured at 70°C for 10 minutes. The samples were then 
immediately cooled on ice. Eight pi of a reaction mixture was added to each sample 
in 0.2 ml thin wall PCR tubes which contained 4pl of 5x reverse transcription buffer 
(50 mM Tris HC1 pH 8.3, 75 mM KCN, 3 mM MgCl2), lp l of 10 mM DTT, lp l of 
dNTP (made up from a combination of 0.5mM each of dATP, dCTP, dGTP and 
dTTP), lp l of lU/pl RNAsin, a non-competitive ribonuclease inhibitor and lp l of 
Superscript®.
The reverse-transcription enzyme(Superscript®) was not added to a duplicate tube of 
each sample (RT minus). This acts as a control for the RT positive sample indicating 
that it was not contaminated with genomic DNA.
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The PCR tubes were placed in a Perkin Elmer Gene Amp 2400 thermocycler 
(Warrington, UK) and followed a reverse transcription programme of : 42°C for 60 
minutes, 95°C for 5 minutes and hold at 4°C until the samples were removed. The 
RT products were either used immediately or stored long-term at -80°C.
3.4.6 Polymerase chain reaction (PCR)
The NCBI Genebank programme which is available on the internet was searched to 
identify human chemokine and chemokine receptor mRNA or cDNA sequences. 
Forward and reverse primers which were each 20 nucleotides long, with an optimum 
G (guanine) and C (cytosine) composition and with annealing temperatures between 
55°C and 65°C were designed using Primer 3 Design software on the internet using 
the sequences obtained from Genebank (Table 3). These primers were designed to 
generate product sizes between 200-500 base pairs. The specificity of primers for the 
required chemokine or receptor only was checked using the NCBI BLAST 
programme on the internet. Oligonucleotide primers were synthesised by Gibco.
Each RT template from an experimental sample was tested for expression of various 
CXC, CC chemokines and chemokine receptors. Each experiment included the 
reverse-transcribed sample, a negative control of nuclease-free water and the RT 
minus control which should indicate any contamination with genomic DNA. Each 
PCR reaction was carried out in a volume of 25pi in 0.2 ml PCR tubes consisting of
2.5 pi of PCR buffer and (1.5mM) Mg2+ (Roche), 200pM (final concentration) of the 
4 deoxynucleoside triphosphates dATP, dCTP, dGTP and dTTP making a total of 0.5 
pi dNTP mix, 15.6pl of nuclease free water, 2pl (500 nM-final concentration) of 
forward primer, 2pl (500 nM-final concentration) of reverse primer, 0.125pl (0.05 
U/pl) of Expand High Fidelity PCR system containing the two DNA polymerase 
enzymes Taq and Pwo. 1.25pl of template cDNA (0.1-0.75pg) was added to the PCR 
tubes. The polymerase enzymes and PCR buffers were used according to ‘Expand™ 
High Fidelity PCR system’ manufacturer’s specifications and the theimocycler was 
operated using the conditions listed below (Fig.7): 5 minutes at 94°C, 35 cycles of 30 
seconds at 94°C, 30 seconds at the annealing temperature between 56°C-65°C
Table 3. RT-PCR Primers
Probe Product 




Sense primer seauence Antisense primer sequence Accession
no.
CCR1 327 bp (56°C) ACCTGCAGCCTTCACTTTCCTCAC GGCGATCACCTCCGTCACTTG L09230
CCR2 255 bp (56°C) CCAACTCCTGCCTCCGCTCTA CCGCCAAAATAACCGATGTGATAC U03882
CCR3 315 bp (56°C) TGGCGGTGTTTTTCATTTTC CCGGCTCTGCTGTGGAT U28694
CCR4 349 bp (57°C) GAAGAAGAACAAGGCGGTGAAGA
T
ATGGTGGACTGCGTGTAAGATGAG X85740
CCR5 280 bp (56°C) TGCTACTCGGGAATCATAAAAACT TTCTGAACTTCTCCCCGA'CAAA U54994
CCR6 266 bp (56°C) ATCGTAATGAAGTTGGGGTT ATCACAAATTTCAGACCCCT U45984
CCR7 362 bp (56°C) ACTCCATCATTTGTTTCGTG TAGTATCCAGATGCCCACAC L31581
CCR8 286 bp (56°C) AGTATGCACATCTTGGATGG TGTAGTCTACGCTGGAGGAA U45983







Sense prim er seauence Antisense prim er seauence Accession
no.
CCR9/10 579 bp (56°C) CAAAGTCTTCCTCCCCCAGTCT ACC AAG AC AC AACC AAT ACG U94888
CXCR1 363 bp (58°C) GGGGCCACACCAACCTTC AGTGCCTGCCTCAATGTCTCC L19591
CXCR2 385 bp (57°C) CCGGGCGTGGTGGTGAG TCTGCCTTTTGGGTCTTGTGAATA M73969
CXCR3 293 bp (55°C) CTCCACCTAGCTGTAGCAGA AGGAAGATGAAGTCTGGGAG X95876
CXCR4 206 bp (56°C) TTCTACCCCAATGACTTGTG ATGTAGTAAGGCAGCCAACA X71635
CXCR5 465 bp (56°C) ATCTTCTTCCTCTGCTGGTG GTTCCTCTAGCTACCCCAAA X68149
CXCL8/
IL-8
562 bp (65°C) TGGGTGC AGAGGGTT GTG CAGACTAGGGTTGCCAGATTTA M28130
CXCL9/
MIG
214 bp (56°C) AAGAAGCACGTGGTAAAACA TCTCGGTGGCTATCTTGTTA X72755











229bp(56°C) CCTGCTTCAAATATTTCCCT CCTTCCTGTATGTGTTTGGA X02530
CXCL12/
SD F-la
132 bp (56°C) AG AGAT G AAAGGGC AAAG AC CGTATGCTATAAATGCAGGG U19495
CXCL13/
BCA-1
199 bp (56°C) TGGTTGTCCAAGAAAAGAAA CTATTCCCTTCTTACGTCCA AJ002211
CCL2/
MCP-1
177 bp (65°C) AGGAAGATCTCAGTGCAGAGG AGTCTTCGGAGTTTGGGTTTG X14768
CCL3/
M IP-la
257 bp (65°C) GCTGACTACTTTGAGACGAGC CCAGTCCATAGAAGAGGTAGC M23452
CCL5/
RANTES
583 bp (60°C) GCTGTCCGTTTGATTTTTGTC TGCTCATTCATCTTCTTTCTA M21121











216 bp (56°C) ACTGAACTGAAAACAAGCCA TCCAAGGCTTTATGTTCAAA X72308
CCL17/
TARC




210 bp (56°C) GATGTCAGTGCTGCTACTCC TGGGTTCAGACGGGACCTAA D86955
p-actin 176 bp (56°C) CTTTTCCAGCCTTCCTCC GCAGTAATCTCCTTCTGCATC
72
Fig. 7 A schematic diagram of the RT-PCR technique
Cells in culture
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followed by 30 seconds at 72°C. Once cycling was completed, an extension phase 
was performed for 7 minutes at 72°C and the product was held at 4°C.
3.4.7 Detection of PCR products
A 2% agarose gel was made using 0.5xTBE (lOmM Tris base, lOmM boric acid, 2 
mM EDTA, pH 8.0). The agarose was dissolved by heating in a microwave, when 
cooled 1 mg/ml of ethidium bromide was added. The gel was poured into a Bio-Rad 
gel tray and allowed to set. Five pi of sample loading buffer was added to each DNA 
sample. The samples and a lane of 100 base pair molecular weight markers were 
loaded onto the agarose-ethidium bromide gel and run by gel electrophoresis with 
100 V/0.1 mA current (Bio-Rad instruments). The resulting bands were observed on 
an ultraviolet transilluminator and photographed using a polaroid camera and film.
3.5 IMMUNOHISTOCHEMISTRY STAINING OF GASTRIC MUCOSA
3.5.1 The patients
Patient consent was obtained and permission from the local Research Ethics 
Committee was granted before this study was carried out.
Samples of gastric mucosa were obtained from patients who had been examined via 
upper gastrointestinal endoscopy at the Royal National Hospital for Rheumatic 
Diseases (RNHRD), Bath. These patients had been referred by their general 
practitioners for a variety of gastrointestinal complaints. Some patients were 
diagnosed as normal when no visual pathological conditions were detected during the 
endoscopy and also if  the ‘CLO’ test for the presence of H. pylori was negative. The 
other patient groups were patients who were diagnosed with gastritis and H. pylori 
infection and patients who had gastritis but no sign of H. pylori infection. Gastritis 
was diagnosed during the endoscopy when areas of inflammation in the stomach 
were detected.
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Gastric biopsies were taken each from the antrum and body of the stomach. 
Generally, biopsies were collected from 4 normal patients, 6 patients with H. pylori- 
associated gastritis and 4 patients with non-H. py/on'-associated gastritis. The 
numbers of biopsies collected from each patient depended on their pathological 
presentation. For the purpose of this study, 3-4 small pieces of gastric biopsies from 
the antrum and the body were collected and quickly collected in HBSS medium (pH 
7.3) on ice for later RNA extraction and PCR analysis. The HBSS medium contained 
lOOU/ml of penicillin, 100pg/ml of streptomycin, 50pg/ml of gentamycin, 2.5pg/ml 
of Amphotericin B/Fungizone , Hepes buffer and sodium bicarbonate. For 
diagnostic purposes, 1 piece of gastric biopsy from the antrum was placed into the 
medium of the ‘CLO’ test to determine the presence of the bacteria H. pylori. The 
‘CLO’ test works on the principle that the urease enzyme released by the bacteria 
converts the urea on the test medium into ammonia which results in a change in the 
colour of the phenol red present in the medium. The medium of the test would 
remain yellow if H. pylori was not present and become red in colour when there were
H. pylori present in the specimen. When more detailed investigations were required 
for certain patients, extra biopsies were taken, usually 5-6 pieces which were put into 
a small plastic container containing formalin to be sent to the pathology laboratory at 
the Royal United Hospital(RUH) in Bath. Slides of gastric biopsies embedded in 
paraffin from the biopsy specimens were provided by the pathology laboratory for 
use in our laboratory. Some of these slides were later used in our laboratory for 
immunohistochemical analysis for the chemokines SDF-la/CXCL12, BCA- 
1/CXCL13 and LARC/CCL20 and the chemokine receptor CXCR4.
3.5.2 Immunostaining for the chemokine receptor. CXCR4 and chemokines 
LARC/CCL20, SDF-la/CXCL12 and BCA-1/CXCL13
Immunohistochemistry was performed on histological slides with paraffin-embedded 
gastric biopsies using the DAKO LSAB®2 System, based on a modified labelled 
avidin-biotin (LAB) technique in which a biotinylated secondary antibody forms a 
complex with peroxidase-conjugated streptavidin molecules (DAKO) (Fig.8). All 
recipes for buffers and solutions are found in section 3.8.5.
Fig.8 A schematic diagram of the avidin-biotin technique in
immunohistochemistrv
Step 1
Application o f primary antibody
Step 2







Application o f streptavidin-enzyme conjugate 
(streptavidin binds to biotin)
Antigen
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Mouse monoclonal antibody against the human CXC chemokine receptor, CXCR4 
and chemokine LARC/CCL20, goat polyclonal antibody against the human 
chemokine BCA-1/CXCL13 and rabbit polyclonal antibody against the human 
chemokine SDF-la/CXCL12 were used in an avidin-biotin method to demonstrate 
the presence of CXCR4/LARC(CCL20)/SDF-la(CXCL12)/BCA-l(CXCL13) on the 
gastric biopsy histological slides.
Gastric biopsy sections which had been fixed in formalin and embedded in paraffin 
were mounted on APES coated slides which were supplied by the pathology 
laboratory in RUH. The mounted slides were deparaffinised twice with Citroclear for 
5 minutes each time. Slides were washed twice in 99% industrial methylated spirit 
for one minute each time. Endogenous peroxidases within the embedded tissues were 
blocked with 2.5% hydrogen peroxide in methanol for 10 minutes and rehydrated in 
distilled water for 5 minutes. The slides were then washed with TBS and then heated 
in a pressure cooker for 2 minutes and soaked immediately in tap water to prevent 
the slide from drying. The primary antibody (mouse monoclonal antibody against 
human CXCR4) was diluted 1:75 in TBS and applied to the slide and left to incubate 
at room temperature for 45 minutes. The mouse monoclonal antibody against human 
LARC/CCL20 was diluted 1:10 in TBS and added to the slides which was incubated 
at room temperature for 45 minutes.
When the anti-human BCA-1/CXCL13 antibody was used, an extra step was 
introduced to improve the quality of the staining and to decrease non-specific 
staining in the background. After the slides were pressure-cooked for 2 minutes, the 
slides were rehydrated in water and then put into a humidified box. The DAKO- 
protein block serum free solution was applied neat to the slides for 20 minutes at 
room temperature. Subsequently, the goat polyclonal antibody against human BCA- 
1/CXCL13 was diluted 1:6 in 10ml TBS containing 1 drop of DAKO protein-block 
serum free liquid in it, to block non-specific binding. The antibody against human 
BCA-1/CXCL13 was applied to slides in a humidified box and left in the refrigerator 
for 24 hours to incubate (Mazzuchelli et al., 1999). An alternative method of antigen 
retrieval was used on slides stained for LARC/CCL20. Instead of heating the slides 
for 2 minutes in a pressure cooker, the slides were subjected to enzyme digestion 
with 0.01% Pronase in TBS for 40 minutes in a humidified box which was put into
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an oven heated to 40°C. Both methods were run concurrently and comparisons were 
made. On each occasion, a negative control slide was included containing a similar 
biopsy section to which primary antibodies were not added, and the slide was 
incubated in TBS alone for the same duration in time as the slides with the primary 
antibodies.
Colour was developed on all slides using the protocol provided by DAKO. Slides 
were rinsed gently with TBS and stained with the yellow solution (biotinylated link 
goat antibody containing anti-rabbit and anti-mouse immunoglobulins in PBS) from 
the LSAB kit and incubated for 10 minutes at room temperature. The slides were 
rinsed again with TBS and treated with the red solution (streptavidin-linked to 
horseradish peroxidase) also from the LSAB kit for 10 minutes before they were 
rinsed again with TBS. The slides were then stained with a mixture of 1 ml DAB 
buffer (imidazole-HCl buffer, pH 7.5 containing hydrogen peroxide and an anti­
microbial agent) and 1 drop of chromogen (3,3’-diaminobenzidine in chromogen 
solution) and this mixture was left on the slide at room temperature for 7 minutes to 
allow colour development. The slide was then washed with tap water and immersed 
in haematoxylin for 30 seconds to 1 minute. After rinsing the slide with water to 
remove the excess haematoxylin, the slide was immersed twice for 1 minute each 
time in 99% industrial methylated spirit to dehydrate the sample. Finally, the slide 
was immersed twice in Citroclear for 3 minutes each time to remove the alcohol. 
Some mounting media was applied onto a coverslip and the sample on the slide was 
covered taking care not to trap any air bubbles against the sample. The slide was then 
left to dry for 30 minutes to 1 hour before it was examined under a light microscope.
3.5.3 Isolation of gastric epithelial cells from gastric biopsies
This method was obtained by direct communication from Dr. G. Kolios.
Small numbers of gastric epithelial cells were isolated under sterile conditions from 
gastric biopsies obtained during upper gastrointestinal endoscopies for possible 
analysis by RT-PCR. Three or four small pieces of gastric biopsies were collected in 
cold HBSS medium (pH 7.3) with added antibiotics and stored in ice. Within 1-2
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hours after collection, the tissues were washed 3 times for 3-5 minutes each time 
using the cold HBSS medium. Following this, the tissues were minced carefully 
using sterile blades and washed in HBSS medium (pH 7.3) which were free from any
9+  9+Ca and Mg ions and contained antibiotics. The tissues were then transferred into a 
mixture of 15 ml of fresh HBSS medium free from any Ca2+ and Mg2+ ions and 
containing ImM dithiothreitol (DTT) and were incubated at room temperature for 10 
minutes. The tissues were then rinsed three times and were digested with 1 mg/ml of 
Dispase which were added to the Ca2+ and Mg2+ free HBSS. This enzyme digestion 
step was carried out at 37°C for 30 minutes and the tube containing the tissues were 
vortexed every 10 minutes. At the end of this process, the tissues were dispersed 
using a 1ml Gilson pippette. The supernatants which contained the epithelial cells 
were then collected. The tissues were then subjected to the Dispase digestion once 
more. Following this, the supernatants from both Dispase treatments were added 
together and centrifuged at 20° C for 10 minutes at 200g. The pelleted cells were 
resuspended in complete RPMI medium and counted. The cell mixture was then 
centrifuged again.
The pelleted cells were then resuspended in a conical tube containing 3ml layers of 
Percoll (pH 7.4) with increasing density gradients from 0% at the top, followed by 
30%, 40%, 60% and 100% at the bottom (Fig.9). The Percoll density gradient was 
prepared by diluting the stock Percoll with RPMI complete medium. The Percoll 
density gradient was used to separate the epithelial cells from the other cells which 
were of different densities. Epithelial cells which are the least dense should be 
present at the 0%-30% interphase, a mixture of small epithelial cells and big 
lymphocytes collect at the 30%-40% interphase, the majority of lymphocytes collect 
at the 40%-60% interphase and red blood cells(erythrocytes) which are the most 
dense are found at the 60%-100% interphase. Cells layered on the Percoll density 
gradient in the conical tube was centrifuged at 500g for 30 minutes at 4°C. A small 
number of epithelial cells which were at the 0%-30% interphase of the Percoll 
gradient were collected and centrifuged for 10 minutes at 4°C and 200g. The pelleted 
epithelial cells were then resuspended in complete RPMI medium and counted before 
they were seeded into a small, sterile petri dish and incubated at 37°C. Isolating 
enough cells from the small pieces and small numbers of biopsies for
Fig. 9 A schematic diagram of the Percoll density gradient used to isolate gastric epithelial cells
The majority of isolated epithelial cells
A mixture of epithelial cells and lymphocytes
The majority of lymphocytes
Red blood cells
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further experimentation was difficult. The epithelial cell yield should have been 
greater had it been possible to use gastric surgical specimens.
3.6 Statistical Analysis
Each experiment was carried out 2-3 times. In the ELISA experiments, the samples 
were run in duplicate on each ELISA plate. The samples were subjected to a one-way 
ANOVA (analysis of variance) followed by a Dunnett’s test which compared the 
results per group to the controls. The data were shown as the mean ± the standard 
error of the mean (SEM). Results which had a probability value of less than 0.05 
(p<0.05) were taken to be statistically significant. It should be noted that the ELISA 
data is unlikely to come from a normal population and hence the validity of the 
statistical analysis is low.
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3.7 MATERIALS
Table 4. A list of materials used and their sources
MATERIAL SOURCE
Absolute ethanol Hayman Ltd.(Witham ,UK)
Acetic acid Aldrich (Gillingham, UK)
Agarose Gibco BRL (Paisley, UK)
Amphotericin B (Fungizone)® Gibco BRL (Paisley, UK)
BCA-1/CXCL13: Goat anti-human 
polyclonal antibody (diluted in TBS to 
make 0.5mg/ml stock)
R & D Systems (Abingdon,UK)
Blocking reagent (for Northern analysis) Roche (Lewes, UK)
Boric acid Sigma (Poole, UK)
Bovine serum albumin (BSA) Sigma (Poole, UK)
Bromophenol blue BDH (Poole, UK)
Cell culture plastics Nunc/Life Technologies (Paisley, UK)
Chloroform Fisons (Loughborough, UK)
Citric acid monohydrate Sigma (Poole, UK)
Citroclear HD Supplies (Poole, UK)
Cold trypsin BioGenex (Berkshire, UK)
CSPD Roche (Lewes, UK)
CXCR4 (Fusin): Purified mouse anti­
human monoclonal antibody (diluted in 
TBS to make lmg/ml stock)
Pharmingen (Oxford, UK)
DAB substrate chromogen solution (3,3- 
diaminobenzidine in chromogen solution)
DAKO (Ely, UK)
Diethyl pyrocarbonate (DEPC) Sigma (Poole, UK)
5’ Digoxigenin labelled probes (cocktails 
containing 3 and 4 antisense 30-mer 
oligonucleotides for IL-8, RANTES and 
p-actin)
R & D Systems (Abingdon, UK)
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MATERIAL SOURCE
Digoxigenin chemiluminescent detection 
kit for Northern blotting
Roche (Lewes, UK)
Dimethyl sulphoxide (DMSO) Sigma (Poole, UK)
Dispase Gibco BRL (Paisley, UK)
Dithiotreitol (DTT) Sigma (Poole, UK)
DNA(lOObp) ladder Gibco BRL (Paisley, UK)
DNAse I Gibco BRL (Paisley, UK)
DNAse reaction buffer Gibco BRL (Paisley, UK)
dNTP Roche (Lewes, UK)
Ethanol Fisher Scientific (Loughborough, UK)
Ethidium bromide Sigma (Poole, UK)
Ethylenediaminetetraacetic acid (EDTA) Sigma (Poole, UK)
Expand polymerase Roche (Lewes, UK)
Ficoll Sigma (Poole, UK)
Filter paper (Whatman) Whatman (Cambridge, UK)
Filter tips (10,20,200 pi) Greiner (Gloucestershire, UK)
Foetal bovine serum (FBS)(heat- 
inactivated)
Gibco BRL (Paisley, UK)
Formaldehyde BDH (Poole, UK)
Formamide BDH (Poole, UK)
Glacial acetic acid Fisons (Loughborough, UK)
Glycerol Fisher Scientific (Loughborough, UK)
Goat anti-mouse peroxidase conjugate DAKO (Ely, UK)
Goat anti-rabbit peroxidase conjugate DAKO (Ely, UK)
Haematoxylin/eosin stains SurgiPath (Bretton, UK)
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MATERIAL SOURCE
Ham’s F I2 Nutrient mixture medium Gibco BRL (Paisley, UK)
Hank's balanced salt solution (HBSS)(pH 
7.3)
GibcoBRL (Paisley, UK)
Hepes buffer Gibco BRL (Paisley, UK)
Hydrochloric acid Fisher Scientific (Loughborough, UK)
Hydrogen peroxide (30% v/v solution) Sigma (Poole, UK)
H2S 04 Fisher Scientific (Loughborough, UK)
IFN-y: human recombinant protein; 
specific activity > 2 X 107 U/mg (diluted 
in sterile PBS + 0.1% (w/v) BSA and 
stored in lOpl aliquots (106U/ml) at 
-70° C)
Roche (Lewes, UK)
IL -la: human recombinant protein; 
specific activity > 1 X 109 U/mg (diluted 
in sterile PBS + 0.1% (w/v) BSA and 
stored in 20pl aliquots (lOpg/ml) at 
-20° C)
PeproTech (London, UK)
IL-4: human recombinant protein; 
specific activity > or = 2 X 106 U/mg 
(diluted in sterile PBS + 0.1% (w/v) BSA 
and stored in 20pl aliquots (100pg/ml) at 
-20°C)
PeproTech (London, UK)
Anti-IL-8/CXCL8 antibody: mouse anti­
human monoclonal antibody (ELISA 
coating antibody) (diluted in PBS and 
stored in 20pl (2pg/ml) aliquots at -20°C)
R & D Systems (Abingdon, UK)
Anti-IL-8/CXCL8 antibody: biotinylated 
mouse anti-human monoclonal antibody 
(ELISA detecting antibody) (diluted in 
PBS and stored in 4pi aliquots (20ng/ml) 
at -20°C
R & D Systems (Abingdon, UK)
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MATERIAL SOURCE
IL-13: purified protein from culture 
supernatants of stable transfected CHO 
cells (Minty et al., 1993) (diluted in 
sterile PBS + 0.1% (w/v) BSA and stored 
in 5 pi aliquots (5pg/ml) at -70°C)
Gift from Dr. A. Minty (Sanofi 
Recherche, Labege, France)
Industrial methylated spirits (IMS) 99% Fisher Scientific (Loughborough, UK)
LSAB kit for immunohistochemistry DAKO (Ely, UK)
Maleic acid Sigma (Poole, UK)
Methanol Fisons, Loughborough (UK)
Anti-human MIP-3a/LARC/CCL20 
antibody: Mouse anti-human antibody 
(reconstituted in PBS to make a stock 
solution of 1 mg/ml and stored at -20°C)




Nuclease-free water Promega (Southampton, UK)
Nylon membranes (positively charged) Roche (Lewes, UK)
Oligo (dT)i2_i8 primer Roche (Lewes, UK)
OPD tablets (o-phenylene-diamine 
(dihydrochloride)
Sigma (Poole, UK)
Pastettes, 3 & 9 inches Alpha lab (Hampshire, UK)
PCR buffer + M g" Roche (Lewes, UK)
PCR tubes Anachem (Luton, UK)
PCR primers (synthesised according to 
sequences provided)
Gibco BRL (Paisley, UK)
Percoll Amersham Pharmacia Biotech (Little 
Chalfont, UK)
PHA-L (leucoagglutinin) Sigma (Poole, UK)
Phosphate buffered saline (PBS) without 
Ca2+ and Mg2+
Gibco BRL (Paisley, UK)
Plastic 7ml pots with lids BIBBY Sterilin (Staffordshire, UK)
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MATERIAL SOURCE
Plastic 60 & 100 ml pots with lids BIBBY Sterilin (Staffordshire, UK)
PMA(phorbol 13-myristate 12-acetate) Sigma (Poole, UK)
Polaroid film (type 55) Sigma (Poole, UK)
Pronase DAKO (Ely, UK)
Propan-2-ol Fisons (Loughborough,UK)
Anti RANTES/CCL5 antibody: mouse 
anti-human monoclonal antibody 
(RANTES coating antibody) (diluted in 
PBS and stored in 20pl aliquots 
(500pg/ml) at -20°C)
R & D Systems (Abingdon, UK)
Anti RANTES/CCL5 antibody: 
biotinylated goat anti-human polyclonal 
antibody (RANTES detecting antibody) 
(diluted in PBS and stored in aliquots of 
lOpg/ml at -20°C)
R & D Systems (Abingdon, UK)
Protein block-serum free liquid DAKO (Ely, UK)
RNAsin Promega (Southampton, UK)
RNAzol B® Tel Test (Texas, USA)
RPM I1640 medium Gibco BRL (Paisley, UK)
Sarcosyl BDH (Poole, UK)
SDF-la: purified rabbit anti-human 
polyclonal antibody (diluted in TBS to 
make 1 mg/ml stock)
Peprotech (London, UK)
Sodium acetate Sigma (Poole, UK)
Sodium azide Sigma (Poole, UK)
Sodium bicarbonate Gibco BRL (Paisley, UK)
Sodium chloride BDH (Poole, UK)
Sodium dodecyl sulfate (SDS) Sigma (Poole, UK)
Sodium hydroxide Sigma (Poole, UK)
Sodium sulphite Sigma (Poole, UK)
8 6
MATERIAL SOURCE
Streptavidin peroxidase (diluted in PBS 
and stored in aliquots at -20°C)
Sigma (Poole, UK)
Sucrose BDH (Poole, UK)
Superscript Pharmacia (Little Chalfont, UK)
TNF-a: human recombinant protein; 
specific activity 6X 107 U/mg (diluted in 
sterile PBS + 0.1% (w/v) BSA and stored 
in lOOpl aliquots (lOOpg/ml) at -20°C)
Gift from Bayer (Slough, UK)
Trisodium citrate dihydrate Aldrich (Gillingham, UK)
Trizma base Sigma (Poole, UK)
Trypsin/EDTA solution Gibco BRL (Paisley, UK)
Tween 20 (polyoxyethylene 20 sorbitan 
monolaurate)
Sigma (Poole, UK)
X-Omat Film Amersham International (Little Chalfont, 
UK)
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3.8 BUFFERS AND SOLUTIONS
3.8.1 Solutions and reagents for cell culture
Tissue culture reagents were (from Gibco unless stated) were used for cell cultures 
and all solutions were made using sterile MilliQ water.





Foetal calf/bovine serum (FCS/FBS)
FCS/FBS (Gibco) was heat-inactivated at 56°C and aliquoted and stored at -20°C. 
HBSS (pH 7.31
10 ml of HBSS (10X) (with calcium and magnesium)
0.6 ml of 7.5% sodium bicarbonate 
2 ml of 1MHEPES 
100 U/ml of Penicillin 
100 pg/ml of streptomycin
2.5 pg/ml of Amphotericin B/Fungizone®
50 pg/ml of gentamicin
8 8
3.8.2 Solutions and buffers for Northern Analysis 
DEPC-treated water or buffer
MilliQ water or buffer were treated with 1 ml of diethyl pyrocarbonate (DEPC, 
Sigma) per litre of water and incubated overnight at 37°C and autoclaved the 
following day for 20 minutes at 121°C. The DEPC was handled in the fiime 
cupboard.
20% (w/v) SDS solution
20g SDS diluted in 100 ml sterile MilliQ water.
0.1% (w/v) SDS solution
20% (w/v) SDS diluted 1:200 using sterile MilliQ water
0.5 M EDTA stock solution. pH 8.0 (when diluted, used to make 20X MOPS 
running buffer)
0.5 M EDTA in MilliQ water, pH adjusted to 8.0 and autoclaved.
3 M Sodium acetate. pH 5.2 (when diluted, used to make 20X MOPS running 
buffer)
3 M Na acetate dissolved in 250 ml MilliQ water. pH adjusted to 5.2 with 3 M acetic 
acid. DEPC treated and autoclaved.
75% (v/v) Ethanol Solution
75 ml absolute ethanol added to 25ml of MilliQ water.
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Ethidium bromide
10 mg ethidium bromide dissolved in 10 ml DEPC-treated water.
(stored in the dark)
20 X MOPS running buffer, pH 7.0
0.4 M MOPS
0.02 M EDTA 4 ml (from 0.5 M stock)
0.2 M Na acetate 6.64 ml (from 3 M stock)
Volume adjusted to 100 ml with MilliQ water and pH adjusted to 7.0 with solid 
NaOH.
IX MOPS running buffer
50 ml 20 X MOPS running buffer diluted with 950 ml DEPC-treated water.
Bromophenol blue solution
0.025 g bromophenol blue 
3 ml glycerol
Volume adjusted to 10 ml with DEPC-treated water 
20 X SSC. pH  7.0 
3M NaCl
0.3M Na citrate or trisodium citrate dihydrate
Volume adjusted to 1 L with MilliQ water, pH adjusted to 7.0, DEPC-treated and 
autoclaved.
90
Buffer 1, pH 7.5
0.1 M maleic acid 
0.15 MNaCl
pH adjusted to 7.5 with solid NaOH
Volume adjusted to 1 L with MilliQ water, DEPC-treated and autoclaved.
Blocking stock solution
10 g Boehringer blocking reagent in 100 ml buffer 1. Microwaved to dissolve (do not 
boil). Autoclaved.
Hybridisation solution
5 X SSC 25 ml (from 20 X SSC)
0.1% Sarcosyl 0.5 ml (from 20% stock)
0.02% SDS 0.1 ml (from 20% stock)
1 % blocking buffer 10 ml (from 10% stock)
Volume adjusted to 100 ml with DEPC-treated water
2 X SSC. 0.1% SDS
50 ml of 20 X SSC
2.5 ml of SDS (from 20% stock)
Volume adjusted to 500 ml with DEPC-treated water.
0.1 X SSC. 0.1% SDS
2.5 ml of 20 X SSC
2.5 ml of SDS (from 20% stock)
Volume adjusted to 500 ml with DEPC-treated water.
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Washing buffer
0.3% (v/v) in buffer 1.
Buffer 2
10% (v/v) blocking stock solution in buffer 1.
Buffer 3, pH 9.5
0.1 M TRIS 
0.1 MNaCl
Volume adjusted to 500 ml with MilliQ water and pH adjusted to 9.5
3.8.3 Solutions and buffers for ELISA
Bovine serum albumin (BSA)
10% (w/v) in MilliQ 
Stored in 1 ml aliquots at -20°C
Phosphate buffered saline (PBS). pH 7.4
Same as for section 2.9.1
Wash buffer
1 L of PBS, pH 7.4 







Filter sterilised and frozen in aliquots of 9.5 ml
Tris buffered saline (TBS), pH7.3
20mM of TRIZMAbase 
150mM ofNaCl
MilliQ added to the specified volume, pH adjusted to 7.3
Dilution buffer
0.5 ml of 10% BSA stock
25 pi of Tween 20
TBS added till the volume 50 ml
Streptavidin peroxidase
1:2000 dilution of 1 mg/ml stock in dilution buffer
Substrate buffer, pH  5.0
7.3 g of citric acid monohydrate 
9.46 g of Na2H P04
Volume adjusted with MilliQ water to 1 L, pH adjusted to pH 5.0 
Substrate solution
50 ml of substrate buffer (37°C)
1 OPD tablet
20 pi hydrogen peroxide
Stopping solution
27 ml of concentrated H2 SO4  made up to 500 ml with MilliQ water
3,8.4 Solutions and buffers for RT-PCR 
5 X TBE stock
54 g of Trizma base
27.5 g of boric acid
20 ml of EDTA (pH 8.0)
Volume adjusted to 1 L
Sample loading buffer
0.25% bromophenol blue 
15% Ficoll (type 400) in water
3.8.5 Solutions and buffers for immunohistochemistry
Blocking reagent
5 ml of hydrogen peroxide 
200 ml of methanol
Tris buffered saline (TBS). pH 7.6
50 mM Tris
150 mM NaCl
pH adjusted to 7.6 with HC1
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Citrate buffer
29.4 g sodium citrate 
27 ml 2M HC1
Volume made up to 10 L and pH adjusted to pH 6.0
4.0 RESULTS
4.1 CHEMOKINE mRNA EXPRESSION BY AGS AND MKN45 GASTRIC
EPITHELIAL CELL LINES IN RESPONSE TO CYTOKINE STIMULATION
In the following results section, the expression and regulation of chemokines have 
been investigated by Northern analysis in the gastric epithelial cell lines AGS and 
MKN45, which are models of ‘real’ gastric epithelial cell lines. These cell lines have 
been used to investigate chemokine expression in place of real isolated gastric 
epithelial cells which are difficult to isolate in large numbers and when they are 
isolated, they are difficult to maintain in culture as they rapidly undergo apoptosis 
(programmed cell death). Northern analysis of chemokine expression was attempted 
on freshly isolated human gastric epithelial cells, but due to low cell numbers and 
rapid cell death, it was not possible to obtain sufficient RNA for chemokine analysis.
IL-8/CXCL8 mRNA has been investigated as an example of the neutrophil 
chemoattractant from the ‘CXC’ chemokine family and RANTES/CCL5 was studied 
as a T cell chemoattractant from the ‘CC’ chemokine family. Pro-inflammatory 
cytokines, IL -la, TNF-a and IFN-y were chosen as stimulants used to activate the 
cells as they are produced by immune cells infiltrating the gastric epithelium during 
infections with H. pylori (Wilson et al., 1998) or during other inflammatory 
conditions. These cytokines have previously been shown in this laboratory to induce 
chemokines in a number of non-immune cell types including fibroblasts, smooth 
muscle cells (Jordan et al., 1997), mesangial cells (Brown et al., 1994; Robson et al., 
1995 (a); Robson et al., 1995(b)) and colonic epithelial cells (Kolios et al., 1999).
4.1.1 IL-8/CXCL8 mRNA expression
All experiments were performed in growth arrested cells which had been cultured in 
Ham’s F12 nutrient medium for the AGS cells or RPMI medium for the MKN45 
cells in the absence of foetal bovine serum overnight prior to the experiment and 
throughout the course of the experiment.
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Confluent monolayers of AGS cells were stimulated with IL -la  (3ng/ml), TNF-a 
(30ng/ml) and IFN-y (lOOU/ml) alone or in combination. Experimental controls were 
cells unstimulated and maintained in serum-free medium throughout the course of 
the experiment. When the three cytokines were added together, this combination was 
called 'cytomix'. The concentrations used in the present study have previously been 
shown in this laboratory to cause maximum stimulation of chemokine expression in a 
number of different ‘non-immune’ cell types (Brown et al., 1994; Robson et al., 
1995; Jordan et al., 1997; Kolios et al., 1999). The experiments were carried out at 
these time intervals 1, 2, 4, 6, 12, 24 and 48 hours to enable a pattern of chemokine 
expression to be determined.
AGS
Detectable IL-8/CXCL8 mRNA was not expressed constitutively by the AGS cell 
line incubated with medium alone. In the AGS cell line, stimulation with IL -la  
(3ng/ml) alone resulted in a time-dependent IL-8/CXCL8 mRNA expression with 
maximum detection 1 hour post-stimulation, which then decreased rapidly. 
Expression of IL-8/CXCL8 mRNA was short-lived in response to IL -la  (Fig.10). As 
shown in F ig .ll, TNF-a(30ng/ml) induced a more prolonged expression of IL- 
8/CXCL8 mRNA in AGS cells, which was still detectable up to 24 hours post­
stimulation, but levels had decreased. IL-la(3ng/ml) and TNF-a(30ng/ml) added in 
combination, induced an early maximum expression at 2 hours post-stimulation and 
the expression was detectable at high levels until 6 hours following which the 
expression decreased (Fig. 12).
IFN-y(100U/ml) alone did not induce IL-8/CXCL8 mRNA expression (results not 
shown) and did not affect IL-la(3ng/ml) or TNF-a(30ng/ml) response in 
combination (Figs. 13 & 14).
IFN-y(100U/ml), TNF-a(30ng/ml) and IFN-y(100U/ml) combination (Fig. 15) 
induced IL-8/CXCL8 mRNA expression rapidly with a maximum expression at 1-2 














Time course of the expression of IL-8 /CXCL8 mRNA by 
AGS cells stimulated with IL -la  (3ng/ml)
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AGS cells were stimulated with IL -la  (3ng/ml) from 1-48 hours.
‘C’ represents unstimulated control cells which were incubated in 
medium only. At the appropriate times the cells were lysed into 
‘RNAzol B’. RNA was extracted and run on 1% agarose/formaldehyde 
gels. IL-8 mRNA was detected by Northern analysis (top panel). 
Relative amounts of IL-8 mRNA were measured by scanning 
densitometry (middle panel). The bottom panel shows the 
ethidium bromide-stained 18S and 28S bands indicating equal 
loading of the lanes. Representative of three independent experiments.
Fig.ll
Time course of the expression of IL-8/CXCL8 mRNA by AGS 
cells stimulated with TNF-a (30ng/ml)
120 t
100 "
I  s  /A






C 1 2 4 6 12 24 48 
Time (h)
M 1L
AGS cells were stimulated with TNF-a (30ng/ml) from 1-48 hours.
‘C’ represents unstimulated control cells incubated in medium only.
At the appropriate times the cells were lysed into ‘RNAzol B’. RNA was 
extracted and run onto a 1% agarose/formaldehyde gel. IL-8 mRNA was 
detected by Northern analysis (top panel). Relative amounts of IL-8 
mRNA were measured by scanning densitometry (middle panel). The 
bottom panel represents the ethidium bromide- stained 18S and 28S bands 
indicating equal loading of the lanes. Representative of three independent 
experiments.
Fig. 12
The time course of IL-8/CXCL8 mRNA expression by AGS cells 
stimulated with IL -la  (3ng/ml) and TN F-la (30ng/ml)
Fig.13
The time course of IL-8/CXCL8 mRNA expression by
AGS cells stimulated with IL -la  (3ng/ml) and IFN-y
(lOOU/ml)
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AGS cells were stimulated with a combination of IL -la  and TNF-a from 1-48 
hours. ‘C’ represents unstimulated control cells incubated in medium only.
At the appropriate times, the cells were lysed into ‘RNAzol B \ RNA was extracted 
and run onto a 1% agarose/formaldehyde gel. Relative concentrations of IL-8 mRNA 
was detected by scanning densitometry (middle panel). The bottom panel shows the 
ethidium bromide-stained 18S and 28S bands indicating equal loading of the lanes. 
Representative of three independent experiments.
AGS cells were stimulated with IL -la  and IFN-y from 1-48 hours. ‘C’ 
represents unstimulated control cells incubated in medium only. At the 
appropriate times the cells were lysed into ‘RNAzol B’. RNA was extracted and 
run on 1% agarose/formaldehyde gels. IL-8 mRNA was detected by Northern 
analysis (top panel). Relative amounts of IL-8 mRNA were measured by 
scanning densitometry (middle panel). The bottom panel shows the ethidium 
bromide-stained 18S and 28S bands indicating equal loading of the lanes. 
Representative of three independent experiments.
Fig.14
The time course of IL-8/CXCL8 mRNA expression by













AGS cells were stimulated with TNF-a and IFN-y from 1-48 hours. ‘C’ represents 
unstimulated control cells which were incubated in medium only. At the 
appropriate times, the cells were lysed into ‘RNAzol B \ RNA was extracted and 
run onto a 1% agarose/formaldehyde gel. IL-8 mRNA was detected by Northern 
analysis (top panel). IL-8 mRNA was detected by scanning densitometry (middle 
panel). The bottom panel is the ethidium bromide-stained 18S and 28S bands 














The time course of IL-8/CXCL8 mRNA expression by 
AGS cells stimulated with IL -la  (3ng/ml), TN F-la 
(30ng/ml) and IFN-y (lOOU/ml)




AGS cells were stimulated with cytomix from 1-48 hours. ‘C’ represents 
unstimulated control cells which were incubated in medium only. At the 
appropriate times, the cells were lysed into ‘RNAzol B \ RNA was extracted 
and mn onto a 1% agarose/formaldehyde gel. IL-8 mRNA was detected by 
Northern analysis (top panel). IL-8 mRNA was detected by scanning 
densitometry (middle panel). The bottom panel is the ethidium bromide- 
stained 18S and 28S bands indicating equal loading of the lanes. 
Representative of three independent experiments.
1 0 0
much more prolonged IL-8/CXCL8 mRNA expression than occurred with any of the 
stimulations individually.
MKN45 cells
MKN45 cells did not express IL-8/CXCL8 mRNA constitutively when the cells were 
incubated overnight with medium alone. This is indicated as “C” in all figures.
Stimulation with IL-la(3ng/ml) resulted in rapid IL-8/CXCL8 mRNA expression 
which was very short-lived, with very low detectable levels between 2-24 hours 
(Fig. 16). As was seen in the AGS cells, TNF-a(30ng/ml) induced a more sustained 
response in MKN45 cells lasting up to 6 hours post-stimulation. The maximum 
expression was still rapid occurring at 1 hour post-stimulation (Fig. 17).
IL-la(3ng/ml) and TNF-a(30ng/ml) added in combination induced high expression 
of IL-8/CXCL8 mRNA from 1-6 hours (Fig. 18). Stimulation with IFN-y alone did 
not induce IL-8/CXCL8 mRNA expression (results not shown). As shown in Fig. 19, 
IFN-y(100U/ml) added in combination with IL-la(3ng/ml) induced a small 
prolonged expression of IL-8/CXCL8 mRNA than occured with IL-lot(3ng/ml) 
alone. Peak expression occured rapidly at 1 hour and response was not detected after 
4 hours stimulation.
Combination TNF-oc(30ng/ml) and IFN-y(100U/ml) demonstrated a very similar 
result to TNF-a(30ng/ml) alone indicating that in this cell line, IFN-y(100U/ml) did 
not significantly regulate IL-8/CXCL8 mRNA expression (Fig.20).
Similarly, ‘cytomix’ stimulation resulted in IL-8/CXCL8 mRNA expression as seen 
with IL-la(3ng/ml) and TNF-a(30ng/ml) in combination, again suggesting that IFN- 
y(100U/ml) does not have an effect (Fig.21).
Fig.16
The time course of IL-8/CXCL8 mRNA expression by MKN45 
cells stimulated with IL -la  (3ng/ml)
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MKN45 cells were stimulated with IL -la  from 1-48 hours. ‘C’ 
represents unstimulated control cells incubated in medium only.
At the appropriate times, the cells were lysed into ‘RNAzol B \
RNA was extracted and run onto a 1% agarose/formaldehyde gel.
IL-8 mRNA was detected by Northern analysis (top panel). Relative 
concentrations of IL-8 mRNA were detected by scanning densitometry 
(middle panel). The bottom panel is the ethidium bromide-stained 18S 














The time course of IL-8/CXCL8 mRNA expression by MKN45 
cells stimulated with TNF-a (30ng/ml)
Time (h)
MKN45 cells were stimulated with TNF-a from 1-48 hours. ‘C’ represents 
unstimulated control cells incubated in medium only. At the appropriate times, 
the cells were lysed into ‘RNAzol B \ RNA was extracted and run onto a 1% 
agarose/formaldehyde gel. IL-8 mRNA was detected by Northern analysis (top 
panel). Relative concentrations of IL-8 mRNA were detected by scanning 
densitometry (middle panel). The bottom panel is the ethidium bromide-stained 
18S and 28S bands indicating equal loading of the lanes. Representative of three 
independent experiments.
Fig.18
The time course for IL-8/CXCL8 mRNA expression by MKN45
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MKN45 cells were stimulated with IL -la  and TNF-a from 1-48 hours. ‘C’ represents 
unstimulated control cell which were incubated in medium only. At the appropriate 
times, the cells were lysed into ‘RNAzol B \ RNA was extracted and run on a 1% 
agarose/formaldehyde gel. IL-8 mRNA was detected by Northern analysis (top panel). 
Relative concentrations of IL-8 mRNA was detected by scanning densitometry 
(middle panel). The bottom panel is the ethidium bromide-stained 18S and 28S bands 
indicating equal loading. Representative of three independent experiments.
Fig.19
Time course of the expression of IL-8/CXCL8 mRNA 
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MKN45 cells were stimulated with IL -la  and IFN-y from 1-48 hours. ‘C’ 
represents unstimulated control cells which were incubated in medium only.
At the appropriate times, the cells were lysed into ‘RNAzol B’. RNA was extracted 
and run on a 1% agarose /formaldehyde gel. IL-8 mRNA was detected by Northern 
analysis (top panel). Relative concentrations of IL-8 mRNA were detected by 
scanning densitometry (middle panel). The bottom panel is the ethidium bromide- 
stained 18S and 28S bands indicating equal loading. Representative of three 
independent experiments.
Fig.20 Fig.21
The time course for IL-8/CXCL8 mRNA expression by 
MKN45 cells stimulated with TNF-a (30ng/ml) and 
IFN-y (lOOU/ml)
Time (h)
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The time course for IL-8/CXCL8 mRNA expression by MKN45






MKN45 were stimulated with TNF-a and IFN-y from 1-48 hours. ‘C’ represents 
unstimulated control cells which were incubated in medium only. At the appropriate 
times, the cells were lysed into ‘RNAzol B \ RNA was extracted and run on 1% 
agarose/ formaldehyde gel. IL-8 mRNA was detected by Northern analysis (top panel). 
Relative concentrations of IL-8 mRNA were detected by scanning densitometry 
(middle panel). The bottom panel is the ethidium bromide-stained 18S and 28S bands 
indicating equal loading of the lanes. Representative of three independent experiments.
MKN45 were stimulated with cytomix from 1-48 hours. ‘C’ represents 
unstimulated control cells which were incubated in medium only. At the appropriate 
times, the cells were lysed into ‘RNAzol B \ RNA was extracted and run on 1% 
agarose/formaldehyde gel. IL-8 mRNA was detected by Northern analysis (top panel). 
Relative concentrations of IL-8 mRNA were detected by scanning densitometry 
(middle panel). The bottom panel is the ethidium bromide-stained 18S and 28S bands 
indicating equal loading of the lanes. Representative of three independent experiments.
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4.1.2 RANTES/CCL5 mRNA expression
RANTES/CCL5 mRNA expression was investigated using Northern analysis on 
AGS cells stimulated in a number of experiments with IL-la(3ng/ml), TNF- 
a  (30ng/ml) and IFN-y(100U/ml) alone and in all possible combinations from 1-48 
hours. RANTES/CCL5 mRNA transcripts were not detected in the AGS cell line 
(results not shown).
MKN45 cells
In MKN45 cells, RANTES/CCL5 mRNA was detected. Requirements for the 
activation and time course of expression were very different from IL-8/CXCL8 
mRNA expression. The minimum stimuli needed to induce expression of 
RANTES/CCL5 mRNA was TNF-a(30ng/ml) and IFN-Y(100U/ml) in combination 
(Fig.22). The only other stimuli which could induce RANTES/CCL5 mRNA 
expression was a combination of IL-la(3ng/ml), TNF-a(30ng/ml) and IFN- 
y(100U/ml) (Fig.23). In contrast to the expression of IL-8/CXCL8 mRNA 
expression, RANTES/CCL5 mRNA expression was also late in onset. 
RANTES/CCL5 mRNA was expressed from 6 hours post-stimulation with a peak at 
12 hours. A combination of TNF-oc(30ng/ml) and IFN-y(100U/ml) with the addition 
of IL-la(3ng/ml) did not induce a different RANTES/CCL5 mRNA expression 
indicating that IL-la(3ng/ml) had no effect. Again, a late peak at 12 hours was 
detected.
Fig.22
Time course of the expression of RANTES/CCL5 mRNA
by MKN45 cells stimulated with TNF-a (30 ng/ml) and
IFN-y (lOOU/ml)
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MKN45 cells were stimulated with TNF-a and IFN-y from 1-48 hours. C 
represents unstimulated control cells which were incubated in medium only. 
At the appropriate times the cells were lysed into ‘RNAzol B’. RNA was 
extracted and mn on 1% agarose/formaldehyde gels. RANTES mRNA 
was detected by Northern analysis (top panel). Relative amounts of RANTES 
mRNA were measured by scanning densitometry (middle panel). The bottom 
panel shows the ethidium bromide-stained 18S and 28S bands indicating 
equal loading of the lanes. Representative of three independent experiments.
Fig.23
Time course of the expression of RANTES/CCL5 
mRNA by MKN45 cells stimulated with IL -la  (3ng/ml), 
TNF-a (30ng/ml) and IFN-y (lOOU/ml)
120 t




MKN45 cells were stimulated with IL-la, TNF-a and IFN-y for 
1-48 hours. C represents unstimulated control cells which were 
incubated in medium only. At the appropriate times the cells were 
lysed into ‘RNAzol B’. RNA was extracted and mn on 1% 
agarose/formaldehyde gels. RANTES mRNA was detected by 
Northern analysis (top panel). Relative amounts of RANTES 
mRNA were measured by scanning densitometry (middle panel). 
The bottom panel shows the ethidium bromide-stained 18S and 
28S bands indicating equal loading of the lanes. Representative of 
three independent experiments.
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4.2 SECRETION OF THE IL-8/CXCL8 PROTEIN BY AGS AND MKN45 
CELL LINES DETECTED BY ELISA
Enzyme-linked immunoassays (ELISA) were carried out to determine whether IL- 
8/CXCL8 and RANTES/CCL5 mRNA expressed by the AGS and MKN45 cells was 
translated into secreted protein. The chemokine protein was measured in supernatants 
collected from the cell cultures, after the cells had been stimulated with high 
concentrations of the cytokines. IL-8/CXCL8 secreted by the AGS and MKN45 cell 
lines which had been stimulated with IL -la  (lOng/ml) alone, TNF-a (lOOng/ml) 
alone or ‘cytomix’ (300U/ml) were measured during a time course from 1-72 hours. 
Higher concentrations of the pro-inflammatory cytokines were used in the ELISA 
experiments compared to those used in the Northern analysis experiments. This was 
to ensure that maximum levels of IL-8/CXCL8 and RANTES/CCL5 protein were 
secreted by these cell lines in anticipation of possible down-regulation by anti­
inflammatory cytokines (IL-4 or IL-13) which would be used together with the pro- 
inflammatory cytokines in the subsequent experiments. RANTES/CCL5 protein 
secretion expression by the MKN45 cells were also measured during a time course 
from 1-72 hours when the MKN45 cells were stimulated with TNF-a(100ng/ml) and 
IFN-y(300U/ml) in combination or ‘cytomix’, which was made up of IL- 
la(10ng/ml), TNF-a(100ng/ml) and IFN-y(300U/ml).
4.2.1 Secretion of IL-8/CXCL8 protein by the AGS cells stimulated with IL- 
la(10ng/mD or TNF-a (IQOng/mO or ‘cytomix’ during a time course
IL-8/CXCL8 protein was not secreted constitutively by unstimulated AGS cells. 
However, stimulation with either one of the cytokines or ‘cytomix’ indicated that 
very low levels of secreted IL-8/CXCL8 could be detected as early as 1 hour post­
stimulation (Fig.24). Very similar levels were secreted at 1 hour post-stimulation 
with IL -la  which was 0.61 ng/ml and 0.34 ng/ml when the AGS cells were 
stimulated with TNF-a. The expression in IL-8/CXCL8 increased up to 24 and 48 
hours, by a similar rate and started to slow between 48-72 hours. This decrease was 
probably due to the fact that the cells were beginning to enter apoptosis since they
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had been in the absence of foetal calf serum for a long period of time or that the 
mRNA expression was short-lived and was not being translated after 24 hours.
The stimulation with IL-la, TNF-a and IFN-yin combination (cytomix) yielded a 
more rapid and higher secretion of IL-8/CXCL8, due to an addition of the separate 
IL -la  and TNF-a effects. These results indicated that a combination of IL -la  and 
TNF-a, that induced high IL-8/CXCL8 mRNA expression was translated into high 
levels of secreted IL-8/CXCL8.
4.2.2 The secretion of IL-8/CXCL8 protein by the MKN45 cell line stimulated 
with IL -la  (lOng/ml) or TNF-a (lOOng/ml) or ‘cytomix’ during a time course
Similar to the results obtained in the Northern analysis experiments and also similar 
to the results of the IL-8/CXCL8 ELISA obtained from the AGS cell line, the 
MKN45 cells did not secrete any IL-8/CXCL8 protein when unstimulated (Fig.25).
When the MKN45 cell line was stimulated with IL-la(10ng/ml), low levels of IL- 
8/CXCL8 protein was secreted in a time-dependent manner. This suggests that IL- 
l a  is a fairly weak stimulant in this cell line as it was also shown to induce very 
short-lived IL-8/CXCL8 mRNA expression. The MKN45 cell line exhibited a time 
dependent increase in the concentration of IL-8/CXCL8 protein secreted from 1.38 ± 
0.13ng/ml at 1 hour to 3.64 ± 0.74ng/ml at 72 hours post-stimulation when it was 
stimulated with IL -la  (lOng/ml) (Fig.25).
Secreted IL-8/CXCL8 protein levels were higher when the MKN45 cells were 
stimulated with TNF-a compared to IL-la. The levels of IL-8/CXCL8 did not 
increase after 48 hours stimulation with TNF-a since the MKN45 cells were starting 
to undergo apoptosis due to foetal bovine serum depletion. This could also be 
explained by the IL-8/CXCL8 mRNA levels which had decreased after a few hours.
When the ‘cytomix’ combination was used to stimulate the MKN45 cells, high IL- 
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The AGS cells were stimulated with IL-la(10ng/ml) or TNF-a(100ng/ml) or 'cytomix' which is a combination of IL-la(10ng/ml), TNF- 
a(100ng/ml) and IFN-7(300U/ml) from 1 hr-72 hrs. Unstimulated cells were in medium only and the supernatants were removed from the 
unstimulated cells at the start of the experiment. At the specific times, the supernatants were collected, centrifuged to remove the cell debris 


















Unstimulated 1 2 4 6 12 24 48 72
Time (hr)
The MKN45 cells were stimulated with IL-la(10ng/ml), TNF-a(100ng/ml) or 'cytomix' which was a combination of IL-la(10ng/ml), TNF-a(100ng/ml) 
and IFN-7(300U/ml) from 1-72 hours. Unstimulated cells were in medium only, the supernatants were removed at the start o f the experiment. At the 
specific times, the supernatants were collected, centrifuged to remove the cell debris and the IL-8/CXCL8 protein was analysed using an ELISA technique. 
Each point is the mean (+/-) SEM of three independent experiments.
1 1 0
4.2.3 The secretion of RANTES/CCL5 protein by the MKN45 cell line 
stimulated with TNF-a(100ng/mO and IFN-yQOOU/mD or ‘cvtomix’
As shown in the Northern analysis, the AGS cells did not express RANTES/CCL5 
mRNA when stimulated with IL-la, TNF-a or IFN-y. Therefore, as expected, 
RANTES/CCL5 protein was also not detected in secretions of this cell line (results 
not shown).
Cytokines added alone to the MKN45 cells did not induce RANTES/CCL5 protein 
(results not shown). Stimulation with TNF-a and IFN-y or cytomix induced a similar 
time-dependent secretion of RANTES/CCL5 protein (Fig.26). This indicated that IL- 
l a  was not important in inducing RANTES/CCL5 expression. The concentration of 
RANTES/CCL5 protein secreted in response to 1 hour stimulation with TNF-a and 
IFN-y was 0.05 ± O.lng/ml and at 72 hours was 2.19 ± 0.76ng/ml. ‘Cytomix’ 
stimulation yielded RANTES/CCL5 protein levels of 0.02 ± 0.05ng/ml at 1 hour 
increasing to 3.29 ± 0.33ng/ml at 72 hours post-stimulation. RANTES/CCL5 protein 
expression was not detected very early (1-2 hours) since the RANTES/CCL5 mRNA 
expression was detected later (6-12 hours).
4.3 THE EFFECTS OF ANTI-INFLAMMATORY CYTOKINES ON THE 
EXPRESSION OF CHEMOKINES
Having investigated IL-8/CXCL8 and RANTES/CCL5 expression in response to 
stimulation with pro-inflammatory cytokines IL -la, TNF-a and IFN-y, this study 
was extended to investigate the modulatory effects of the cytokines IL-4 and IL-13 
produced by Th2 cells. These cytokines are known to have anti-inflammatory effects 
in some situations. IL-4 and IL-13 have previously been shown to be inhibitory in 
HT-29 colonic epithelial cell RANTES/CCL5 protein expression (Kolios et al., 
1999) but in other cells, these cytokines can be stimulatory. In smooth muscle cells, 
IL-13 increased IL-1 induced IL-8/CXCL8 expression (Jordan et al., 1997). The 
experiments in this next section were carried out to determine the effects of these 
cytokines on gastric epithelial cells.
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MKN45 cells were stimulated with TNF-a(100ng/ml) and IFN-7(300U/ml) or 'cytomix' which is a combination of IL-la(10ng/ml), TNF-a(100ng/ml) and 
IFN-y (300U/ml) from 1 hr-72 hrs. Unstimulated cells were in medium only and the supernatants were removed at the start o f the experiment. At the specific 
times, the supernatants were collected, centrifuged to remove the cell debris and the RANTES/CCL5 protein was studied using an ELISA technique. Each 
point is the mean (+/-) SEM of three independent experiments.
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4.3.1 The effect of IL-4 and IL-13 on the expression of induced IL-8/CXCL8 
protein in AGS cells
AGS cells were incubated overnight in serum free medium prior to the experiment. 
IL-4 or IL-13 was added to the cells and incubated for 1 hour at 37°C, then cytomix 
was added and incubation continued for 24 hours. The medium was removed and IL- 
8/CXCL8 was measured by ELISA. Unstimulated AGS cells did not secrete IL-8 
protein. Cells stimulated for 24 hours with ‘cytomix’ secreted IL-8/CXCL8 protein 
as shown in Fig.27 and Fig.28 when they were pre-stimulated with IL-4 and IL-13 
respectively. The effects of IL-4 and IL-13 on the secretion of IL-8/CXCL8 protein 
were studied. All concentrations of IL-4 and IL-13 (0.3-30ng/ml) did not have any 
significant effect on IL-8/CXCL8 production. The ANOVA and Dunnett’s tests 
carried out on this data indicated that in this cell line, IL-4 and IL-13 did not act as 
stimulating or inhibitory cytokines on IL-8/CXCL8 production (P>0.05).
4.3.2 The effect of IL-4 on the expression of induced IL-8/CXCL8 protein and 
mRNA by the MKN45 cell line
The MKN45 cells were stimulated with cytomix in the presence of IL-4 as described 
for the AGS cells (section 4.3.1). The ELISA results demonstrated that there was no 
significant effect of IL-4 (0.3-30ng/ml) on IL-8/CXCL8 protein secretion in the 
MKN45 cell line (Fig.29) as shown by the ANOVA and Dunnett’s statistical tests. 
This was similar to the results obtained with the AGS cells. The expression of IL- 
8/CXCL8 mRNA in this experiment was also investigated by Northern analysis after 
a 24 hour stimulation with IL-4 and cytomix (Fig.30). Similar to the results obtained 
via the ELISA experiment, the Northern experiment did not show that there was any 
change in the relative concentration of IL-8/CXCL8 mRNA with increasing 














F i ^ The secretion of IL-8/CXCL8 protein by AGS cells pre-treated with IL-4 (1 hour) and stimulated with IL -la
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Cytomix + Concentration of IL-4(ng/ml)
The effect o f pre-treating the AGS cells with IL-4 for an hour before stimulating them with 'cytomix' for 24 hours on the expression o f IL- 



















Fig.28 The secretion of IL-8/CXCL8 protein by AGS cells pre-treated with IL-13 (1 hour) and stimulated with IL -la  (lOng/ml), TNF- 






The effect o f pre-stimulating the AGS cells with IL-13 for an hour before stimulating them with 'cytomix* for 24 hours on the expression 
o f IL-8/CXCL8 protein. Each bar is the mean (+/- ) SEM o f three independent experiments.
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£12,29 The expression of IL-8/CXCL8 protein by MKN45 cells pre-stimulated with IL-4 (1 hour) and stimulated with
IL -la  (lOng/ml), TNF-a (100ng/ml) and IFN-y (300U/mD for 24 hours
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Cytomix + Concentration of IL-4 (ng/ml)
The effect o f pre-stimulating the MKN45 cells with IL-4 for an hour before stimulating them with ’cytomix' for 24 hours on the expression 
o f IL-8/CXCL8 protein. Each bar is the mean (+/-) SEM o f three independent experiments.
Fig. 30
The expression of IL-8 mRNA by MKN45 cells pre­
stimulated with IL-4 (for an hour) and stimulated with 
IL -la  (lOng/ml) ,TN F-la (lOOng/ml) and IFN-y 
(300U/ml) for 24 hours
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The expression of RANTES mRNA by MKN45 cells 
pre-stimulated with IL-4 (for an hour) and stimulated with 
IL -la  (lOng/ml), TNF-a (lOOng/ml) and IFN-y (300U/ml) 
for 48 hours
CT\
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28S
MKN45 cells were pre-stimulated with different concentrations of IL-4 for an hour and 
stimulated with a combination of IL -la, TNF-a and IFN-y for 24 hours. ‘C’ represents 
cells stimulated with IL-la, TNF-a and IFN-y only. After 24 hours, the cells were lysed 
into ‘RNAzol B \ RNA was extracted and run onto a 1% agarose/formaldehyde gel.
IL-8 mRNA was detected by Northern analysis (top panel). Relative concentrations of 
IL-8 mRNA were measured by scanning densitometry (middle panel). The bottom panel 
shows the ethidium bromide-stained 18S and 28S bands indicating equal loading of the 
lanes. Representative of three independent experiments.
MKN45 cells were pre-stimulated with different concentrations of IL-4 for an hour 
and stimulated with a combination of IL-la, TNF-a and IFN-y for 48 hours. ‘C’ 
represents cells stimulated with IL-la, TNF-a and IFN-y only. After 48 hours, 
the cells were lysed into ‘RNAzol B \ RNA was extracted and run onto a 1% agarose/ 
formaldehyde gel. RANTES mRNA was detected by Northern analysis (top panel). 
Relative concentrations of RANTES mRNA were measured by scanning densitometry 
(middle panel). The bottom panel shows the ethidium bromide-stained 18S and 28S 
bands indicating equal loading of the lanes. Representative of three independent 
experiments.
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4.3.3 The effect of IL-4 on the expression of induced RANTES/CCL5 mRNA 
and protein by MKN45 cell line
RANTES/CCL5 mRNA and protein were measured in the MKN45 cells which were 
pre-treated for 1 hour with IL-4 (0.3-30ng/ml) and stimulated with cytomix for 48 
hours. The ELISA results demonstrated that unstimulated MKN45 cells did not 
secrete any RANTES/CCL5 protein. RANTES/CCL5 was secreted after 48 hours 
stimulation with cytomix (Fig.32). The highest concentrations of IL-4 used, lOng/ml 
and 30ng/ml (together with cytomix) caused an approximately 31% and 25% 
decrease in RANTES/CCL5 secretion respectively compared to cytomix only 
control. Dunnett’s test indicated that these concentrations of IL-4 significantly 
(P<0.05) inhibited RANTES/CCL5 secretion by MKN45 cells compared to cytomix 
only control.
The Northern analysis shown in Fig.31 indicated diminished expression of cytomix- 
induced RANTES/CCL5 mRNA with higher concentrations of IL-4 which were 10, 
30 and 50ng/ml.
4.3.4 The effect of IL-13 on the expression of IL-8/CXCL8 mRNA by MKN45 
cells
As shown in Fig.30, IL-4 did not modulate cytomix-induced IL-8/CXCL8 mRNA 
expression in MKN45 cells, similarly the Th2 cytokine, IL-13 at concentrations 0.3- 
30ng/ml did not modulate IL-8/CXCL8 mRNA expression (Fig.33).
4.3.5 The effect of IL-13 on the expression of RANTES/CCL5 protein by 
MKN45 cell line
RANTES/CCL5 protein were measured in MKN45 cells pre-treated for 1 hour with 
IL-13 (0.3-30ng/ml) and stimulated with cytomix for 48 hours. Unstimulated 
MKN45 cells did not express any RANTES/CCL5 protein (Fig.35). RANTES/CCL5 
protein was secreted when the MKN45 cells were stimulated with cytomix (7.57 ± 
0.61 ng/ml). Significance was assessed by ANOVA and Dunnett’s test (P<0.05) 
(Fig.35). Similar to the effect of IL-4, IL-13 was found to inhibit the expression of
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RANTES/CCL5 protein. The highest concentrations of IL-13 used (10 and 30ng/ml), 
together with cytomix caused a 33.3% and 60% decrease in RANTES/CCL5 
secretion compared to cytomix only control. Dunnett’s test indicated that these 
concentrations of IL-13 significantly (P<0.05) inhibited RANTES/CCL5 secretion 
compared to cytomix only control.
The effect of IL-13 on RANTES/CCL5 mRNA expression was investigated by 
Northern analysis. IL-13(30ng/ml) caused a decrease in cytomix stimulated 




















The secretion of RANTES/CCL5 protein by MKN45 cells pre-stimulated with IL-4 (1 hour) and stimulated with
IL -la  (lOng/mlL TNF-a (lOOng/ml) and IFN-y (300U/ml) for 48 hours
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The effect of pre-stimulating the MKN45 cells with IL-4 for an hour and stimulating them with ’cytomix' for 48 hours on the expression of RANTES 
protein. Each bar is the mean ( +/-) SEM of three independent experiments. The significance of using IL-4 with cytomix compared to cytomix alone on 
the secretion of RANTES/CCL5 protein was assessed bv ANOVA and Dunnett's test (P<0.05L
Fig.33
The expression of IL-8/CXCL8 mRNA by MKN45 
cells pre-stimulated with different concentrations of 
IL-13 (for an hour) and stimulated with IL -la  (10 









MKN45 cells were pre-stimulated with different concentrations of IL-13 for an hour.
‘C’ represents unstimulated control cells. After stimulation with IL-13, the cells were 
stimulated with IL -la, TNF-a and IFN-y for 24 hours before the cells were lysed in 
‘RNAzol B \ RNA was extracted and run onto a 1% agarose/formaldehyde gel. IL-8 
mRNA was detected via Northern analysis (top panel). Relative concentrations of IL-8 
mRNA were detected by scanning densitometry (middle panel). The bottom panel is the 
ethidium bromide-stained 18S and 28S bands indicating equal loading of the lanes. 
Representative of three independent experiments.
Cytomix + Concentration of IL-13 (ng/ml)
Fig.34
The expression of RANTES/CCL5 mRNA by MKN45 cells pre­
stimulated with different concentrations of IL-13 (for an hour) 
and stimulated with IL -la  (lOng/ml), TNF-a (lOOng/ml) and 
IFN-y (300U/ml) for 48 hours
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MKN45 cells were pre-stimulated with different concentrations of IL-13 for an 
hour. ‘C’ represents unstimulated control cells. After stimulation with IL-13, the 
cells were stimulated with IL -la, TNF-a and IFN-y for 48 hours before the cells 
were lysed in ‘RNAzol B \ RANTES mRNA was detected by Northern analysis (top 
panel). RNA was extracted and run onto a agarose/formaldehyde gel. Relative 
concentrations of IL-8 mRNA were detected by scanning densitometry (middle 
panel). The bottom panel is the ethidium bromide-stained 18S and 28S bands 






















The secretion of RANTES/CCL5 protein by MKN45 cell pre-stimulated with IL-13 (1 hour) and stimulated with
IL -la  (lOng/ml). TNF-a(100ng/ml) and IFN^y(300U/ml) for 48 hours
Cytomix + Concentration of IL-13 (ng/ml)
The effect of pre-stimulating the MKN45 cells with IL-13 for an hour and stimulating them with 'cytomix' for 48 hours on the expression of RANTES
protein. Each bar is the mean (+/-) SEM of three independent experiments. The significance of using IL-13 together with cytomix compared to using cytomix alone
on the RANTES/CCL5 protein secretion was assessed by ANOVA and Dunnett's test (P<0.05).
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4.4 THE EXPRESSION OF A RANGE OF ‘CC’ AND ‘CXC’ CHEMOK3NE 
mRNA IN AGS AND MKN45 CELLS DETECTED BY RT-PCR
The expression of the prototype chemokines from the ‘CXC’ and ‘CC’ families, IL- 
8/CXCL8 and RANTES/CCL5 were initially investigated in detail by Northern 
analysis. This study provided information about time courses of expression of IL- 
8/CXCL8 and RANTES/CCL5 and the combination of cytokines required for gastric 
epithelial cell activation. This information was used to generate suitable MKN45 and 
AGS samples which were then analysed for expression of a range of novel ‘CXC’ 
and ‘CC’ chemokines using the sensitive technique of PCR.
For each cell line, 10 samples were used per experiment, which were the 
unstimulated AGS/MKN45 cell line serum-starved overnight, the AGS/MKN45 cell 
line stimulated with 'cytomix' for 1, 3 and 12 hours and a positive control. Negative 
controls included RT minus samples for each cell line sample and a water only 
control to detect any contamination in reagents. Positive control samples were used 
to validate that the primer pairs could detect the appropriate mRNA.
Cytomix stimulated HT-29 cells were used as a positive control for PCR primers 
against IL-8/CXCL8, MIG/CXCL9, IP-10/CXCL10 and MCP-1/CCL2. White blood 
cells stimulated with 50ng/ml PHA were used as positive controls for BCA- 
1/CXCL13, MIP-la/CCL3, TARC/CCL17 and LARC/CCL20. U937 cells 
stimulated with 50ng/ml PM A was the positive control for RANTES/CCL5 and 
MCP-3/CCL7. Fibroblasts were used as a positive control for SDF-la/CXCL12. 
'Cytomix' or a combination of IL -la  (3ng/ml), TNF-a (30ng/ml) and IFN-y 
(lOOU/ml) were used as a stimuli for the AGS and MKN45 cell lines so that maximal 
expression of chemokines could be observed. These results were obtained from three 
separate experiments. On all gels, a 100 base pair DNA ladder was used and the 
lanes were numbered from left to right. The results obtained from the PCR analysis 
are summarised in Table 5.
Table 5. Chemokine expression by the AGS and MKN45 gastric epithelial cell lines as derived from RT-PCR


























+ + + + + + + + ++ + + + + + + + + + + +
MIG
(CXCL9)
+ + + + + +++ + + + + + + + + + + + + + + + +
IP-10
(CXCL10)
- - - - ++ - ++ +++ + + + + +
SDF-la
(CXCL12)
- - - - ++ - - - - + +
BCA-1
(CXCL13)




- + + - ++ - + + + + + + +
MIP-la
(CCL3)
- - - - -H-+ - - - - + + +
RANTES
(CCL5)
- - - - + + + - - - + + +-H-
MCP-3
(CCL7)
- - + + + + - + + + ++
TARC
(CCL17)
- - - - ++ - - - - ++
LARC
(CCL20)
+ + + + + + + + + + + + + + + + + + + + + + + + + +++
Results shown on gels
■H-+ = very strong signal; ++ = strong signal; + = weak signal; - = not detected
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AGS cells
The AGS cell line was shown to express barely detectable constitutive levels of the 
‘CXC’ chemokines IL-8/CXCL8 (Fig.36) and MIG/CXCL9 (Fig.37) mRNA. These 
low levels were able to be detected probably due to the sensitivity of the RT-PCR 
technique compared to the Northern analysis which was not able to detect the 
constitutive levels of IL-8/CXCL8 mRNA. IL-8/CXCL8 mRNA expression was 
stimulated by cytomix to a maximum by 3 hours and had decreased by 12 hours and 
this supports the results detected by Northern analysis. When the AGS cell line was 
stimulated with ‘cytomix’, the expression of MIG/CXCL9 was stimulated higher 
than the basal levels with prolonged high expression between 1-12 hours. Expression 
of other members of the ‘CXC’ family, IP-10/CXCL10, SDF-loc/CXCL12 and BCA- 
1/CXCL13 mRNA expression were also analysed by PCR, no expression was 
detected in ‘cytomix’ stimulated or unstimulated AGS cells (see Table 5).
The ‘CC’ chemokine MCP-1/CCL2 (Fig.39) mRNA was expressed very weakly 
(barely detectable) in ‘cytomix’ stimulated cells, from 1-3 hours while MCP-3/CCL7 
(Fig.40) was also detected faintly at 3-12 hours. In contrast, the ‘CC’ chemokine 
LARC/CCL20 was detected at high levels in cells stimulated between 1-12 hours 
with cytomix, with the highest level of expression at 12 hours. LARC/CCL20 was 
also expressed at low levels in unstimulated cells (Fig.38). Fig.41 demonstrates a 
representative p-actin blot for the samples, indicating equal loading of all samples.
Expression of other members of the ‘CC’ chemokine family were also investigated 
by RT-PCR. mRNA expression in stimulated or unstimulated cells were not detected 
for MIP-la/CCL3, RANTES/CCL5 and TARC/CCL17 (see Table 5).
Chemokine expression by AGS cells stimulated with cytomix
On all gels, a 100 bp DNA ladder was used and lanes are numbered from left to right.
Fig36 PCR analysis of IL-8/CXCL8 mRNA expression in 
1 2 3 4 5 6 7 8 9  10 AGS cells (562 bp)
1= Unstimulated AGS cells (very faint)
2= AGS cells stimulated with cytomix for 1 hour (very faint) 
3= AGS cells stimulated with cytomix for 3 hours 
4= AGS cells stimulated with cytomix for 12 hours (very faint) 
5= Positive control (HT-29 cells stimulated with cytomix)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
Fig.37 PCR analysis of MIG/CXCL9 expression in AGS cells 1214 
bp)
1 2 3 4 5 6 7 8 9  10
1= Unstimulated AGS cells (very faint)
2= AGS cells stimulated with cytomix for 1 hour 
3= AGS cells stimulated with cytomix for 3 hours 
4= AGS cells stimulated with cytomix for 12 hours 
5= Positive control (HT29 stimulated with cytomix)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
1 2 3 4 5 6 7 8 9 10
3 2 3 4 5 6 7 8 9 10
Fig.38 PCR analysis of LARC/CCL20 mRNA expression in AGS cells (210 bp)
1= Unstimulated AGS cells (very faint)
2= AGS cells stimulated with cytomix for 1 hour 
3= AGS cells stimulated with cytomix for 3 hours 
4= AGS cells stimulated with cytomix for 12 hours 
5= Positive control (white blood cells stimulated with PHA) 
6-9= samples of 1 -4 minus reverse transcriptase 
10= water
This gel is reprsentative of three independent experiments
Fig.39 PCR analysis of M CP-1/CCL2 mRNA expression in AGS cells 
(177 bp)
1= Unstimulated AGS cells
2= AGS cells stimulated with cytomix for 1 hour (very faint)
3= AGS cells stimulated with cytomix for 3 hours (very faint)
4= AGS cells stimulated with cytomix for 12 hours 
5= Positive control (HT29 stimulated with cytomix)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
1 2 3 4 5 6 7 8 9  10
Fig.40 PCR analysis of MCP-3/CCL7 mRNA expression in
AGS cells (216 bp)
1= Unstimulated AGS cells
2= AGS cells stimulated with cytomix for 1 hour
3= AGS cells stimulated with cytomix for 3 hours (very faint)
4= AGS cells stimulated with cytomix for 12 hours (very faint)
5= Positive control (U937 stimulated with PMA)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
Fig. 41 PCR analysis of B-actin mRNA expression in AGS cells (176 bp)
1= Unstimulated AGS cells 
2= AGS cells stimulated with cytomix for 1 hour 
3= AGS cells stimulated with cytomix for 3 hours 
4= AGS cells stimulated with cytomix for 6 hours 
5 =AGS cells stimulated with cytomix for 12 hours 
6= Positive control (HT29 stimulated with cytomix)
7-11= samples of 1-4 minus reverse transcriptase 
12= water
This gel is representative of three independent experiments
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MKN45 cells
The MKN45 cell line has been shown by RT-PCR to express the ‘CXC’ chemokines 
IL-8/CXCL8 (Fig.42). MKN45 cells expressed low levels of IL-8/CXCL8 mRNA 
constitutively, expression was increased from 1-12 hours stimulation with cytomix, 
with a peak at 1 hour, as seen in the Northern analysis experiment. The constitutive 
expression of IL-8/CXCL8 mRNA was detected by the RT-PCR experiment but not 
the Northern analysis experiment probably because RT-PCR is a more sensitive 
technique compared to the Northern analysis and is able to detect small quantities of 
the IL-8/CXCL8 mRNA. MIG/CXCL9 (Fig.43) mRNA was also expressed at low 
levels constitutively in MKN45 cells. MIG/CXCL9 mRNA was expressed very 
strongly between 1 and 12 hours (as was detected in the AGS cells). IP-10/CXCL10 
peak expression occurred in MKN45 cells at 3 hours post-stimulation (Fig.44). The 
chemokines which were not detected in the unstimulated or cytomix stimulated AGS 
and MKN45 cell lines were SDF-la/CXCL12 and BCA-1/CXCL13 (results listed in 
Table 5).
LARC/CCL20 (Fig.45) was expressed in MKN45 cells at high levels constitutively 
which is in contrast to the constitutive expression detected in AGS cells. In the 
presence of cytomix, LARC/CCL20 mRNA expression in MKN45 cells remained 
high from 1-12 hours. MCP-1/CCL2 (Fig.46) mRNA was expressed at high levels 
while MCP-3/CCL7 (Fig.47) mRNA was expressed at low levels in the blot.
The ‘CC’ chemokines MIP-la/CCL3 and TARC/CCL17 were not detected (Table 
5). This result was similar to that obtained for the AGS cell line. RANTES/CCL5 
(Fig.48) mRNA expression was similar to that detected by MKN45 cells in the 
Northern analysis experiments with a late peak expression at 12 hours post­
stimulation. A representative p-actin blot is shown showing equal loading in Fig.49.
Chemokine expression by MKN45 cells stimulated with cytomix
Fig.42 PCR analysis of IL-8/CXCL8 mRNA expression in MKN45 cells 
(562 bp)
1= Unstimulated MKN45 cells
2= MKN45 cells stimulated with cytomix for 1 hour
3= MKN45 cells stimulated with cytomix for 3 hours
4= MKN45 cells stimulated with cytomix for 6 hours
5 = MKN45 cells stimulated with cytomix for 12 hours
6= Positive control (HT29 cells stimulated with cytomix for 6 hours)
7 = Positive control (HT29 cells stimulated with cytomix for 12 hours)
8 = Water
9-13= samples of 1-5 without reverse transcriptase 
This gel is representative of three independent experiments
Fig. 43 PCR analysis of MIG/CXCL9 mRNA expression in MKN45 cells 
(214 bp)
1= Unstimulated MKN45 cells (very faint)
2= MKN45 cells stimulated with cytomix for 1 hour 
3= MKN45 cells stimulated with cytomix for 3 hours 
4= MKN45 cells stimulated with cytomix for 12 hours 
5= Positive control (HT-29 stimulated with cytomix)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
Fig.44 PCR analysis of IP-10/CXCL10 mRNA expression in MKN45 cells (229 bp)
1 2 3 4 5 6 7 8 9  10
1= Unstimulated MKN45 cells 
2= MKN45 cells stimulated with cytomix for 1 hour 
3= MKN45 cells stimulated with cytomix for 3 hours 
4= MKN45 cells stimulated with cytomix for 12 hours 
5= Positive control (HT29 stimulated with cytomix)
6-9= samples of 1-4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
Fig.45 PCR analysis of LARC/CCL20 mRNA expression in MKN45 cells (210 
bp)
1= Unstimulated MKN45 cells
2= MKN45 cells stimulated with cytomix for 1 hour
3= MKN45 cells stimulated with cytomix for 3 hours
4= MKN45 cells stimulated with cytomix for 12 hours
5= Positive control (White blood cells stimulated with PHA)
6-9= samples of 1-4 minus reverse transcriptase
10= water
This gel is representative of three independent experiments
Fig.46 PCR analysis of MCP-1/CCL2 mRNA expression in MKN45 cells (177 bp)
1 2 3 4 5 6 7 8 9  10
1 2 3 4 5 6 7 8 9  10
1= Unstimulated MKN45 cells 
2= MKN45 cells stimulated with cytomix for 1 hour 
3= MKN45 cells stimulated with cytomix for 3 hours 
4= MKN45 cells stimulated with cytomix for 12 hours 
5= Positive control (HT29 stimulated with cytomix)
6-9= samples of 1 -4 minus reverse transcriptase 
10= water
This gel is representative of three independent experiments
Fig. 47 PCR analysis of MCP-3/CCL7 mRNA expression in MKN45 cells (216 bp) ^
OJ
H—*
1= Unstimulated MKN45 cells
2= MKN45 cells stimulated with cytomix for 1 hour (very faint)
3= MKN45 cells stimulated with cytomix for 3 hours (very faint)
4= MKN45 cells stimulated with cytomix for 12 hours (very faint)
5= Positive control (U937 stimulated with PMA)
6-9= samples of 1-4 minus reverse transcriptase 
10= water




1 2 3 4 5 6 7 8 9  10 Fig. 48 PCR analysis of RANTES/CCL5 mRNA expression in the MKN45 cells (583 bp)
1 = Unstimulated MKN45 cells
2 = MKN45 cells stimulated with cytomix for 1 hour
3 = MKN45 cells stimulated with cytomix for 3 hours
4 = MKN45 cells stimulated with cytomix for 12 hours
5 = Positive control (U937 stimulated with PMA)
6-9 =  samples o f  1-4 minus reverse transcriptase
10 =Water
This gel is representative o f  three independent experiments
Fig. 49 PCR analysis of B-actin mRNA expression in the MKN45 cells (176 bp)
to
1 = Unstimulated MKN45 cells
2 = MKN45 cells stimulated with cytomix for 1 hour
3 = MKN45 cells stimulated with cytomix for 3 hours
4 = MKN45 cells stimulated with cytomix for 12 hours
5 =  Positive control (HT29 cells stimulated with cytomix) 
6-9 = samples o f  1 -4 minus reverse transcriptase
10 = Water
This gel is representative o f  three independent experiments
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4.5 THE EXPRESSION OF NOVEL CHEMOKINES DETECTED IN 
GASTRIC BIOPSIES BY RT-PCR
A preliminary study was conducted on gastric biopsies collected from patients from 
the RNHRD Hospital to determine the expression of chemokines in patients with 
various disease conditions. The main limitation of this study was the small number of 
patients, however, preliminary data has been generated which will be useful for a 
larger study in the future involving a bigger sample size.
Gastric biopsies were obtained from patients who were divided into 3 categories, the 
normal patients, the patients with gastritis who were negative for the bacteria H. 
pylori and the patients with gastritis who were also positive for H. pylori.
The patients were diagnosed with their conditions using the rapid urease test (‘CLO’ 
test) and histological tests performed on slides of the gastric biopsies. The ‘CLO’ test 
detects urease produced by H. pylori which converts urea on the test medium to 
ammonia and results in a red colour shown by phenol red present on the test medium. 
Normal patients were characterised by endoscopy as those having normal antrum and 
body biopsies from the stomach without any inflammation or H. pylori infection. 
Patients with H. pylori-associated gastritis tended to have mild to moderate atrophy 
and inflammation in either the antrum and/or body sections of their stomach with a 
positive ‘CLO’ test indicating the presence of H. pylori. Patients with non-H. pylori- 
associated gastritis did not have any diagnosed H. pylori infections, yet their antral 
and gastric body biopsies still revealed active chronic superficial or quiescent 
gastritis, with or without atrophy.
Six patients were studied from the H. /ry/on-associated gastritis category, 4 patients 
were studied from the non- H. /?y/on'-associated gastritis category and 4 patients from 
the normal category. Three or four biopsies were taken from the antrum and the body 
of the stomach. The biopsies contained many different types of cells such as 
epithelial cells, fibroblasts, smooth muscle cells, connective tissue cells, 
inflammatory cells and possibly some H. pylori bacteria. The gastric biopsies from 
each patient were examined separately for chemokine expression by 35 cycles of RT-

















cxc Antrum Body Antrum Body Antrum Body
IL-8/CXCL8 ---------- ---------- + + -------- + +-------- + ------ ----------
MIG/CXCL9 ---------- ---------- + ------------ + ------------ ++++ + + - -
IP-10/CXCL10 ---------- ---------- + ------------ + ------------ + + - - ----------
SDF-la/CXCL12 + ------ + ------ + ------------ + ------------ + + - - + ------
BCA-1/CXCL13 ---------- ---------- + ------------ + ------------ + + - - + ------
CC
MCP-1/CCL2 + + - - ++++ +++------ +++------ + + + - + + + -
MIP-la/CCL3 ---------- ---------- + +-------- --------------- + + - - + ------
RANTES/CCL5 ---------- ---------- + ------------ --------------- + + - - + ------
MCP-3/CCL7 ---------- ---------- + ------------ + ----------- ---------- ----------
TARC/CCL17 ---------- ---------- --------------- --------------- ---------- ----------
LARC/CCL20 ---------- ---------- + ----------- ++ -------- + + + - + + + -
U)
NB. Each + sign symbolises a patient out of the total number of patients listed at the top of each column. The + sign which is in bold 
signifies a strong expression of the specific chemokine. The -  sign signifies a negative expression of the specific chemokine.
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PCR and the results tabulated (Table.6). Representative blots from the patients are 
shown in Figures 50-68. On all gels, a 100 base pair DNA ladder was used and the 
lanes were numbered from left to right.
The samples were run concurrently with a positive control and negative controls 
including water and a RT minus control for every sample. The cells used as positive 
controls were the same as those used in the RT-PCR experiments performed on the 
MKN45 and AGS cell lines (see section 4.4).
These experiments were performed to determine if H. pylori infection had any effect 
on the expression of chemokines in gastric mucosa and if the chemokine expression 
was dependent upon the presence of gastritis. In all experiments, the positive controls 
were positive and the negative controls were negative. A representative blot for p- 
actin, which is the housekeeping gene in all of the samples were included in each 
category. All cDNA derived from each sample was tested for the expression of the 
housekeeping gene, p-actin, indicating that cDNA was of acceptable quality and 
loaded equally in each experiment. These experiments were performed 2-3 times 
depending on the amount of mRNA extracted.
4.5.1 Normal patients
The polymerase chain reaction (PCR) experiments conducted on the gastric biopsies 
of 4 normal patients without gastritis revealed that chemokine expression was low. 
As shown in Table 6, the only chemokines detected were the monocyte 
chemoattractant MCP-l/CCL2(Fig.50) which was expressed in biopsies taken from 
the antrum and body in all 4 patients and SDF-la/CXCL12 (Fig.51) which was 
detected in 1 out of the 4 patients. All other chemokines investigated were not 
detected (results not shown). Fig.52 represents a p-actin blot of the samples.
4.5.2 Patients with non-/£ gy/or/-associated gastritis
Four patients were studied in this category. The chemokines expressed by many of 
the patients in this group were LARC/CCL20 (Fig.53), MCP-1/CCL2 (Fig.54) and
I 
■
CH EM O KINES EXPRESSED BY A REPRESENTATIVE NO RM AL PATIENT
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
Fig. 50 PCR analysis of MCP-1/CCL2 mRNA expression (177 bp)
1 = gastric antrum
2 = gastric body
3 = positive control (HT-29 cells stimulated with cytomix)
4 = gastric antrum minus reverse transcriptase
5 = gastric body minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
Fig. 51 PCR analysis of SDF-la/CXCL12 mRNA expression 1132 bp)
1 = gastric antrum
2 = gastric body
3 = positive control (fibroblasts)
4 = gastric antrum minus reverse transcriptase
5 = gastric body minus reverse transcriptase
6 = water
This gel is representative of three independent experiments. The DNA ladder 
taken from another part of the same gel.
Fig. 52 PCR analysis of B-actin mRNA expression (176 bp)
1 = gastric antrum
2 = gastric body
3 = positive control (HT-29 stimulated with cytomix)
4 = gastric antrum minus reverse transcriptase
5 = gastric body minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
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MIG/CXCL9 (Fig.55). Many other chemokines were also expressed by some of the 
patients examined for example SDF-la/CXCL12 (Fig.56), MIP-la/CCL3 (Fig.57),
RANTES/CCL5 (Fig.58) and BCA-1/CXCL13 (Fig.59). A representative blot 
showing equal p-actin expression in all samples is shown in Fig.60. Three out of 4 
patients in this category expressed the novel chemokine LARC/CCL20 in the antrum 
and gastric body, which was a majority of the patient numbers. Similar to the case of 
the patients with H. /ry/on'-associated gastritis, LARC/CCL20 was expressed at 
higher levels in the gastric antrum compared to the gastric body, as was 
demonstrated by the bright PCR band on the gels. This emphasises the importance of 
LARC/CCL20 in the gastric mucosa. All of the patients expressed the chemokine 
MCP-1/CCL2 at apparently higher levels compared to normal patients. All of the 
patients expressed MIG/CXCL9 faintly in the antrum and 2 out of 4 patients 
expressed MIP-la/CCL3, RANTES/CCL5, IP-10/CXCL10, SDF-la/CXCL12 and 
BCA-1/CXCL13 mRNA in the antrum. IL-8/CXCL8 mRNA was only detected in 
the antrum of 1 patient. One interesting finding from these experiments was the 
observed expression of high levels of BCA-1/CXCL13 mRNA, which is a novel 
chemokine which attracts B lymphocytes, in half of the patients.
4.5.3 Patients with H. pylori- associated gastritis
Some of the 6 patients with H. /?y/on'-associated gastritis expressed a multitude of 
chemokines. The chemokines expressed were BCA-1/CXCL13 (Fig.61), 
LARC/CCL20 (Fig.62), IP-10/CXCL10 (Fig.63), MIG/CXCL9 (Fig.64), MCP- 
1/CCL2 (Fig.65), IL-8/CXCL8 (Fig.66) and SDF-la/CXCL12 (Fig.67). Only 
TARC/CCL17 was not expressed in samples taken from any of the patients. Most of 
the chemokines were expressed by the antrum. Interestingly, the chemokine 
expressed in 3 out of 6 patients in this category was LARC/CCL20, this is similar to 
the RT-PCR data generated from the AGS and MKN45 cell lines which also showed 
a significant expression of LARC/CCL20 mRNA in stimulated cells. MCP-1/CCL2 
mRNA was also important as it was expressed in 3 out of the 6 patients in this 
category, however, from the normal patient category, it has been shown that MCP- 
1/CCL2 was expressed constitutively in the gastric body of all of the patients,
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therefore MCP-1/CCL2 may not necessarily be induced by gastritis. As was seen in 
H. pylori negative gastritis samples, MCP-1/CCL2 and LARC/CCL20 mRNA were 
expressed in many patients with H. pylori. IL-8/CXCL8 mRNA was expressed in the 
antrum of 2 out of 6 patients with H. py/on-associated gastritis and this chemokine 
has been well-known to be expressed in inflammation and H. pylori infections as 
reported in previous studies. MIP-la/CCL3 was expressed by 2 patients, while 
MCP-3/CCL7, RANTES/CCL5, MIG/CXCL9, IP-10/CXCL10 and SDF- 
la/CXCL12 were expressed in 1 patient respectively. Fig.68 demonstrates the p- 
actin representative of the patients.
CHEMOKINES EXPRESSED BY A REPRESENTATIVE PATIENT WITH NON-//. P Y L O R I
ASSOCIATED GASTRITIS
Fig.53 PCR analysis of LARC/CCL20 mRNA expression (210 bp)
1 - gastric antrum
2 = gastric body
3 = positive control (white blood cells stimulated with PHA)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments.
1 2 3 4 5 6 The DNA ladder was taken from another part of the same gel.
Fig.54 PCR analysis of MCP-1/CCL2 mRNA expression (177 bol
1 2 3 4 5 6
1 = gastric antrum
2 = gastric body
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
CHEMOKINES EXPRESSED BY A REPRESENTATIVE PATIENT WITH NON-//. P Y L O R I
ASSOCIATED GASTRITIS
1 2 3 4 5 6 Fig.55 PCR analysis of MIG/CXCL9 mRNA expression (214 bp)
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments. 
The DNA ladder was taken from another part of the same 
gel.
Fig.56 PCR analysis of SDF-la/CXCL12 mRNA expression 
(132 bp)
1 = gastric antrum (very faint)
2 = gastric body
3 = positive control (fibroblasts)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
Fig.57 PCR analysis of MIP-la/CCL3 mRNA expression (257 bp)
1 = gastric antrum
2 = gastric body
3 = positive control (white blood cells stimulated with PHA)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments. 
The DNA ladder was taken from another part of the same 
gel.
Fig.58 PCR analysis of RANTES/CCL5 mRNA expression 
(583 bp)
1 = gastric antrum (very faint)
2 = gastric body
3 = positive control (U937 stimulated with PMA)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
1 2 3 4 5 6
Fig.59 PCR analysis of BCA-1/CXCL13 mRNA expression
(199 bp)
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (white blood cells stimulated with PHA)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments to
1 2 3. 4 5 6
Fig. 60 PCR analysis of B-actin mRNA expression (176 bp)
1= gastric antrum 
2= gastric body
3= positive control (HT29 cells stimulated with cytomix)
4= gastric antrum sample minus reverse transcriptase 
5= gastric body sample minus reverse transcriptase 
6= water
This gel is representative of three independent experiments
CHEMOKINES EXPRESSED BY A REPRESENTATIVE PATIENT WITH
H. P Y L O R I  ASSOCIATED GASTRITIS
Fig. 61 PCR analysis of BCA-1/CXCL13 mRNA expression (199 bp)
1 2 3 4 5 6
1 = gastric antrum (very faint)
2 = gastric body
3 = positive control (white blood cells stimulated with PH A)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
Fig.62 PCR analysis of LARC/CCL20 mRNA (210 bp)
1 2 3 4 5 6
1 = gastric antrum
2 = gastric body
3 = positive control (white blood cells stimulated with PHA)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments. The 
DNA ladder was taken from another part of the same gel.
1 2 3 4 5 6 Fig.63 PCR analysis of IP-10/CXCL10 mRNA expression (229 bp)
■
 1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (HT-29 stimulated with cytomix) 
4 = gastric antrum sample minus reverse transcriptase 
5 = gastric body sample minus reverse transcriptase 
6 = water
This gel is representative of three independent experiments
1 2 3 4 5 6
Fig. 64 PCR analysis of MIG/CXCL9 mRNA expression 
(214 bp)
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
1 2 3 4 5 6 Fig.65 PCR analysis of MCP-1/CCL2 mRNA expression (177 bp)
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
Fig.66 PCR analysis of IL-8/CXCL8 mRNA expression (562 bp)
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum sample minus reverse transcriptase
5 = gastric body sample minus reverse transcriptase
6 = water
This gel is representative of three independent experiments
1 2 3 4 5 6 Fig.67 PCR analysis of SDF-la/CXCL12 mRNA expression
■
 (132 bp j
1 = gastric antrum (very faint)
2 = gastric body (very faint)
3 = positive control (fibroblasts)
4 = gastric antrum sample minus reverse transcriptase 
5 = gastric body sample minus reverse transcriptase 
6 = water
This gel is representative of three independent experiments.
The DNA ladder was taken from another part of the same gel.
£
os
1 2 3 4 5 6
Fig. 68 PCR analysis of B-actin mRNA expression (176 bp)
1 = gastric antrum
2 = gastric body
3 = positive control (HT29 stimulated with cytomix)
4 = gastric antrum minus reverse transcriptase
5 = gastric body minus reverse transcriptase
6 = water
This gel is representative of three independent experiments. 
The DNA ladder was taken from another part of the same gel.
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In conclusion, these experiments demonstrated the detection of a larger number of 
different chemokines in patients with gastritis compared to the ‘normal’ patients. 
Since LARC/CCL20 was not detected in gastric samples from ‘normal’ patients, but 
was expressed in many of the patients with gastritis, this suggests that it may be up- 
regulated in gastric epithelium in response to inflammation.
4.6 THE EXPRESSION OF CHEMOKINE RECEPTORS ON AGS AND 
MKN45 GASTRIC EPITHELIAL CELL LINES
The chemokine receptors investigated included a range of ‘CXC’ and ‘CC’ 
chemokine receptors including those known to be the receptors for the chemokines 
found to be expressed by the AGS and MKN45 cell lines. The receptors studied for 
the ‘CXC’ chemokines were CXCR1-5 and the receptors studied for the ‘CC’ 
chemokines were CCR1,2,3,4,5 and 7. The chemokine receptor expression was 
investigated in unstimulated cells in the absence of foetal bovine serum to study the 
constitutive expression of chemokine receptors. To investigate whether pro- 
inflammatory cytokines could modify chemokine receptor expression, analysis of 
CCR7, CXCR1 and CXCR5 expression in AGS cells and CCR2 and CXCR5 
expression in MKN45 cells was additionally performed using cells which had been 
stimulated for 1, 3 and 12 hours with cytomix. A positive control was included to 
validate primer pairs and was made up of unstimulated white blood cells or U937 
cells stimulated with PMA. Each experiment was repeated at least two times and 
representative blots have been shown. On all gels, a 100 base pair DNA ladder was 
used and the lanes were numbered from left to right. The results from these 
experiments are tabulated in Table 7.
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Table 7: Chemokine receptors expressed expressed by the AGS 















CXCR1 + +++ (#) - N/A
CXCR2 - N/A - N/A
CXCR3 - N/A - N/A
CXCR4 - N/A ++ (*) N/A
CXCR5 - - + (#) -
CCR1 + (#) N/A - N/A
CCR2 + (#) N/A - + (#)
CCR3 N/A - N/A
CCR4 - N/A - N/A
CCR5 - N/A - N/A
CCR6 - N/A - N/A
CCR7 - N/A - N/A
+++ = very strong signal; ++ = strong signal; + = weak signal; - = not detected 
N/A = not available; * = potentially important; # = preliminary data
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The unstimulated AGS cell line did not express any chemokine receptors except low 
levels of CCR1 (Fig.69), CCR2 (Fig.70) and CXCR1 (Fig.75). CXCR2 (Fig.76), 
CXCR3 (Fig.77), CXCR4 (Fig.78) and CXCR5 (Fig.79) were not detected in AGS 
cells. CXCR1 was detected in unstimulated cells and the expression increased in 
response to 1, 3 and 12 hour stimulation with pro-inflammatory cytokines. CXCR5 
expression was not induced by cytokines.
PCR analysis of unstimulated MKN45 cells demonstrated that these cells expressed 
low levels of CCR2 (Fig.81) and CXCR5 (Fig.87) as shown by very faint bands on 
the gels with relatively high expression of CXCR4 as shown by a bright band on the 
gel (Fig.86) which was detected reproducibly in 3 separate experiments. CCR1 
(Fig.80), CCR3 (Fig.82) and CXCRL (Fig.83), CXCR2 (Fig.84) and CXCR3 
(Fig.85) mRNA were not detected in the MKN45 cells. The primers were known to 
work as positive control bands were seen on the gel, although with different grades 
of brightness for different primers used.
In conclusion, in this study, most of the chemokine receptors were not shown to be 
expressed in unstimulated gastric epithelial cell lines. Low expression of CCR2 in 
both the AGS and MKN45 cell lines may be important as CCR2 is the receptor for 
MCP-1/CCL2 and MCP-1/CCL2 mRNA has been shown to be expressed in gastric 
biopsies (section 4.5). CXCR5 may also play an important role since its ligand, 
BCA-1/CXCL13 was shown by immunohistochemistry to be expressed in gastric 
epithelial cells (section 4.7). The detection of high levels of CXCR4 in MKN45 cells 
is similar to the results obtained in HT-29 colonic epithelial cells (Jordan et al., 
1999), where CXCR4 was the only chemokine receptor detected.
4.7 IMUNOHISTOCHEMICAL STAINING FOR CHEMOKINES AND 
CHEMOKINE RECEPTORS IN GASTRIC BIOPSIES
Paraffin-embedded sections of human gastric biopsies taken from the gastric antrum 
and body of patients with different pathological conditions were stained with 
antibodies for the CXC chemokine receptor, CXCR4 and its corresponding ligand, 
SDF-la/CXCL12. The slides were also stained for the novel chemokine, 
LARC/CCL20 mRNA, since the mRNA for this chemokine had been detected earlier
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PCR analysis of the chemokine receptor mRNA expression
bv the AGS cells
CCR1 (327bp)
1 = AGS (very faint)
2 = AGS RT minus
3 = water
4 = unstimulated white blood cells
5 = white blood cells stimulated with PHA and LPS
This gel is representative o f three independent experiments
CCR2_(255bp)
1 = AGS (very faint)
2 = AGS RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with
PHA and LPS
This gel is representative o f three independent 
experiments. The DNA ladder was taken from another 
part o f the same gel.
CCR3 (315bp)
1 =A G S
2 = AGS RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with
PHA and LPS
This gel is representative o f two independent experiments
Fig.69
1 2 3 4 5
Fig.70
1 2 3 4 5
Fig.71








2 = AGS RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments. 
The DNA ladder was taken from another part o f the same ge
Fig.73 CCR5 (280 bp)
1 2 3
1 =A G S
2 = AGS RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative of two independent
experiments
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PCR analysis for the chemokine receptors mRNA expressed 
by the AGS cells
Fig.74
CCR7 (362 bp)
1 2 3 4 5 6
1 = Unstimulated AGS
2 = AGS stimulated with cytomix for 1 hour
3 = AGS stimulated with cytomix for 3 hours
4 = AGS stimulated with cytomix for 12 hours
5 = U937 stimulated with PMA
6 = White blood cells stimulated with PHA
This gel is representative o f two independent 
experiments
Pig-75
1 2 3 4 5 6
CXCR1 (363 bp)
1 = Unstimulated AGS
2 = AGS stimulated with cytomix for 1 hour
3 = AGS stimulated with cytomix for 3 hours
4 = AGS stimulated with cytomix for 12 hours
5 = U937 stimulated with PMA
6 = White blood cells stimulated with cytomix
This gel is representative o f three independent 
experiments. The DNA ladder was taken from another 
part o f the same gel.
Fig.76
1 2 3 4 5 CXCR2 (385 bp)
1 =A G S
2 = AGS RT minus 
3= water
4 = Unstimulated white blood cells
5= White blood cells stimulated with PHA and LPS




PCR analysis for the chemokine receptors mRNA expressed
by the AGS cell line
Flg‘ 77 CXCR3 (293 bp)
1 2 3 4 5
■
 1 = Unstimulated AGS
2 = AGS RT minus 
3 = Water
4 = Unstimulated white blood cells 
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments.Fig.78 CXCR4 (206 bp)
1 = Unstimulated AGS
2 = AGS RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments. 
The DNA ladder was taken from another part o f the same gel.
Fig. 79
1 2 3 4 5 6 7 8 9  10
CXCR5 (465 bp)
1 = Unstimulated AGS
2 = AGS stimulated with cytomix for 1 hour
3 = AGS stimulated with cytomix for 3 hours
4 = AGS stimulated with cytomix for 12 hours
5 = U937 stimulated with PMA (very faint)
6 = Unstimulated AGS RT minus
7 = AGS stimulated with cytomix for 1 hour RT minus
8 = AGS stimulated with cytomix for 3 hours RT 
minus
9 = AGS stimulated with cytomix for 12 hours RT 
minus
10 = Water
This gel is representative o f two independent 
experiments.
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PCR analysis of chemokine receptors mRNA expressed by the MKN45 cell line
CCR1 (327 bp)
1 = Unstimulated MKN45
2 = Unstimulated MKN45 RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent 
experiments
Fig.81 CCR2 (255 bp)
1 2 3 4 5 6 7 8 9  10 1 = Unstimulated MKN45 cells
2 = MKN45 stimulated with cytomix for 1 hour (very faint)
3 = MKN45 stimulated with cytomix for 3 hours
4 = MKN45 stimulated with cytomix for 12 hours (very faint)
5 = White blood cells stimulated with PHA
6 = U937 cells stimulated with PMA (very faint)
7 = Unstimulated MKN45 cells RT minus
8 = MKN45 stimulated with cytomix for 1 hour RT minus
9 = MKN45 stimulated with cytomix for 3 hours RT minus 
10= MKN45 stimulated with cytomix for 12 hours RT minus 
11 = water





1 = Unstimulated MKN45
2 = Unstimulated MKN45 RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments. The 
DNA ladder was taken from another part o f the same gel.
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PCR analysis of the chemokine receptors mRNA expression by the MKN45 cell line
Fig.83 CXCR1 (363 bp)
1 2 3 4 5
1 = U nstim ula ted  M K N 45 cells
2 = U nstim ula ted  M K N 45 cells RT minus 
, water
^ i  4 = U nstim ula ted  w hite  b lood  cells
5 = W hite b lood cells stim ulated  with PH A  and LPS
This gel is representative o f  two independent experim ents
Fig.84 CXCR2 (385 bp)
1 2  3 4 5 i  = Unstimulated MKN45 cells
2 = Unstimulated MKN45 cells RT minus
3 = water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments. 
The DNA ladder was taken from another part o f the same gel.
CXCR3 (293 bp)
1 = Unstimulated MKN45 cells
2 = Unstimulated MKN45 cells RT minus
3 = water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f two independent experiments
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PCR analysis of the chemokine receptors mRNA expressed by the MKN45 cells
CXCR4 (206 bDl
1 =Unstimulated MKN45 cells
2 = Unstimulated MKN45 cells RT minus
3 = Water
4 = Unstimulated white blood cells
5 = White blood cells stimulated with PHA and LPS
This gel is representative o f three independent experiments. 
The DNA ladder was taken from another part o f the same gel.
Fig.87
CXCR5 (465 bp)
1 2 3 4 5 6 7 8 9  10
1 = Unstimulated MKN45 cells (very faint)
2 = MKN45 stimulated with cytomix for 1 hour
3 = MKN45 stimulated with cytomix for 3 hours
4 = MKN45 stimulated with cytomix for 12 hours
5 = White blood cells stimulated with PHA (very faint)
6 = U937 cells stimulated with PMA
7 = Unstimulated MKN45 cells RT minus
8 = MKN45 stimulated with cytomix for 1 hour RT minus
9 = MKN45 stimulated with cytomix for 3 hours RT minus
10 = MKN45 stimulated with cytomix for 12 hours RT 
minus 
11=  Water
This gel is representative o f three independent experiments
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in this study in AGS and MKN45 gastric epithelial cell lines and in inflamed human 
gastric biopsies in patients with H. pylori-associated gastritis and non-H. pylori- 
associated gastritis.
Immunohistochemistry staining was also performed on biopsy sections for BCA- 
1/CXCL13. BCA-1/CXCL13 mRNA had been shown previously by RT-PCR to be 
expressed by patients with H. pylori-associated gastritis and non-H. pylori-associated 
gastritis.
Staining of the slides from each patient were usually carried out in duplicate. One 
slide was stained with the specific antibody and the other slide from the same patient 
was stained in exactly the same way with no antibody used. The second slide 
provided a negative control. This control indicated that the primary antibody used did 
not stain non-specifically.
The SDF-la/CXCL12 and LARC/CCL20 antibodies did not give any specific 
staining on any of the slides investigated. This was the first known time that 
LARC/CCL20 staining was attempted on human gastric tissues. The absence of 
positive LARC/CCL20 staining suggests that LARC/CCL20 protein is not expressed 
in the tissues examined. Our previous results obtained from gastric biopsies indicated 
that LARC/CCL20 mRNA was expressed, therefore it is possible that this is not 
translated into detectable quantities of protein in gastric tissue. An alternative 
explanation could be that the antibody used was not suitable for 
immunohistochemical detection of LARC/CCL20. Unfortunately, no other anti­
human LARC/CCL20 antibodies tested in immunohistochemistry were commercially 
available at the time these experiments were carried out. Different concentrations of 
the SDF-la/CXCL12 and LARC/CCL20 antibodies were used in an attempt to 
improve results. A different method of antigen retrieval other than the pressure- 
cooking method in which the slides were treated with Pronase enzyme was also tried. 
However, despite using this other technique, no staining was observed for 
LARC/CCL20. The lack of specific staining for SDF-la/CXCL12 in our studies, 
could possibly be explained by the absence of a suitable anti-human SDF- 
la/CXCL12 antibody in our laboratory.
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In the immunohistochemical analysis of CXCR4, slides from 9 patients with H. 
/jy/on-associated gastritis, 7 patients with non-H. j^y/on-associated gastritis, 2 
patients with adenocarcinoma and 1 normal patient were stained. 
Immunohistochemical staining was performed for CXCR4 since this receptor was 
expressed in the gastric epithelial cell line, MKN45 (see section 4.4). The aim of 
immunohistochemical analysis was to determine if  ‘real’ gastric epithelial cells in 
human gastric mucosa could be identified to express CXCR4 protein.
Histological slides were successfully stained with the antibody for the chemokine 
receptor CXCR4. Slides representative of each pathological category such as normal 
and healthy patients, patients with adenocarcinoma, patients with H. pylori- 
associated gastritis and patients with non-H. py/on'-associated gastritis were stained. 
The positively stained cells were stained brown in colour, whereas unstained cells 
appeared blue since these cells did not take up the DAB chromogen colour. The 
inflammatory cells made up of probably lymphocytes, macrophages and plasma cells 
found in the lamina propria of the gastric mucosa also stained positively for CXCR4.
An interesting observation made was that in the antrum, the mucosa were made up of 
gastric glands which were loosely packed and these glands occupied half of the 
gastric mucosal thickness. The antral mucosa also contains glands with a bubbly or 
foamy appearance. These glands mostly secreted mucin only and it was not common 
to find chief cells in these glands, although parietal cells could be present either 
singly or in small groups.
In contrast, the mucosa in the gastric body are made up of gastric glands which are 
tightly packed and straight. The cells in the gastric body consist of chief cells at the 
base, parietal cells further up the gland and mucous neck cells at the upper part of the 
glands. Therefore the gastric gland in the gastric body is made up of specific cell 
types.
In the gastric body, although CXCR4 was found to be expressed strongly on the 
surface epithelial cells, diffuse positive staining for CXCR4 was also found 
throughout the gastric glands. This is shown in Fig.88(a). This biopsy was obtained 
from a patient with H. pylori positive active chronic superficial gastritis.
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Interestingly, most of the positive staining for CXCR4 in the antrum was observed to 
be in the surface epithelial cells. The staining for CXCR4 decreased further down the 
gastric glands. This is best demonstrated by Fig.89(a) which was taken from the 
antrum of a patient with H. pylori negative reactive gastritis.
CXCR4 was observed in gastric epithelial cells found in the gastric glands in patients 
with H. /Ty/on'-associated gastritis (Fig.88a), non-H. py/on-associated gastritis 
(Fig.89a), adenocarcinoma (Fig.91) and normal patients (Fig.90). The most dense 
staining for CXCR4 was observed in histological slides taken from patients with H. 
/ry/on-associated gastritis (Fig.88a). No H. pylori bacteria were visibly present in 
these slides. In all of these positively-stained slides, there was a little background 
staining in the lamina propria area and this was probably due to the scattered 
presence of CXCR4 in the inflammatory cells in the lamina propria, although the 
majority of the cells which were positively-stained for CXCR4 were the gastric 
epithelial cells. The positive staining for CXCR4 in the patients with 
adenocarcinoma was parallel with our detection of CXCR4 mRNA in the MKN45 
cell line (section 4.6), since this is a gastric epithelial cell line derived from an 
adenocarcinoma. In the patients with adenocarcinoma, even the abnormal gastric 
epithelial cells within the area of the tumour stained positively for CXCR4. These 
results implied that CXCR4 was up-regulated in tissues which were undergoing 
either inflammatory processes such as in gastritis and also tissues which were 
undergoing neoplastic changes into tumour tissues.
Immunohistological staining of patients slides for BCA-1/CXCL13 were also carried 
out. In this experiment, the number of patients studied were 1 patient with 
‘MALT’oma, 2 patients with H. /?y/on-associated gastritis, 2 patients with non-//. 
/7y/on-associated gastritis and 1 normal patient. In these experiments, positively 
stained slides appeared brown, which was the colour of the DAB chromogen which 
stained the gastric tissues, while all the negatively-stained slides appeared blue. 
Similar to the immunohistochemical experiments for CXCR4, the inflammatory cells 
in the lamina propria also stained positively for BCA-1/CXCL13.
In the antral mucosa, positive staining for BCA-1/CXCL13 was observed in the 
upper part of the gastric glands with a gradual decrease further down the gastric
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gland. Similar as for the positive staining for CXCR4, the gastric body demonstrated 
a diffuse positive staining for BCA-1/CXCL13 throughout the gastric glands from 
the surface epithelial cells to the cells at the base of the gastric glands.
Sections from the normal patient (without gastritis) (Fig.92a) showed low levels of 
positive staining for BCA-1/CXCL13. This suggested very low constitutive BCA- 
1/CXCL13 was expressed in normal patients. The BCA-1/CXCL13 staining 
appeared in the gastric epithelial cells. The corresponding negative control slide 
(Fig.92b) for the normal patient was totally blue, showing that the antibody used was 
not staining non-specifically.
Faint positive staining for BCA-1/CXCL13 was also detected in the sections from 
the patients with non-H. /?y/on'-associated gastritis (Fig.94a). The negative control 
showed no staining (Fig.94b). These sections were taken from the gastric antrum as 
demonstrated by the less dense arrangement of the gastric glands and the bubbly and 
foamy appearance of the gastric glands. The positive staining also appeared mainly 
in the gastric epithelial cells in the upper region of the gastric glands. Some staining 
was also found in the lamina propria, although this was to a lesser degree compared 
to the epithelial cells in the gastric glands.
Very dense staining was present in the gastric epithelial cells of the gastric glands in 
the patients with H. /?y/on-associated gastritis (Fig. 93a). The negative control for 
this section is stained blue and is shown in Fig.93(b). These sections were taken from 
the gastric body as shown by the appearance of the gastric glands which are very 
tightly packed. The epithelial cells in the gastric glands were stained very strongly 
for BCA-1/CXCL13. Some positive staining was observed in the lamina propria 
although very strong and diffuse staining for BCA-1/CXCL13 was observed in the 
lymphoid follicle in the gastric mucosa as BCA-1/CXCL13 attracts B lymphocytes 
and there are many B lymphocytes in the lymphoid follicle. The presence of the 
lymphoid follicle is indicative of H. pylori infection.
Positive staining for BCA-1/CXCL13 was also observed in the gastric epithelial cells 
in Fig.94(a). This slide was taken from a patient with H. py/on-negative chronic 
reactive gastritis. Interestingly, the staining was not as dense as that observed in the
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gastric epithelial cells in Fig.93(a) which was taken from a patient infected with the 
H . pylori bacteria. However, the staining in Fig.94(a) was darker than the positive 
staining seen in a normal patient (Fig.92(a). This suggests that BCA-1/CXCL13 
expression was elevated in gastritis and inflammatory states in the stomach compared 
to the levels normally expressed constitutively. H. pylori infection may possibly also 
play a role in increasing the expression of BCA-1/CXCL13. Inflammatory cells in 
the lamina propria also demonstrated positive staining for BCA-1/CXCL13 in slides 
92(a), 93(a), 94(a) and 95(a), although the most dense staining was observed in the 
slide taken from the patient with H. pylori-associatcd gastritis.
Similarly, very dense staining for BCA-1/CXCL13 was observed in the patient with 
H. pylori-induced ‘MALT’oma lymphoma (mucosal-associated lymphoid tissue 
lymphoma) (Fig.95a). H. pylori infection is marked by the presence of the lymphoid 
follicle. Very dense staining for BCA-1/CXCL13 was observed in the lymphoid 
follicle suggesting there was an accummulation of BCA-1/CXCL13 within the area 
of the lymphoid follicle.where B lymphocytes were present (Fig.95a). There was also 
some lighter positive staining for BCA-1/CXCL13 in the gastric epithelial cells as 
well as in the inflammatory cells in the lamina propria. Fig. 95(b) is the negative 
control slide for this patient with ‘MALT’oma lymphoma.
In conclusion, these immunohistochemistry experiments successfully demonstrated 
positive staining for the CXCR4 chemokine receptors in normal and inflamed gastric 
tissues, where it was strongly expressed by the gastric epithelial cells in patients who 
had H. /?y/on'-associated gastritis. CXCR4 was also expressed to a lesser degree in 
patients with non-H. /?y/on-associated gastritis. CXCR4 was also expressed in 
abnormal gastric tissues as in adenocarcinoma. This supports the detection for 
constitutive and induced CXCR4 mRNA in gastric epithelial cells.
BCA-1/CXCL13 positive staining was also observed in small numbers of gastric 
epithelial cells in normal patients suggesting some constitutive expression of this 
chemokine in these cells. Both the staining for CXCR4 and BCA-1/CXCL13 were 
more diffuse for gastric tissues which were undergoing inflammatory processes such 
as gastritis and carcinogenesis including ‘MALT’oma. Interestingly, H. pylori also 
seemed to play an important role in causing stronger expression of CXCR4 and
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BCA-1/CXCL13 in the gastric tissues of patients with H. /?y/on-associated gastritis. 
These can be seen by very dense staining for CXCR4 and BCA-1/CXCL13 in the 
sections where the H. pylori infection is present.
Sections of biopsy samples taken from human gastric mucosa
Fig.88(a)
Taken from a patient (15741) with H .  p y l o r i  positive active 
chronic superficial gastritis. Immunostaining with anti-human 
CXCR4. Magnification X200. Positive staining was observed in the 
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Taken from a patient (15741) with H .  p y l o r i  positive active 
chronic superficial gastritis. Negative control for Fig.88(a). 
No staining was observed when the primary anti-human 
CXCR4 was omitted. Magnification X200.
Sections of biopsy samples taken from human gastric mucosa
Fig.89(a)
Taken from the gastric antrum of a patient (8170) with H .  
p y l o r i  negative reactive gastritis. Immunostaining with anti­
human CXCR4. Magnification X I00. Very dense staining for 
CXCR4 was observed in the surface gastric epithelial cells 
(top left hand comer) (A) as shown by the arrows. The 
staining for CXCR4 was fainter further down in the gastric 
glands (B).
Fig.89(h)
Taken from the gastric antrum o f a patient (8170) with 
H .  p y l o r i  negative reactive gastritis. Negative control 
for Fig.(89a). No staining was observed when the 
primary anti-human CXCR4 was omitted. Magnification 
XI00.
Fig,90
Sections of biopsy samples taken from human gastric mucosa
Taken from the gastric body o f a normal patient (2719). 
Immunostaining with anti-human CXCR4 antibody. Magnification 
X I00. Very dense staining for CXCR4 was observed in the surface 
gastric epithelial cells (on the left side o f the photograph-see 
arrows) and very light positive staining for CXCR4 was observed 
further down the gastric glands (right side o f  the photograph).
Figt91
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Taken from a patient (954) with adenocarcinoma. 
Immunostaining with anti-human CXCR4. Magnification X I00. 
Positive staining for CXCR4 was observed in the gastric 
epithelial cells in the gastric glands (left side o f the photograph 
marked A) and in the area o f abnormal-looking gastric epithelia 
to the right o f the photograph marked B).
Fig.92(al
Sections of biopsy samples taken from human gastric mucosa
Taken from the gastric antrum in a normal patient (9813). 
Immuno-staining with anti-human BCA-1/CXCL13 antibody. 
Magnification X I00. Some light brown positive staining for 
BCA-1/CXCL13 was observed in the gastric glands in the 
middle o f the photograph (see arrows), as well as some lighter 
staining present on the surface gastric epithelial cells (to the 
left side o f the photograph). Some inflammatory cells in the 
lamina propria also stained positively for BCA-1/CXCL13, 
although this staining was rather light.
Fig.92(lri
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Taken from the gastric antrum in a normal patient (9813). 
Negative control for Fig. 92(a). No staining was observed when 
the primary anti-human BCA-1/CXCL13 antibody was omitted. 
Magnification X 100.
Sections of biopsy samples taken from human gastric mucosa
Fig.93(a)
r  >.vj3
Taken from the gastric body o f a patient (10630) with H .  p y l o r i -  
positive active superficial gastritis. Immunostaining with anti­
human BCA-1/CXCL13 antibody. Magnification X I00. Very 
heavy staining for BCA-1/CXCL13 throughout the gastric glands 
(A) (see arrows), lymphoid follicle (B) in the top right com er o f 
the photograph and in the surface gastric epithelial cells (C). Some 




' . ‘( V 'V l ,-  ■ .
______
Taken from the gastric body o f a patient (10630) with H .  p y l o r i -  
positive active superficial gastritis. Negative control for Fig. (93a). 
No staining was observed when the primary anti-human BCA- 
1/CXCL13 antibody was omitted. Magnification X I00.
Fig.94(a^ Sections of biopsy samples taken from human gastric mucosa
Taken from the gastric antrum o f a patient (2299) with H .  p y l o r i -  
negative chronic reactive gastritis. Immunostaining with anti-human 
BCA-1/CXCL13. Magnification X I00. Strong positive staining for 
BCA-1/CXCL13 was observed in the gastric epithelial cells in the 
middle field o f the photograph (see arrows). Some positive staining for 
BCA-1/CXCL13 was also observed in the inflammatory cells in the 
lamina propria.
Fig.94(hl
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Taken from the gastric antrum of a patient (2299) with H .  p y l o r i -  
negative chronic reactive gastritis. Negative control for Fig.94(a). No 
staining was observed when the primary anti-human antibody for BCA- 
1/CXCL13 was omitted. Magnification X I00.
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Sections of biopsy samples taken from human gastric mucosa
Fig.95(a)
Fig,95(b)
Taken from a patient with ‘MALT’oma (MALT lymphoma). 
Immunostaining with anti-human BCA-1/CXCL13 antibody. 
Magnification X I00. Very heavy positive staining for BCA- 
1/CXCL13 in the area o f the tumour on the right side o f the 
photograph (marked A). The normal gastric epithelial cells are seen 
on the left o f the photograph (marked B). In the middle o f the 
photograph is an area o f abnormal gastric epithelial cells (marked 
C). Some positive staining for BCA-1/CXCL13 can be seen in the 
lamina propria area.
- _____ ______
Taken from a patient with ‘MALT’oma (MALT lymphoma). 
Negative control for Fig.95(a). No staining was seen when the 




Gastric epithelial cells are important as they are the first-line cells in contact with 
ingested pathogens in the stomach. As they are involved with the body’s defence in 
the stomach, their response against infections makes an interesting study. Gastric 
epithelial cells express chemokines which recruit specific leukocyte populations to 
the site of infection and induce inflammation of the stomach. Inflammation in the 
stomach is a precursor to other pathological conditions such as gastric ulcers, 
gastritis, gastric carcinoma and MALT-lymphoma.
Characterization of the kinetics of IL-8/CXCL8 and RANTES/CCL5 expression 
and production in gastric epithelial cell lines
This study involved two gastric epithelial cell lines, the AGS and MKN45 cell lines 
which were derived from human adenocarcinomas. They were used as gastric 
epithelial cell models as they had been well-established and have been used by many 
other researchers who implied they are suitable models of real gastric epithelial cells. 
They were also easy to maintain in culture, being adherent and immortal cell lines. 
Gastric cell lines were easy to use compared to real gastric epithelial cells which 
apoptosed rapidly in culture easily and could only be isolated in small numbers from 
gastric biopsies. Primary cultures of epithelial cells were also often contaminated 
with fibroblasts and other leukocytes from the biopsies which made it difficult to 
obtain results from a pure epithelial cell population. Cell lines are useful for 
obtaining detailed information about stimulation and regulation pathways but since 
the AGS and MKN45 cells used were derived from adenocarcinomas, there was still 
a possibility that they might behave in a different way compared to normal gastric 
epithelial cells.
In an H. pylori infection of real gastric epithelium, many types of leukocytes are 
recruited to the site of inflammation which involves chemokines from the ‘CXC’ and 
‘CC’ families (Watanabe et al., 1997). Therefore, two chemokines were chosen for 
the purpose of this study, IL-8/CXCL8 from the ‘CXC’ chemokine family and 
RANTES/CCL5 from the ‘CC’ chemokine family. IL-8/CXCL8 has been shown to 
attract mainly neutrophils while RANTES/CCL5 attracts monocytes, lymphocytes,
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basophils, eosinophils and T cells. A number of studies have shown that IL- 
8/CXCL8 and RANTES/CCL5 were expressed by inflamed gastric and intestinal 
mucosa. The pro-inflammatory cytokines IL-la, TNF-a and IFN-y, alone or in 
combination were used to stimulate the gastric cells to secrete chemokines (Strober, 
1998). These cytokines are known to be expressed in response to H. pylori infection 
and have an adverse effect on the gastric mucosa (Crabtree et al., 1991; Moss et al., 
1994; Noach et al., 1994; Fan et al., 1995; Peek et al., 1995 and Yamaoka et al.,
1995). So far, the source of IL-la, TNF-a and IFN-a which are increased in H. 
py/on-associated gastritis is unknown but it is hypothesised that activated 
macrophages may be the source of IL -la  and TNF-a (Sartor, 1994) while IFN-y 
may be produced by natural killer cells or T lymphocytes (Karttunen et al., 1995). 
Pro-inflammatory cytokines are released in smaller amounts compared to 
chemokines when epithelial cells are in contact with pathogens but are potent cell 
activators. These pro-inflammatory cytokines can activate leukocytes, for example 
macrophages to mount inflammatory reactions to protect the host against the 
infection. An example of this mechanism in vivo in the gastric mucosa is as follows. 
IFN-y which is expressed by intraepithelial T cells, found next to the epithelial cells 
on the basement membrane, up-regulates adhesion molecules on the epithelial cells. 
These adhesion molecules attract neutrophils and binds them with intercellular 
adhesion molecule-1 (ICAM-1) on to the apical part of the epithelial cells where they 
ingest pathogens.
IL-8/CXCL8 expression was studied because it is widely known that IL-8/CXCL8 
mRNA, which is a ‘CXC’ chemokine is expressed when the gastric mucosa is 
infected with H. pylori and also it is very commonly expressed in inflammatory 
reactions in the stomach (Moss et al., 1994; Yamaoka et al., 1995; Yamaoka et al.,
1996). IL-8/CXCL8 protein levels were also found to be raised with H. pylori 
infections (Crabtree et al., 1993; Noach et al., 1994; Gionchetti et al., 1994; Fan et 
al., 1995; Peek et al., 1995 and Yamaoka et al., 1997).
In our study, it was found that the AGS and MKN45 cell lines exhibited similar 
profiles of IL-8/CXCL8 mRNA expression. In Northern experiments, both cell lines 
did not demonstrate IL-8/CXCL8 mRNA expression when they were unstimulated. 
Interestingly, both the AGS and MKN45 cell lines were found to express the IL-
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8/CXCL8 transcript in the RT-PCR experiments. This difference was since the RT- 
PCR experiments were more sensitive in detecting small amounts of IL-8/CXCL8 
mRNA compared to the Northern analysis experiments. These RT-PCR results 
indicate that even in quiescent cells maintained in a ‘defined’ system in the absence 
of serum, low levels of IL-8/CXCL8 mRNA are expressed.
Stimulation of the AGS and MKN45 cells with IL -la  (3ng/ml) alone caused a rapid 
response of IL-8/CXCL8 mRNA expression within 1 hour of stimulation. This rapid 
IL-8/CXCL8 response has also been detected in the HT-29 colonic epithelial cell line 
(Kolios et al., 1996). In gastric epithelial cell lines, the IL-8/CXCL8 mRNA 
expression in response to IL -la  was short-lived, it was only detected for about 1 
hour. TNF-a also caused a rapid response within 1 hour, but the mRNA expression 
was prolonged up to 12 hours in the AGS and MKN45 cells. This suggested that in 
gastric epithelial cells, TNF-a was a stronger pro-inflammatory stimulus for IL- 
8/CXCL8 expression than IL-la.
In synovial fibroblasts and human vascular smooth muscle cells, IL-1 was a more 
potent stimulator of IL-8/CXCL8 mRNA than TNF-a (Jordan et al., 1996; Jordan et 
al., 1997). In these cells, peak expression was also later (4-6 hours) than the rapid 1 
hour response detected in gastric cell lines. Is is thought that IL-8/CXCL8 expression 
in gastric carcinoma cell lines involves protein kinase C and tyrosine kinase activity 
(Beales et al., 1996).
When added simultaneously, IL -la  and TNF-a were additive and increased and 
prolonged the expression of IL-8/CXCL8 mRNA compared to the levels expressed 
by either one of the cytokines alone. These results are similar to the results in the 
HT-29 cells in a study conducted by Kolios et al.(1999). In the gastric mucosa, in 
vivo the presence of both cytokines would induce more gastric mucosa inflammatory 
damage compared to the effect from just one of the cytokines. It has been suggested 
that IL -la  and TNF-a may be expressed by a common pathway as their expression 
profile in intestinal epithelium was nearly identical to each other and they are both 
produced in response to the same stimuli and that they may compliment each other in 
inflammatory processes (Warhurst et al., 1998).
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The cytokine IFN-y (lOOU/ml) on its own did not induce the expression of IL- 
8/CXCL8 mRNA in either the AGS or MKN45 cell lines, this is similar to the results 
previously reported in the HT-29 colonic epithelial cells (Kolios et al., 1996). Similar 
results were also observed in the HT-29-19A cells, which are intestinal crypt cells 
and the intestinal villus absorptive cells, Caco-2 (Warhurst et al., 1998). This 
experiment demonstrated that IFN-y did not play a role in initiating the expression of 
IL-8/CXCL8. Similarly, when IFN-y (lOOU/ml) was added concurrently with IL- 
l a  (lOng/ml) or TNF-a, the IL-8/CXCL8 mRNA expression was not modulated 
significantly from the profile obtained when IL -la  and TNF-a were added 
individually. However, in combination, (the cytomix combination of IL-la, TNF-a 
and IFN-y), there was generally a small prolongation of IL-8/CXCL8 mRNA 
expression.
The lack of response to IFN-y in gastric epithelial cell lines emphasises a difference 
from colonic epithelial cells (HT-29) where the addition of cytomix increased the 
expression of IL-8/CXCL8 mRNA above that of IL -la  and TNF-a added together 
without IFN-y (Kolios et al.,1996). IFN-y belongs to the Thl type of response which 
usually is involved with the initiation of inflammatory responses unlike the Th2 type 
of response which is more anti-inflammatory in some cell lines (Kolios et al., 1996).
Expression of RANTES/CCL5 mRNA, a ‘CC’ chemokine was also studied in both 
the AGS and MKN45 cell lines. Unstimulated cells did not express RANTES/CCL5 
mRNA constitutively. A difference was observed between the AGS and the MKN45 
cells, since under all the stimuli conditions tested, RANTES/CCL5 mRNA 
expression was not induced in the AGS cells. Interestingly, the stimuli needed to 
induce the expression of RANTES/CCL5 mRNA in the MKN45 cell line was 
different from that required to induce IL-8/CXCL8 mRNA. The minimum stimuli 
which could induce the expression of RANTES/CCL5 mRNA were a combination of 
TNF-a (30ng/ml) and IFN-y (lOOU/ml). Since TNF-a alone did not induce 
RANTES/CCL5, IFN-y was important in activating the appropriate signalling 
pathway not required in gastric cells for IL-8/CXCL8 production. This synergistic 
effect of TNF-a and IFN-y in expressing RANTES/CCL5 had previously been found 
in fibroblasts (Rathanaswami et al., 1993), endothelial cells (Marfaing-Koka et al.,
1995), bronchial epithelial cells (Berkman et al., 1995; Stellato et al., 1995) and HT-
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29 cells (Kolios et al., 1999). In the current study, the addition of IL -la  did not 
significantly modulate RANTES/CCL5 expression. This suggests that the signalling 
pathways activated may vary in different cell types, since low levels of 
RANTES/CCL5 have been shown to be expressed in vascular smooth muscle cells in 
response to IL -la  alone (Jordan et al., 1997).
The profile of RANTES/CCL5 mRNA expression in MKN45 cells was different 
from IL-8/CXCL8 mRNA since the onset of RANTES/CCL5 mRNA was later, it 
was first expressed at 6 hours post-stimulation with a peak at 12 hours post­
stimulation. The late expression of RANTES/CCL5 mRNA at 24 hours has 
previously been reported in HT-29 cells (Kolios et al., 1996), human airway (John et 
al., 1997) and vascular smooth muscle cells (Jordan et al., 1997). It has previously 
been suggested that the late onset of RANTES/CCL5 may be due to the requirement 
of an unknown intermediary protein to initiate RANTES/CCL5 mRNA expression 
(Rathanaswami et al., 1993).
A possible explanation for this patterned release of chemokines, IL-8/CXCL8 (early) 
and RANTES/CCL5 (late) may play a role in mediating the accumulation of specific 
leukocyte populations at different phases of the inflammatory response (Strober, 
1998).
Interestingly, even though both the AGS and MKN45 epithelial cell lines were 
derived from gastric adenocarcinomas, they both behaved similarly in IL-8/CXCL8 
mRNA expression but differently with respect to RANTES/CCL5 production. There 
were also differences in the other types of chemokines which were detected to be 
expressed by these two cell lines. The differences could be due to these cell lines 
being derived from different individuals and possibly from different stages of cancer 
type and development.
ELISA analysis of the AGS and MKN45 cell supernatants indicated that 
unstimulated quiescent (serum free) cells did not secrete IL-8/CXCL8 or 
RANTES/CCL5 protein. The concentration of IL-8/CXCL8 protein secreted into the 
medium increased in a time-dependent manner (1-24 hours) when the AGS and 
MKN45 cells were stimulated with IL-la, TNF-a or cytomix indicating that mRNA
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was translated into secreted protein, and that the protein was still produced even once 
the short-lived mRNA was no longer detectable.
In the AGS cells in response to all stimuli, IL-8/CXCL8 increased steadily in the 
medium until 48 hours. Increases were not detected from 48-72 hours for two 
possible reasons, mRNA was expressed rapidly (1 hour) and was short-lived, hence 
its translation into protein decreased after 48 hours. Since these experiments were 
performed in a ‘defined’ serum-free medium, beyond 48 hours in the absence of 
serum, the cells were probably starting to enter apoptosis, although the viability 
assays did not indicate any significant decrease in viability up to 72 hours.
Protein secretion indicated that in the AGS cells, IL -la  and TNF-a stimuli induced a 
similar IL-8/CXCL8 protein secretion, even though IL -la  induced less detectable 
mRNA than TNF-a. IL -la  and TNF-a added simultaneously induced approximately 
twice the amount of IL-8/CXCL8 compared to individual responses indicating 
responses to these stimuli were additive.
The amount of IL-8/CXCL8 secreted after 48 hours of maximum stimulation with 
cytomix in the AGS cells was approximately 8ng/ml, this was a similar concentration 
to the amount secreted after 48 hours in the MKN45 cells.
In the MKN45 cells, the IL-8/CXCL8 mRNA induced by IL -la  was not translated 
into high levels of secreted IL-8/CXCL8 protein, indicating that in contrast to the 
AGS cells, TNF-a was a more potent inducer of secreted IL-8/CXCL8 in the 
MKN45 cells.
ELISA analysis demonstrated that RANTES/CCL5 protein was secreted by the 
MKN45 cells stimulated with TNF-a and IFN-y, with similar results when IL -la  
was added simultaneously. Secreted RANTES/CCL5 remained low until 6 hours 
post-stimulation and a late expression occurred since the RANTES/CCL5 mRNA 
was not detected until 6 hours. The concentration of RANTES/CCL5 protein 
secreted at 24 hours was 3ng/ml, this was lower than the peak levels of IL-8/CXCL8 
secreted by the MKN45 cells over 24 hours.
RANTES/CCL5 continued to be secreted as protein even after the mRNA levels had 
decreased. The kinetics of TNF-a and IFN-y induced RANTES/CCL5 secretion
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suggest that this chemokine may be involved in the recruitment and activation of T 
cells over long periods.
Regulation of IL-8/CXCL8 and RANTES/CCL5 expression and production by 
IL-4 and IL-13
Previous studies have indicated that gastric epithelial cell lines demonstrated a Thl 
type of reaction in response to pro-inflammatory mediators, such as cytokines or H. 
pylori. In the current study, the novel immunomodulatory effects of the Th2 
cytokines, IL-4 and IL-13 on gastric epithelial cell line chemokine expression were 
examined. These cytokines did not always behave in the same way in regulating 
chemokine expression in every cell line.
The cells were stimulated with higher concentrations of IL -la  (lOng/ml), TNF-a 
(lOOng/ml) and IFN-y (300U/ml) (‘cytomix’) to obtain maximal stimulation of these 
cell lines and high expression of IL-8/CXCL8 and RANTES/CCL5 protein in the 
AGS and MKN45 cell lines. These high concentrations for the cytokines had 
previously been used in our laboratory on the HT-29 cell line to induce maximum 
expression of IL-8/CXCL8, MCP-1/CCL2 and RANTES/CCL5 mRNA and protein 
(Kolios et al., 1996).
Pre-stimulation with EL-4 did not have any significant effect on the production of IL- 
8/CXCL8 protein or mRNA in the AGS or MKN45 cell lines when they were 
stimulated with ‘cytomix’. Therefore, IL-4 did not act as a stimulating or inhibitory 
cytokine on the production of IL-8/CXCL8 protein in either cell line. Pre-stimulation 
with IL-13 also had no significant effect on the IL-8/CXCL8 protein secretion by the 
AGS cells or IL-8/CXCL8 mRNA and protein expression in the MKN45 cells. 
Similar to the results obtained by Kolios et al. (1996), when HT-29 cells were 
stimulated with TNF-a and IFN-y, IL-4 and IL-13 had no effect on IL-8/CXCL8 
production.
A differential effect of IL-4 and IL-13 on IL-8/CXCL8 and RANTES/CCL5 
chemokine expression was demonstrated, since IL-4 and IL-13 were both able to 
inhibit RANTES/CCL5 protein production in a concentration-dependent way in the 
MKN45 cell line. The Northern analysis experiment indicated that the mechanism of 
action was by the down-regulation of mRNA expression.
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Both of these results were similar to the effects reported by Kolios et al., (1997) in 
the HT-29 colonic epithelial cell line where the ‘CC’ chemokines MCP-1/CCL2 and 
RANTES/CCL5 were inhibited by IL-4 and IL-13 whereas IL-8/CXCL8 was not 
affected. RANTES/CCL5 induced by a combination of TNF-a and IFN-y has also 
been inhibited by IL-13 in endothelial cells (Marfaing-Koka et al., 1995) and human 
airway smooth muscle cells (John et al., 1997). Responses may be cell-dependent 
since IL-13 did not affect the secretion of RANTES/CCL5 protein in smooth muscle 
cells (Jordan et al., 1997) and in human airway epithelial cells (Berkman et al.,
1996).
These results indicate that both the MKN45 gastric epithelial cells and HT-29 
colonic epithelial cells have functional IL-4 and IL-13 receptors. IL-4 and IL-13 
receptors are closely related but are distinct. These receptors are known to have 
independent biological functions; although RANTES/CCL5 down-regulation in the 
MKN45 cells was a similar response to both IL-4 and IL-13.
The ability to inhibit RANTES/CCL5 but not IL-8/CXCL8 production indicates that 
differential signalling pathways by TNF-a and IFN-y are used by these two 
chemokines and that in the MKN45 and HT-29 cells, there is no common inhibitory 
target for IL-4 and IL-13. The ability of Th2 cytokines to inhibit RANTES/CCL5 in 
vivo may play an important role in modulating the inflammatory process by 
inhibiting T cell monocyte and eosinophil recruitment into the gastric epithelium. IL- 
4 and IL-13 may be able to decrease inflammation associated with infection with H. 
pylori and other monocyte and macrophage derived cytokines and chemokines 
(Minty et al., 1993).
In vivo, it is known that chemokine regulation is complex. In a separate study by 
Kolios et al. (1996; 1999), it has been shown that stimulation of HT-29 cells with 
TNF-a alone induced IL-8/CXCL8 production which was not inhibited by IL-13. 
This suggests that it is signalling by IFN-y (when TNF-a and IFN-y are added in 
combination), which enables the IL-8/CXCL8 production to be inhibited by IL-13. In 
HT-29 cells (Kolios et al., 1996) and vascular smooth muscle cells (Jordan et al.,
1997), stimulation of EL-8/CXCL8 production by IL -la  alone showed a significant 
increase by IL-13. Therefore, IL-13 has a bifimctional role, depending on the type of 
stimulus used.
178
It has been suggested that the anti-inflammatory effect of IL-13 could be due to the 
enhancement of the IL-1 receptor antagonist (IL-ra) which blocks the IL-1 signalling 
and results in a direct inhibition of chemokine transcription (Muzio et al., 1994). 
However, this theory cannot explain the increase in IL-1 induced IL-8/CXCL8 
detected in the HT-29 (Kolios et al., 1996) and vascular smooth muscle cells (Jordan 
et al., 1997). Since RANTES/CCL5 production in the MKN45 cells is not stimulated 
by IL-1, the inhibition of cytomix induced RANTES/CCL5 by IL-4 and IL-13 cannot 
be due to the enhancement of the IL-lra.
In conclusion, the responses measured as a result of IL-4 and IL-13 modulation are 
variable depending on the cell type studied, the stimulus used and the chemokine 
expression investigated. The inability of IL-4 and IL-13 to increase or decrease IL- 
8/CXCL8 production in cytomix stimulated gastric epithelial cells suggests that these 
Th2 cytokines may not modulate neutrophil infiltration in vivo.
Chemokine expression in gastric epithelial cells
Chemokine expression has been widely studied in leucocytes where they are 
involved in chemotaxis. Chemokines have also been shown to be produced by ‘non- 
immune’/haematopoietic cells such as epithelial cells, endothelial cells, smooth 
muscle cells, mesangial cells and others. This expression may be important in 
attracting inflammatory cells into the extravascular tissue site. Some chemokine 
receptors had also been found to be expressed by normal tissue (‘non-immune’ cells) 
on these cells suggesting that they may also be able to respond to stimulation with 
certain chemokines which may modulate cell functions and behaviour.
In this study, it has been shown by Northern analysis and RT-PCR that gastric 
epithelial cell lines express the chemokines IL-8/CXCL8 and RANTES/CCL5 when 
stimulated by pro-inflammatory cytokines, with RANTES/CCL5 showing later 
expression. Using RT-PCR, but not Northern analysis, IL-8/CXCL8 mRNA could be 
detected in unstimulated cells suggesting that IL-8/CXCL8 is expressed by epithelial 
cells at low levels constitutively. IL-8/CXCL8 expression in gastric epithelium has 
been reported to be expressed by unstimulated and increased in pro-inflammatory 
cytokine-stimulated AGS cells (Beales et al., 1997; Nakachi et al., 2000) and
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MKN45 epithelial cells (Aihara et al. 1997, Sharma et al.,1995; Yasumoto et al., 
1996.).
In addition to IL-8/CXCL8 , the current study has also shown that other CXC 
chemokines including MIG/CXCL9 and DMO/CXCLIO are expressed in gastric 
epithelial cells in response to pro-inflammatory cytokines. Both of these CXC (ELR 
negative) chemokines are chemoattractants for activated T cells.
Prior to this, DMO/CXCLIO has been associated with psoriasis. Eck et al. (2000) 
found that in H. pylori gastritis, MIG/CXCL9 and DMO/CXCLIO were expressed by 
endothelial cells and mononuclear cells in the lamina propria, at the sites of T cell 
infiltration.
MIG/CXCL9 was also expressed constitutively in unstimulated AGS and MKN45 
cells, therefore, may play a role in maintaining ‘normal’ gastric epithelial cell 
function. MIG/CXCL9 has been implicated in regulating the homing of 
intraepithelial lymphocytes (IEL) in the host gastric mucosa.
‘CC’ chemokines for example the monocyte chemoattractant proteins, MCP-1/CCL2 
and MCP-3/CCL7 and LARC/CCL20 in addition to RANTES/CCL5 have also been 
shown to be increased in expression in gastric epithelial cells stimulated with pro- 
inflammatory cytokines. MCP-1/CCL2 has been implicated in a number of diseases 
including rheumatoid arthritis, inflammatory heart disease, granulomatous disease, 
bone trauma and atherosclerosis. MCP-1/CCL2 has also been found to be induced in 
H. pylori gastritis (Shimoyama et al., 1998; Mori et al., 2001).
The chemokine LARC/CCL20 has not been previously reported to be expressed in 
the gastric epithelium. It is a known monocyte/T cell chemoattractant and the 
expression has been shown to be increased to high levels by pro-inflammatory 
cytokines. These results suggest that it is an important chemokine in gastric 
inflammation. In the AGS and MKN45 cells, LARC/CCL20 mRNA was also 
expressed at high levels constitutively, since it was detected in unstimulated cells and 
the very high levels stayed the same throughout the stimulation with ‘cytomix’ 
indicating that LARC/CCL20 may play a role in ‘normal’ homeostasis. 
LARC/CCL20 was shown for the first time in our study to be expressed by gastric 
epithelial cells and this implied that gastric epithelial cells behaved in a similar way
180
to mouse intestinal epithelial cells (Tanaka et al., 2 0 0 0 ) and human colonic epithelial 
cells (Izadpanah et al., 2001). The probable function of LARC/CCL20 is to attract 
lymphocytes and dendritic cells towards the epithelial cells for immunosurveillance 
when the epithelial cells were not stimulated. LARC/CCL20 may also be involved in 
inflammatory processes when the epithelial cells are stimulated with ‘cytomix’.
Chemokine receptor expression by gastric epithelial cells
RT-PCR analysis was included in this study to provide information about the 
chemokine receptors expressed by gastric epithelial cells. Although there have been 
many studies published about receptor expression on leukocytes, there is less known 
about receptor expression on ‘normal tissue’ cells. To date, there has been no studies 
demonstrating receptor expression on gastric epithelial cells. It is generally accepted 
that only low levels of most chemokine receptors are expressed by normal tissue 
(‘non-immune’ cells). In the current study, most chemokine receptors except CXCR4 
were not expressed at high enough levels to be reproducibly detected in unstimulated 
AGS or MKN45 cells. The RT-PCR technique used, although highly sensitive and 
specific, sometimes gives variable accuracy. It is dependent on several factors such 
as the choice of primers, the choice of target DNA, preparation of the specimen and 
technical issues pertaining to the experimental procedure (Dunn et al., 1997). The 
expression of CXCR4 obtained in the MKN45 cells is comparable to the results 
reported on the HT-29 colonic epithelial cells, where no receptors except CXCR4 
were detected (Jordan et al., 1999). Dwinell et al. (1999) showed that CXCR4 and 
CCR5 were expressed in all human intestinal epithelial cell lines investigated. Other 
chemokine receptors were only detected in some of the cell lines suggesting 
variations in different cells. Although CXCR4 was expressed by the MKN45 gastric 
epithelial cells, this receptor was not expressed by the AGS cells. This proved that 
although there was a lot of homology between the AGS and MKN45 cell lines, there 
were still differences between each cell line. Other receptors expressed faintly by the 
MKN45 cells were CCR2 and CXCR5, while the AGS cells expressed CCR1, CCR2 
and CXCR1. CXCR4 has also been found on endothelial cells (Feil et al., 1998) and 
astrocytes (Tanabe et al., 1997).
SDF-la/CXCL12, which is the only ligand for CXCR4, was not expressed by the 
AGS and MKN45 cell lines as shown by RT-PCR experiments. Shibuta et al. (1997)
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also found that SDF-la/CXCL12 was not expressed in a premalignant colonic 
adenocarcinoma. This result was also found in the HT-29 cells by Jordan et al. 
(1999). However, Agace et al. (2000) found that SDF-la/CXCL12 mRNA was 
found to be expressed constitutively in normal small intestine epithelial cells.
Therefore, CXCR4 cannot be bound in these epithelial cells by an autocrine 
stimulation. Since SDF-la/CXCL12 is known to be expressed by fibroblasts 
(Tashiro et al., 1993) and has also been detected in normal gastric tissue (Shibuta et 
al., 1997), CXCR4 may be activated by paracrine stimulation.
SDF-la/CXCL12 and CXCR4 is a unique chemokine-receptor ligand pair as 
CXCR4 is one of only a few chemokine receptors which has only one identified 
specific ligand. SDF-la/CXCL12 plays a fundamental role in development, in the 
formation of the vasculature of the gastrointestinal tract (Tachibana et al., 1998). In 
our study, one normal patient was shown to express SDF-la/CXCL12 and CXCR4 
constitutively by RT-PCR, this result is parallel to the findings of Jordan et al. (1999) 
who found that SDF-la/CXCL12 was expressed constitutively in many tissues 
including the colon. Since both SDF-la/CXCL12 and CXCR4 can be detected in the 
gastric epithelium constitutively, this suggests that there is a physiological role for 
the receptor in normal gastric homeostasis. SDF-la/CXCL12 may have a role in 
immune surveillance where it recruits T cells and monocytes.
The role of CXCR4 and SDF-la/CXCL12 in normal gastric epithelium is unclear, 
Since it is expressed in epithelial cells which normally undergoes rapid cell division 
and maturation, this may suggest a role for SDF-la/CXCL12 and CXCR4 in the 
renewal and maintenance of epithelium (Jordan et al., 1999). SD F-la also plays a 
role in carcinogenesis as a tumour suppressor gene, by inhibiting tumour 
vascularization (Shibuta et al., 1997), which is important in many digestive tract 
cancers including primary colon cancers and hepatomas. This report also suggests 
that unusually in gastric cancer, there is no correlation between gastric cancer and 
clinico-pathological characteristics.
Although in colonic epithelium and other tissues, CXCR4 may mediate HIV (Feng et 
al., 1996; Endres et al., 1996) infection, however the role of CXCR4 in mediating 
HIV infections in the stomach is presently uncertain. CXCR4 might play a role for
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the entry of this virus into the human via the gastrointestinal tract. Similarly, if anti- 
CXCR4 drugs could be designed in the future, HIV entry into the host cells could be 
blocked.
In gastric epithelial cells, for example the MKN45 cell line as shown by RT-PCR and 
the epithelial cells as shown by immunohistochemical staining of the gastric 
biopsies, CXCR4 was expressed at high levels, other chemokine receptors were also 
detected but appeared to have very low or variable expression.
Interestingly, pro-inflammatory cytokines such as IL-ip and TNF-a have been 
shown to down-regulate the expression of CXCR4 on human umbilical vein 
endothelial cells (HUVEC) and then up-regulating it (Gupta et al., 1998). In the same 
study, however IFN-y was found to down-regulate the expression of CXCR4 on the 
endothelial cells.
Even though the AGS and MKN45 cell lines expressed MIG/CXCL9 constitutively, 
both cell lines did not express the chemokine receptor for MIG/CXCL9 , which was 
CXCR3. The absence of this chemokine receptor implies that MIG/CXCL9 did not 
have an autocrine effect on the gastric epithelial cells.
CXCR1 and CXCR5 were expressed constitutively and were up-regulated by pro- 
inflammatory cytokines. In our RT-PCR experiments, this was demonstrated by the 
AGS cells which expressed constitutive CXCR1 receptor faintly, and this expression 
was enhanced when the AGS cells were stimulated with ‘cytomix’ for the duration of 
1, 3 and 12 hours. The major ligand for CXCR1 is IL-8/CXCL8 and the only CXCR5 
ligand is BCA-1/CXCL13. Both of these chemokines have been shown to be up- 
regulated in gastric epithelium by gastritis. CXCR1 expression was not detected in 
colonic epithelial cells (Dwinell et al., 1999) and has not previously been 
investigated in gastric epithelial cells. Expression of CXCR1 by human 
microvascular endothelial cells (Salcedo et al., 2000) may be important in 
angiogenesis. The role of CXCR1 in epithelial cells is unknown, but may be 
important in inflammatory responses since in the AGS cells it was up-regulated by 
pro-inflammatory cytokines.
CXCR5 expression has not been previously reported in gastric epithelial cells. It is 
known to be expressed by B and T lymphocytes (Legler et al., 1998; Zlotnik et al.,
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1999) and has previously been detected in the stomach (Gunn et al., 1998). It is also 
known to be a specific co-receptor for HIV-2 (Kanabe et al., 1999). It’s role in 
gastric epithelial cell homeostasis is unknown, but our immunohistochemical studies 
have shown that BCA-1/CXCL13 is expressed by ‘normal’ gastric tissue, therefore 
paracrine stimulation of epithelial cells through the CXCR5 receptor is possible. 
BCA-1/CXCL13 was not expressed by the MKN45 cells.
CCR1 and CCR2, the receptors for MCP-1/CCL2 and MCP-3/CCL7 and 
RANTES/CCL5 were also expressed at very low levels by some gastric epithelial 
cell lines. In our study, the unstimulated AGS cells expressed the CCR1 chemokine 
receptor and this receptor appeared to have been down-regulated after the cells had 
been stimulated with ‘cytomix’. This is similar to some other studies which reported 
that pro-inflammatory cytokines could also down-regulate the expression of 
chemokine. All of their ligands were shown to be expressed by stimulated gastric 
epithelial cells, therefore autocrine responses are possible. The AGS cells in our 
study expressed both CCR2 and the ligand for CCR2 which was MCP-1/CCL2. 
Interestingly, CCR2, was also found on the MKN45 cells which expressed MCP- 
1/CCL2 constitutively as well as during stimulation with ‘cytomix’ for 1, 3 and 12 
hours. Therefore, MCP-1/CCL2 may have autocrine regulatory effects on gastric 
epithelial cells which express the CCR2 chemokine receptor. However, the AGS or 
MKN45 cell line did not express any BCA-1/CXCL13 at all, which is the 
corresponding ligand for the CXCR5 receptor.
Both of these receptors, CCR1 and CCR2, have been reported to be expressed by 
colonic epithelial cells (Dwinell, et al., 1999). They have not previously been 
reported in gastric epithelium. Expression of CCR1 and CCR2 have also been 
reported in human vascular smooth muscle cells (Hayes et al., 1998) and it has been 
speculated that responses via these receptors may stimulate smooth muscle cell 
regrowth and migration (Yue et al., 1994). It is possible that BCA-1/CXCL13 may 
stimulate ‘normal’ gastric epithelium to divide/proliferate but this needs to be 
investigated in further studies.
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Chemokine expression by gastric mucosal biopsies
Chemokines have been shown in numerous studies to be important in the 
pathogenesis of various inflammatory type-diseases including atherosclerosis (MCP- 
l/CCL2)(Yla-Herttuala et al., 1991), asthma (RANTES/CCL5)(Stellato et al., 1995); 
(eotaxin/CCLll)(Lamkhioued et al., 1997), psoriasis (MIG/CXCL9)(Goebeler et al., 
1998), psoriasis (DMO/CXCLIO) and arthritis (MCP-l/CCL2)(Koch et al., 1992). A 
number of ‘CXC’ chemokines (GRO-ot/CXCLl (Kusugami et al., 1997), 
ENA/CXCL5 (Rieder et a l, 1997), IL-8/CXCL8 (Ishihara et a l, 1996; Martin- 
Guerrero et al., 2000), MIG/CXCL9 (Eck et al., 2000), IP-10/CXCL10 (Eck et al., 
2000) and ‘CC’ chemokines MCP-1/CCL2 (Mori et al., 2001), MIP-la/CCL3 
(Yamaoka et al., 1998) and RANTES/CCL5 (Yamaoka et al., 1998) have previously 
been shown to be involved in gastritis.
In the current study, chemokine expression in mucosal gastric biopsies enabled a 
comparison between ‘normal’ patients, patients with H. pylori-positive gastritis and 
patients with H. py/on-negative gastritis. In the latter patient group, there is a 
possibility that dietary components or drugs acted as antigens when ingested 
(Yamaoka et al., 1998).
The biopsies examined in this study were from the mucosa and therefore included a 
number of cell types. In addition to epithelial cells, samples included smooth muscle 
cells, fibroblasts, endothelial cells and especially in the inflamed samples, numerous 
leukocytes were also present. Comparison of the results obtained by RT-PCR 
analysis of gastric biopsies and cultured gastric epithelial cell lines has enabled the 
data to be assessed regarding the possibility that ‘real’ epithelial cells in biopsies may 
be contributing to the expression of individual chemokines. This information would 
be enhanced if analysis was performed on gastric epithelial cells purified from 
biopsy material. The poor viability and apoptosis previously reported (Ohsuga et al.,
2000) prevented this analysis in the current study. Future studies may be improved if 
human gastric epithelial cells could be isolated from large gastric surgical specimens, 
but such samples are not easily obtained.
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Gastric biopsies from patients without gastritis did not express IL-8/CXCL8 mRNA, 
suggesting this chemokine is not especially important in normal gastric mucosal 
homeostasis. IL-8/CXCL8 expression was detected in some patients with gastritis.
IL-8/CXCL8 expression increases in gastritis and H. pylori infection (Crabtree et al., 
1994; Noach et al., 1994; Ishihara et al., 1996; Katagiri et al., 1997; Yamaoka et al., 
1998). Even though H. pylori is non-invasive of the epithelial cells it causes gastric 
mucosal damage. The presence of H. pylori infection can also stimulate the 
leukocyte production of pro-inflammatory cytokines which induce production of 
chemokines, such as IL-8/CXCL8 by the epithelial cells. Pathogenic factors 
produced by the H. pylori have also been shown to directly stimulate IL-8/CXCL8 
production by gastric epithelial cells (McGee et al., 2000). Increased IL-8/CXCL8 
production attracts more neutrophils to infiltrate the gastric epithelium, helping to 
eliminate the H. pylori infection but it can also cause additional gastric mucosal 
damage (Martin-Guerrero et al., 2000).
IL-8/CXCL8 is known to be expressed by epithelial cells, endothelial cells, 
monocytes and fibroblasts (Baggiolini et al., 1989). However, in organ cultures of 
gastric mucosal tissues, epithelial cells were shown to be the main producers of IL- 
8/CXCL8 and GRO-a/CXCLl (Ohsuga et al., 2000), therefore in the gastric biopsies 
in the current study, the epithelial cells are most likely to be the main producers of 
IL-8/CXCL8 (Martin-Guerrero et al., 2000). Other cells might be expressing IL- 
8/CXCL8 at lower levels. IL-8/CXCL8 is known to attract neutrophils to the site of 
infection. In addition, IL-8 /CXCL8 and other ‘CXC’ chemokines which contain the 
‘ELR’ motif demonstrate the ability to induce angiogenesis via proliferation of 
endothelial cells (Gale et al., 1999). Angiogenesis is important in tissue repair and 
the development such as in the increased growth and metastasis of gastric cancers. In 
a study by Wang et al. (1996), IL-8/CXCL8 had been implicated in the development 
of non-small cell lung cancer via the angiogenesis process.
Other ‘CXC’ chemokines including MIG/CXCL9 and IP-10/CXCL10 were not 
expressed in detectable levels in normal gastric mucosa. Expression of both was 
increased in patients with gastritis. Expression was highest in patients with gastritis 
but with no H. pylori infection. In biopsies taken from the antrum, 100% of the
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patients expressed MIG/CXCL9 and 50% expressed IP-10/CXCL10, compared to 
only 16% of patients infected with H. pylori who expressed both MIG/CXCL9 and 
IP-10/CXCL10. These results strongly suggest that MIG/CXCL9 is an important 
chemokine in inflammation in gastric tissue. MIG/CXCL9 and IP-10/CXCL10 act 
synergistically to recruit T cells in H. py/on'-associated gastritis (Eck et al., 2000).
Expression of MIG/CXCL9 and DP-10/CXCL10 demonstrate that a Thl reaction 
occurs in response to H. pylori infection (Sallusto et al., 1998(b)). These chemokines 
can be produced in gastric tissue and induce responses in cells expressing CXCR3, 
which includes Thl cell types. As Thl reactions are not adequate to eradicate 
extracellular bacterial infections such as H. pylori infections, it has been implied that 
this Thl reaction has a pathogenic rather than a protective role towards the gastric 
mucosa (D’Elios et al., 1997; Bamford et al., 1998). Results in the current study 
suggest that MIG/CXCL9 and IP-10/CXCL10 are not only involved in H. pylori 
induced gastritis, but are equally important in gastritis induced by other unknown 
factors.
Unlike IL-8/CXCL8 , MIG/CXCL9 and IP-10/CXCL10 chemokines, both of these 
‘non-ELR’ -containing ’ ‘CXC’ chemokines are important for the angiostatic process 
in the stomach (Strieter et al., 1995). Angiostasis may inhibit the growth of gastric 
tumours in the stomach (Moore et al., 1998). Therefore, MIG/CXCL9 and IP- 
10/CXCL10 are important as they act opposite to the effects of the angiogenic 
‘ELR’-containing ‘CXC’ chemokines chemokines GRO-a/CXCLl and IL- 
8/CXCL8 , therefore maintaining a fine balance between angiogenic and angiostatic 
processes in the stomach. The presence of MIG/CXCL9 and IP-10/CXCL10 limit the 
damage achieved by the other angiogenic stimuli, such as IL-8/CXCL8 .
The cell source of MIG/CXCL9 and IP-10/CXCL10 expression in gastric biopsies is 
unknown. Other reports have found that MIG/CXCL9 and IP-10/CXCL10 were not 
expressed by gastric epithelial cells but were expressed by the endothelial cells in the 
small blood vessels in the lamina propria and by mononuclear cells where there are T 
cell infiltrations (Eck et al., 2000). RT-PCR analysis in this study have shown that 
cytokine stimulated AGS and MKN45 cells express MIG/CXCL9 and IP- 
10/CXCL10. Bronchial epithelial cells produce MIG/CXCL9 and IP-10/CXCL10
187
and it is known that epithelial cells can express these chemokines when infected with 
tuberculosis (Sauty et al., 1999).
The ‘CXC’ chemokine SDF-la/CXCL12 was expressed by some patients in all 
disease categories, it was also detected in some samples from ‘normal’ patients. The 
inability to induce SDF-lct/CXCL12 in the AGS and MKN45 cells suggests that it 
was not secreted by epithelial cells. Fibroblasts that are present in gastric biopsies are 
a probable source of SDF-la/CXCL12 expression (Jordan et al., 1999). The 
detection of SDF-la/CXCL12 in non-gastritis patients suggests it may play a role 
with the CXCR4 receptor in normal gastric homeostasis. SDF-la/CXCL12 is known 
to be important in the development of the heart (cardiogenesis) and haematopoiesis 
and nothing is known about its role in the stomach apart from encouraging 
vascularization of the stomach by angiogenesis. Another possible function of the 
SDF-la/CXCL12 chemokine was in immune surveillance where SDF-la/CXCL12 
had been shown to recruit resting T lymphocytes, monocytes and intraepithelial T 
cells in the gut. SDF-la/CXCL12 expression was not increased in gastritis 
suggesting it did not play an important role in inflammation. H. pylori also did not 
have an effect on the expression of SDF-la/CXCL12.
MCP-1/CCL2 has been shown to be expressed by many types of cells such as 
monocytes, macrophages, fibroblasts and epithelial cells but in the stomach, 
epithelial cells may be the biggest producers of MCP-1/CCL2 (Watanabe et al.,
1997). MCP-1/CCL2 was detected in samples from gastric body (100%) and antrum 
(50%) in normal patients suggesting it may play a role in normal cell behaviour. 
MCP-1/CCL2 expression was similarly detected in patients with gastritis in the 
presence or absence of H. pylori. Mori et al. (2001) found that H. pylori could cause 
the expression of MCP-1/CCL2 mRNA and protein to be increased in gastric 
epithelial cells. Our result is concordant with the result of Watanabe et al. (1997) 
who showed that MCP-1/CCL2 was expressed in gastric biopsies independent of the 
presence of H. pylori and they suggested that MCP-1/CCL2 may have a physiologic 
role for it to be expressed constitutively. One possible role for MCP-1/CCL2 would 
be to stimulate angiogenesis in the stomach, although it may also have a pathological 
role in contributing to the aetiology of tumour formation (Salcedo et al., 2000).
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MCP-1/CCL2 has also been shown to be elevated in inflammatory bowel diseases 
such as Crohn’s disease and ulcerative colitis. In these clinical conditions, MCP- 
1/CCL2 was responsible for attracting macrophages and eosinophils into the lamina 
propria, hence increasing the inflammatory reactions at the site of action (Reinecker 
et al., 1995). MCP-1/CCL2 may have the same role in gastritis since the expression 
of MCP-1/CCL2 is increased in gastritis and the strong detection indicated increased 
expression.
The ‘CC’ chemokines MIP-la/CCL3 and RANTES/CCL5 were detected in more 
patients with gastritis than in gastric tissue from ‘normal’ patients. These results have 
been contradicted in a study by Yamaoka et al. (1998) who concluded that ‘CXC’ 
chemokine levels increased in H. pylori infection but concluded that ‘CC’ 
chemokines did not play a role in infiltration of monocytes in H. pylori infection. 
These chemokines are involved in attracting lymphocytes, monocytes and 
macrophages. In the current study, both chemokines were detected in the gastric 
body samples in more patients with gastritis without H. pylori infection, than in 
patients who were also infected with H. pylori. Interestingly, the main producers of 
MEP-la/CCL3 were found to be macrophages and not gastric epithelial cells 
(Kusugami et al., 1999). MIP-la/CCL3 protein levels were also found by Ando et al. 
(1998) to be mostly expressed in patients with gastric ulcers or duodenal ulcers 
compared to patients with erosive gastritis or normal patients.
In previous studies, elevated levels of MIP-la/CCL3 mRNA and protein levels have 
been found to be increased in patients infected with H. pylori (Kusugami et al., 1999; 
Sato et al., 1999). It has been suggested that raised levels of these chemokines were 
used to mount an inflammatory response against H. pylori. Similarly, Yamaoka et al. 
(1998) found that MIP-la/CCL3 mRNA levels were raised with H. pylori infection, 
however, the protein levels were below sensitivity levels in the experiment and no 
conclusions could be made. Separate studies have shown that MIP-la/CCL3 protein 
levels were raised in parallel with positive H. pylori infection (Ando et al., 1998).
More association of MIP-la/CCL3 expression with H. pylori infection may have 
been detected in the current study if the number of patients included had been
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increased. Variation between individual patients can be expected since the length of 
time that each patient has been infected/suffered from gastritis will not be identical. 
Some patients will be in the early stages of an inflammatory response, whereas other 
patients may be at a later stage when cell infiltration is different.
RANTES/CCL5 mRNA was detected in patients with gastritis in the current study. It 
has previously been reported that RANTES/CCL5 mRNA is elevated in H. pylori 
infection but protein levels are not always increased. This is explained since H. 
pylori may interrupt the translation of RANTES/CCL5 mRNA into protein or the 
amount of RANTES/CCL5 mRNA was too little to be translated into protein 
(Yamaoka et al., 1998). In this study, there did not also seem to be any correlation 
between mononuclear cells and polymorphonuclear leucocytes with RANTES/CCL5 
in H. pylori infections. More studies would have to be carried out to determine the 
role of RANTES in H. pylori infections especially since eradication of H. pylori did 
not demonstrate a decrease in RANTES/CCL5 expression. In the current study, more 
patients were demonstrated to have RANTES/CCL5 expression in the absence of H. 
pylori than those suffering from the infection. This suggests that H. pylori is less 
important in inducing RANTES/CCL5 than general unknown causes of gastritis.
In the current study, particularly evident from the detection of MIP-la/CCL3 and 
RANTES/CCL5, it is evident that chemokines are detected in more patients in the 
antrum than in the body sections of the stomach. This suggests that gastritis might be 
more pronounced in the antrum (Queiroz et al., 1988; Stolte et al., 1990). In some 
cases, higher levels of expression (strong bands detected by RT-PCR) were also 
detected in the samples from the antrum (BCA-1/CXCL13 and MCP-1/CCL2).
Stolte et al (1990) found that the grade of antral gastritis correlated with the grade of 
H. pylori colonization. Possible explanations for more severe gastritis to be found in 
the antrum could be due to gastrin secretion in the antrum induced by H. pylori 
urease which increases the secretion of gastric acid and induce mucosal damage 
(Bayerdoffer et al., 1992) or decreased mucin production in the antrum as a result of 
H. pylori ammonia production which weakens the antral mucosal barrier (Tsuji et al., 
1989). The antrum and gastric body could also exhibit different mucosal reactivity in 
response to H. pylori.
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The ‘CC’ chemokine TARC/CCL17 was not detected in the AGS or MKN45 gastric 
epithelial cell lines, nor in any gastric biopsies. This novel chemokine which has 
previously been detected in bronchial epithelial cells was not expressed in gastric 
epithelial cells. In the bronchial epithelial cells, TARC/CCL17 was expressed by the 
bronchial epithelial cells and was up-regulated by the Thl cytokine, IFN-y and the 
Th2 cytokines IL-4 and IL-13 (Sekiya et al., 2000). TARC/CCL17 functions in a 
paracrine way to attract Th2 cells to the respiratory tract.
Two chemokines which have not been widely studied, were also found to be 
expressed in gastric mucosal biopsies. It has been proposed that both of these 
chemokines could be expressed constitutively to regulate homeostatic processes in 
the body (Mantovani, 1999). Gastric epithelial cell lines can express LARC/CCL20 
constitutively, since it was detected in the AGS and MKN45 cell lines. Neither 
LARC/CCL20 nor BCA-1/CXCL13 were however detected in ‘normal’ gastric 
biopsies but they were present in patients with gastritis. This suggested that both 
could be induced in inflammation, but this was not dependent on the presence of H. 
pylori.
LARC/CCL20 expression was detected in most patients with gastritis. Expression 
was strong suggesting that the levels of this chemokine were high. In the small 
intestine and colon of the mice, where LARC/CCL20 is known to be expressed 
(Hieshima et al., 1997) the main function of LARC/CCL20 is to attract immature 
dendritic cells (Dieu et al., 1998) and T lymphocytes close to the epithelial surface to 
capture antigens in the intestinal lumen. The same process might be occuring in the 
stomach. LARC/CCL20 was also found to be expressed by mouse intestinal 
epithelial cells over Peyer’s patches and mucosal lymphoid follicles in normal mice 
mucosa (Tanaka et al., 1999).
LARC/CCL20 probably plays a role in immunosurveillance in unstimulated 
epithelium. Since expression increases in gastritis, it appears to play a role in the 
inflammatory processes. LARC/CCL20 attracts CCR6 -expressing memory T cells 
and immature dendritic cells (Dieu-Nosjean et al., 1999; Liao et al., 1999).
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From the RT-PCR analysis of gastric biopsies, it cannot be determined whether it is 
epithelial cells that are predominantly expressing LARC/CCL20. 
Immunohistochemistry with an anti-LARC antibody was attempted on gastric 
biopsies. Since a suitable antibody was unavailable, it was not possible to identify 
which cells were expressing LARC/CCL20. Recently, Izadpanah et al. (2001) 
successfully stained inflamed colonic histologic specimens for LARC/CCL20. 
LARC/CCL20 was found to be minimally expressed in normal colonic epithelium 
but were markedly increased in epithelial cells in inflamed human colon. Izadpanah 
et al. (2001) also found constitutive expression of LARC/CCL20 in the HT-29, 
Caco-2, LS174T and 1-407 colonic epithelial cell lines. LARC/CCL20 was up- 
regulated after these cell lines were stimulated with pro-inflammatory cytokines such 
as IL -la  or TNF-a. This indicated that LARC/CCL20 plays an important role in 
inflammation.
Similar to LARC/CCL20, BCA-1/CXCL13 was detected in some patients with 
gastritis but was not detected in samples from ‘normal’ patients. Expression was also 
not related to H. pylori infection in the small number of samples examined. 
However, BCA-1/CXCL13 expression was shown to be dependent upon H. pylori 
presence in the immunohistochemistry experiments.
BCA-1/CXCL13 has not previously been reported to be expressed by gastric 
epithelial cells and was not detected in stimulated AGS or MKN45 gastric epithelial 
cell lines. Previous studies have shown that in all biopsy samples from patients with 
H. pylori, BCA-1/CXCL13 is expressed by primary and secondary lymphoid 
follicles (Mazzucchelli et al., 1999).
BCA-1/CXCL13 plays a role in recruiting B cells. B lymphocytes can make 
antibodies which are important in eliminating foreign antigens and pathogens. 
(Abbas et al., 1997). This suggests it may be most important in bacterial infections. 
BCA-1/CXCL13 has also been found to be expressed in germinal centre-like 
structures of lymphoid aggregates in many patients with rheumatoid arthritis and in a 
few patients with osteoarthritis (Shi et al., 2001).
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BCA-1/CXCL13 seems to be important in inflammation with less role in normal 
homeostasis, however, a study with larger numbers of patients would have to be 
studied to confirm this. The cell types expressing BCA-1/CXCL13 investigated by 
immunohistochemical analysis of gastric biopsy sections will be discussed in a later 
section.
To summarise, these results suggest that many chemokines play a role in 
inflammation associated with gastritis. Pro-inflammatory cytokines which are 
expressed in gastritis and inflammatory conditions in the gastric mucosa are 
increased during H. pylori infections. Although H. pylori has been associated with 
many pathological complications of the stomach, gastric inflammation due to other 
factors may also be important for chemokine expression. In this study, there were no 
obvious correlations between H. pylori with the mRNA expression of the other 
chemokines such as MIG/CXCL9, IP-10/CXCL10 and LARC/CCL20. This implied 
that these chemokines were more related to gastritis. These chemokines were 
probably expressed in the gastric mucosa to recruit inflammatory cells to the site of 
inflammation which can be caused by non-steroidal anti-inflammatory drug-induced 
gastritis or gastritis due to an over-production of gastric acid, but not H. pylori- 
associated gastritis.
None of the chemokines investigated in this study showed significant increase in 
expression in patients with H. pylori. The only possible exception is IL-8/CXCL8 
which has previously been investigated (Moss et al., 1994; Yamaoka et al., 1995; 
Ando et al., 1996; Yamaoka et al., 1996; Kusugami et al., 1997).
The role of the chemokine BCA-1 in gastric disease and normal mucosal tissue
Immunohistochemical analysis of gastric biopsies clearly demonstrated that BCA- 
1/CXCL13 protein is expressed, therefore the BCA-1/CXCL13 mRNA detected by 
RT-PCR of biopsy samples was translated into chemokine protein in vivo.
Immunostaining with anti-human BCA-1/CXCL13 antibody detected this protein in 
sections taken from the gastric antrum in a ‘normal’ patient. Expression levels were 
low but positive staining was detected in a number of gastric epithelial cells in
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gastric glands. The normal gastric cells could be expressing the BCA-1/CXCL13 
chemokine as a homing chemokine which is needed for immunosurveillance of the 
gastric epithelial cells and tissues.
Some light positive staining for BCA-1/CXCL13 was observed in the lamina propria 
which consisted of inflammatory cells such as lymphocytes, macrophages and 
plasma cells.
It has previously been reported that gastric epithelial cells do not produce BCA- 
1/CXCL13 (Mazzucchelli et al., 1999). In the current study, the AGS and MKN45 
gastric epithelial cell lines were also shown not to express BCA-1/CXCL13 even 
when stimulated in culture. The identification of the BCA-1/CXCL13 staining 
apparently in the gastric epithelium would need to be confirmed by analysis of larger 
numbers of biopsy samples from ‘normal’ patients. The presence of BCA-1/CXCL13 
positive staining in the normal gastric epithelial cells in the current study could 
possibly be due to BCA-1/CXCL13 being expressed constitutively as a ‘homing 
chemokine’ for immunosurveillance of the gastric mucosa.
Since CXCR5, which is the chemokine receptor for BCA-1/CXCL13, may be 
constitutively expressed (faintly) by some gastric epithelial cells suggested by RT- 
PCR analysis of the MKN45 cells, BCA-1/CXCL13 detection may simply reflect its 
binding to CXCR5 expressed in the epithelium and this may contribute to their 
retention within the gastric mucosa (Mazzucchelli et al., 1999).
In the gastric antrum of the patient with non -Helicobacter associated gastritis, BCA- 
1/CXCL13 was stained strongly in the gastric tissues. RT-PCR analysis of similar 
samples also detected BCA-1/CXCL13 expression. The positive staining for BCA- 
1/CXCL13 was observed in some gastric epithelial cells in the gastric glands. In the 
antrum, BCA-1/CXCL13 stained positively in the upper region of the gastric glands 
with a little staining seen in the base of the gastric glands. The staining for BCA- 
1/CXCL13 was more dense in this patient than in the normal patient suggesting that 
more BCA-1/CXCL13 was induced as a result of the gastric inflammation associated 
with gastritis. Some BCA-1/CXCL13 was also expressed by inflammatory cells in 
the lamina propria. The increased expression of BCA-1/CXCL13 in gastritis suggests
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that in addition to homeostasis, BCA-1/CXCL13 also has an inflammatory function. 
BCA-1/CXCL13 is known to be produced by B cells and it attracts memory T cells 
that express the receptor CXCR5 (Schaerli et al., 2000). CXCR5 was expressed by 
lymphocytes in lymphoid follicles and also in transformed B cells in ‘MALT’ 
lymphomas (Mazzucchelli et al.,1999). This retains the BCA-1/CXCL13 chemokine 
within the lymphoid follicle and ‘MALT’ lymphoma and makes the ‘MALT’ 
lymphoma less invasive compared to some other tumours.
In the section taken from the gastric body of a patient with H. pylori positive 
gastritis, there was dense staining for BCA-1/CXCL13 in the gastric epithelial cells 
in the majority of the gastric glands observed. The positive staining for BCA- 
1/CXCL13 was observed to be the more dense compared to the staining in H. pylori- 
negative patients with gastritis. There was also a lymphoid follicle in the slide which 
constitutes the mucosa-associated lymphoid tissue which was indicative of a chronic 
gastritis induced by H. pylori (Stolte et al., 1989; Genta et al., 1994; Parsonnet et al., 
1994; Nakamura et al., 1998; Mazzucchelli et al., 1999; Hjelstrom, 2001). ‘MALT’ 
can disappear after eradication of the H. pylori infection, but in some instances, it can 
lead to the formation of gastric lymphomas (cancer).
The lymphoid follicle was stained very strongly for BCA-1/CXCL13 which suggests 
that BCA-1/CXCL13 was expressed by the B cells accumulating in the lymphoid 
follicle. This result is parallel to the findings of Mazzucchelli et al, (1999). B 
lymphocytes can make antibodies which are important in eliminating foreign 
antigens and bacterial pathogens, including H. pylori.
H. pylori does seem to play a role in increasing BCA-1/CXCL13 production in 
gastric tissues. BCA-1/CXCL13 could be expressed in order to eliminate H. pylori 
by the recruitment of antibodies by a Thl reaction.
In summary, BCA-1/CXCL13 seems to play a small role in homing and 
immunosurveillance in normal gastric tissues but levels increase dramatically in 
gastritis tissues. This is possible as BCA-1/CXCL13 has both homeostatic and 
inflammatory functions and can be expressed constitutively or can be induced. H. 
pylori is a strong inducer of BCA-1/CXCL13 production which may be the reason H.
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pylori infections can cause increased gastric cancers. Inflammation caused by factors 
other than H. pylori can also increase BCA-1/CXCL13 production as levels increase 
in gastritis.
Chemoattractants and their receptors are promising targets for treating inflammatory 
diseases. Blocking individual chemokines has proved to be surprisingly effective in 
suppressing a variety of immune reaction (Sallusto et al., 1998). BCA-1/CXCL13 or 
CXCR5 could be important targets to decrease inflammation which may also help to 
decrease cancer in the stomach.
CXCR4 expression in gastric epithelium
Immunohistochemical analysis clearly demonstrated that CXCR4 was expressed in 
‘real’ gastric epithelial cells in vivo, since strong staining was detected at the surface 
of the mucosa in a normal patient. This suggested that CXCR4 was expressed 
constitutively in gastric epithelial cells. The expression of CXCR4 in ‘normal’ 
tissues indicates that it plays a role in gastric homeostasis.
CXCR4 expression was not restricted to epithelial cells but was also observed in 
inflammatory cells consisting of lymphocytes, plasma cells and macrophages in the 
lamina propria. CXCR4 has also been detected in endothelial cells (Gupta et al.,
1998) and colonic epithelial cells (Jordan et al., 1999; Dwinell et al., 1999).
Examination of slides from 9 patients with H. pylori gastritis and 7 patients with non- 
H. py/on'-associated gastritis showed very strong CXCR4 staining in the gastric 
epithelial cells of the gastric glands although more dense staining for CXCR4 was 
observed in the surface epithelial cells. This finding is different from the pattern of 
staining of BCA-1/CXCL13, suggesting that the chemokine receptor CXCR4 was 
mostly found in the surface epithelial cells of the gastric glands. Interestingly, Jordan 
et al. (1999) found that more dense staining for CXCR4 appeared at the base of the 
colonic glands and crypts. Therefore Jordan et al. (1999) hypothesised that SDF- 
la/CXCL12 and CXCR4 were important for colonic epithelial cell renewal and 
maintenance. In the stomach, CXCR4 may play a different role, which requires for 
CXCR4 to be expressed on the surface of the epithelial cells, such as in defence.
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More positive staining was observed in the patients with H. py/on-associated 
gastritis compared to the patients with non-#, ^/on-associated gastritis and normal 
patients. CXCR4 may have a physiologic role in gastric epithelial cell homeostasis 
and appears to be up-regulated in gastritis. H. pylori may play a role in up-regulating 
the expression of CXCR4 which may then activate the gastric epithelial cells to 
launch an immunological response against the bacteria. More studies would have to 
be performed to examine the CXCR4 for any other function.
In a patient with adenocarcinoma, CXCR4 was clearly stained in epithelial cells 
which looked abnormal. However, there was no obvious differences in the density of 
the staining from the ‘normal’ (non cancerous) cells surrounding the tumour. 
Tachibana et al. (1998) found that CXCR4 was important for the development of 
mice gastrointestinal vasculature in utero. The development of the gastrointestinal 
vasculature might be important if  extrapolated to the development of gastric cancers 
and lymphomas. It is assumed that good vasculature was needed for cancer growth. 
However, the role of CXCR4 in gastric cancer is speculative as Mitra et al. (1999) 
found that there was no difference in the expression of CXCR4 mRNA between 
gastric, colon and squamous oesophageal cancers compared to normal tissues. This 
was also demonstrated in the current study. SDF-la/CXCL12 was found to be 
decreased or not expressed in cancer tissues including gastric cancers (Shibuta et al.,
1997). This suggests that the signalling via the SDF-la/CXCR4 pathway is reduced 
in cancer. Therefore, CXCR4 might just have a homeostatic role in the development 
of the gastric vasculature in the stomach. In other cancerous tissue, like the breast, 
CXCR4 is up-regulated and is believed to induce invasive responses (Strieter, 2001) 
and possibly to stimulate angiogenesis and tumour vascularization. It is not known 
whether CXCR4 levels increase in gastric cancer and increase metastasis. Further 
studies would be required to ascertain the role of CXCR4 in gastric cancer.
There is still plenty more to study regarding how chemokines expressed as a result of
H. pylori infections generate gastric mucosa damage as the mechanisms are still not 
fully understood. H. pylori infection is responsible for initiating Thl type of reaction 
by the epithelial cells. An inadequate Th2 response leads to failure of the host to 
eradicate the bacteria (Wilson et al., 1999). Therefore, epithelial cells only play a
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secondary role in the pathogenesis of disease, which is more related to the final 
histopathology of the disease instead of the initiation of gastric lesions (Strober,
1998). Other than the cytokine/chemokine secretion of epithelial cells in response to
H. pylori infection, signalling pathways are important in initiating gastric mucosa 
damage. An example of this is the ability of H. pylori to induce gastric epithelial 
apoptosis which is achieved by direct contact between the bacteria and the epithelial 
cells and expression of the Bcl-2 family protein called Bak (Chen, et al., 1997).
5.1 FUTURE W ORK
I. It would be interesting to obtain a larger number of gastric biopsy samples from 
the antrum and gastric body of patients with different pathological conditions 
such as gastritis with H. pylori, gastritis without H. pylori, normal, gastric ulcers, 
gastric cancer/adenocarcinoma and MALT lymphoma. Novel chemokine 
expression would be investigated. This work could be conducted in parallel with 
the AGS and MKN45 gastric epithelial cell lines to determine if these 
chemokines detected could potentially be expressed by gastric epithelial cells in 
the gastric biopsies.
2. If possible, surgical specimens of the stomach could be obtained to enable larger 
amounts of gastric tissue to be harvested for isolation of gastric epithelial cells. 
This would possibly overcome the problem of poor isolated epithelial cell yield 
from biopsies. The isolated epithelial cells maintained in culture would provide 
information about chemokine expression and secretion and chemokine receptor 
expression by epithelial cells alone.
3. The chemokine receptors that would be useful to study on the gastric epithelial 
cells would be CCR6  which is the receptor for LARC/CCL20 and CXCR5, 
which is the receptor for BCA-1/CXCL13. This would compliment the studies 
already carried out which have indicated that these chemokines are expressed in 
the gastric mucosa. This would be very interesting particularly since CCR6  is 
known to be abundantly expressed by normal colonic epithelial cells (Izadpanah 
et al., 2 0 0 1 ).
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4. H. pylori could be cultured and added to a culture of gastric epithelial cell lines in 
vitro to compare which chemokines are induced by H. pylori. These results could 
be compared to those obtained from the analysis of biopsies from H. pylori- 
infected patients.
5. Once a suitable antibody for anti-human LARC/CCL20 antibody for 
immunohistochemistry is available, the gastric histological slides could be 
stained for LARC/CCL20 to determine whether its levels are increased in 
gastritis.
There is a great deal still unknown about the role of chemokines in the gastric 
mucosa. Studies need to be conducted to find a link between the chemokines induced 
by H. pylori and carcinogenicity in the stomach. So far, BCA-1/CXCL13 has been 
linked with MALT-lymphoma. The possible connection between chemokines and 
other cancer pathways might also be worth investigating as a full understanding of 
chemokines and their mechanisms of action may be extremely useful in therapeutic 
treatments of clinical diseases of the stomach in the future.
199
REFERENCES
1. Abbas, A. K., Lichtman, A. H. and Pober, J. S. General properties of immune 
responses. In: Cellular and Molecular Immunology. (3rd Edition). W. B. Saunders 
Company (Philadelphia); (1997): 4-11.
2. Agace, W.W, Roberts, A.I., Wu, L., Greineder, C., Ebert, E.C. and Parker, C.M. 
Human intestinal lamina propria and intraepithelial lymphocytes express 
receptors specific for chemokines induced by inflammation. Eur. J. Immunol. 
2000;30:819-826.
3. Agace, W.W., Amara, A., Roberts, A.I., Pablos, J.L., Thelen, S., Uguccioni, M., 
Li, X.Y, Marsal, J., Arenzana-Seisdedos, F., Delaunay, T., Ebert, E.C., Moser, B. 
and Parker, C.M. Constitutive expression of stromal derived factor-1 by mucosal 
epithelia and its role in HIV transmission and propagation. Curr. Biol. 2000; 
10:325-328.
4. Aggarwal, B.B. and Natarajan, K. Tumour necrosis factors: Developments during 
the last decade. Eur. Cytokine Netw. 1996;7:93-124.
5. Aihara, M., Tsuchimoto, D., Takizawa, H., Azuma, A., Wakebe, H., Ohmoto, Y., 
Imagawa, K., Kikuchi, M., Mukaida, N. and Matsushima, K. Mechanisms 
involved in Helicobacter pylori-induced interleukin-8  production by a gastric 
cancer cell line, MKN45. Infect, and Immun. 1997;65:3218-3224.
6 . Alam, R., Forsythe, D. A., Lettbrown, M. A. and Grant, J. A. Interleukin-8  and 
RANTES inhibit basophil histamine release induced with monocyte chemotactic 
and activating factors, monocyte chemoattractant peptide 1 and histamine 
releasing factor. Am. J. Respir. Cell Mol. Biol. 1993;7:427-433.
7. Ando, T., Kusugami, K., Ohsuga, M., Shinoda, M., Sakakibara, M., Saito, H., 
Fukatsu, A., Ichiyama, S. and Ohta, M. Interleukin-8  activity correlates with 
histological severity in Helicobacter pylori-associated antral gastritis. Am. J. 
Gastroenterol. 1996;91:1150-1156.
200
8 . Ando, T., Kusugami, K., Ohsuga, M., Ina, K., Shinoda, M., Konagaya, T., Sakai, 
T., Imada, A., Kasuga, N., Nada, T., Ichiyama, S. and Blaser, M J. Differential 
normalization of mucosal interleukin-8  and interleukin-6  activity after 
Helicobacter pylori eradication. Infect. Immun. 1998;66:4742-4747.
9. Ando, T., Kusugami, K., Ohsuga, M., Ina, K., Ichiyama, S., Nada, T. and Ohta, 
M. Mucosal macrophage inflammatory protein-1 a  levels are increased in 
Helicobacter pylori infection. J. Clin. Gasteroenterol. 1998;27: (Suppl.l):144- 
149.
10. Applemelk, B. J., Negrini, R., Moran, A. P. and Kuipers, E. J. Molecular 
mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997;5:70- 
73.
11. Arenberg, D. A., Polverini, P. J., Kunkel, S. L., Shanafelt, A., Hesselgesser, J., 
Horuk, R. and Strieter, R. M. The role of CXC chemokines in the regulation of 
angiogenesis in non-small cell lung cancer. J. Leukoc. Biol. 1997;62:554-562.
12. Atherton, J.C. H. pylori virulence factors. Br. Med. Bull. 1998:54:105-120.
13. Audibert, C., Burucoa, C., Janvier, B. and Fauchere, J.L. Implication of the 
structure of the Helicobacter pylori cag pathogenicity island in induction of 
Interleukin-8  secretion. Infect. Immun. 2001;69:1625-1629.
14. Axon, A.T.R. Are all helicobacters equal? Mechanisms of gastroduodenal 
pathology and their clinical implications. Gut. 1999;45(Suppl.l)l 1-14.
15. Baggiolini, M., Waltz, A. and Kunkel, S. L. Neutrophil-activating-peptide/IL-8 , a 
novel cytokine that activates neutrophils. J. Clin. Invest. 1989;84:1045-1049.
16. Baggiolini, M., Dewald, B. and Moser, B. Interleukin-8  and related chemotactic 
cytokines-CXC and CC chemokines. Adv. Immunol. 1994;55:97-179.
201
17. Baggiolini, M. and Moser, B. Blocking chemokine receptors. J. Exp. Med. 
1997;186:1189-1191.
18. Balkwill, F. The molecular and cellular biology of the chemokines. J. Viral 
Hepat. 1998;5:1-14.
19. Bamford, K. B., Fan, X. J. and Crowe, S. E. Lymphocytes in the human gastric 
mucosa during Helicobacter pylori infection have a T helper cell 1 phenotype. 
Gastroenterol. 1998;114:482-492.
20. Bamford, K. B. Chronic gastrointestinal inflammation. FEMS Immunol, and 
Med. Microbiol. 1999;24:161-168.
21. Bayerdorffer, E., Lehn, N., Hatz, G., Mannes, G.A., Oertel, H., Sauerbruch, T. 
and Stolte, M. Differences in expression of Helicobacter pylori gastritis in 
antrum and body. Gastroenterol. 1992;102:1575-1582.
22. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, 
D. R., Zlotnik, A. and Schall, T. J. A new class of membrane-bound chemokine 
with a CX3C motif. Nature. 1997;385:640-644.
23. Barella, L., Loetscher, M., Tobler, A., Baggiolini, M. and Moser, B. Sequence 
variation of a novel heptahelical leukocyte receptor through alternative transcript 
formation. Biochem. J. 1995;309:773-779.
24. Beales, I. and Calam, J. Mechanism of IL-8  production in gastric epithelial cells 
stimulated by H. pylori, IL-1 andTNF-a. Gastroenterol. 1996;110:A609.
25. Berkman, N., Robichaud, A., Krishnan, V. L., Roesems, G. and Robbins, R. 
Expression of RANTES in human airway epithelial cells: effect of corticosteroids 
and interleukin-4, -10 and-13. Immunol. 1996;87:599-603.
26. Blanchard, T. G., Czinn, S. J. and Nedrud, J. G. Host responses and vaccine 
development to Helicobacter pylori infection. In: Gastroduodenal Disease and
202
Helicobacter pylori Pathophysiology Diagnosis and Treatment. Edited by 
Westblom, T. U., Czinn, S. J., Nedrud, J. G. (Berlin Springer-Verlag). 1999;181- 
213.
27. Bleul, C. C., Fuhlbrigge, R. C., Casanovas, J. M., Aiuti, A. and Springer, T. A. A 
highly efficacious chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. 
Med. 1996;184:1101-1109.
28. Bleul, C. C., Wu, L. J., Hoxie, J. A., Springer, T. A. and Mackay, C. R. The HIV 
coreceptors CXCR4 and CCR5 are differentially expressed and regulated on 
human T lymphocytes. Proc. Natl. Acad. Sci. USA. 1997;94:1925-1930.
29. Bliss, C. M., Golenbock, D. T., Keates, S., Linevsky, J. K. and Kelly, C. P. 
Helicobacter pylori lipopolysaccharide binds to CD 14 and stimulates release of 
interleukin-8, epithelial neutrophil-activating peptide 78 and monocyte 
chemotactic protein 1 by human monocytes. Infect. Immun. 1998;66:5357-5363.
30. Bodger, K. and Crabtree, J. E. Helicobacter pylori and gastric inflammation. Br. 
Med. Bull. 1998;54:139-150.
31. Borysenko, M. and Beringer, T. Oral cavity and alimentary tract. In: Functional 
Histology. (3rd Edn.). Little, Brown and Company, Boston (1989): 317-325.
32. Brombacher, F. The role of interleukin-13 in infectious diseases and allergy. 
BioEssays. 2000;22:646-656.
33. Brown, Z., Robson, R. L. and Westwick, J. EL-8 regulation in human mesangial 
cells by IL-1 is independent of CAMP but may involve the cGMP pathway. J. 
Am. Soc. Nephrol. 1994;5:7090-7099.
34. Calam, J. Helicobacter pylori modulation of gastric acid. Yale J. Biol. Med. 
1999;72:195-202.
203
35. Campbell, J. J. and Butcher, E.C. Chemokines in tissue-specific and 
microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 
2000;12:336-341.
36. Censini, S., Lange, C., Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., 
Rappuoli, R. and Covacci, A. Cag A pathogenicity island of Helicobacter pylori 
encodes type I, specific and disease associated virulence factors. Proc. Natl. 
Acad. Sci. USA. 1996;93:14648-14653.
37. Chang, H. K. and Broxmeyer, H. E. Chemokines: signal lamps for trafficking of 
T and B cells for development and effector function. J. Leukoc. Biol. 1999; 65: 
6-15.
38. Chen, G., Sordillo, E. M., Ramey, W. G., Reidy, J., Holt, P. R., Krajewski, S., 
Reed, J. C., Blaser, M. J. and Moss, S. F. Apoptosis in gastric epithelial cells is 
induced by Helicobacter pylori and accompanied by increased expression of 
BAK. Biochem. Biophys. Res. Commun. 1997;239:626-632.
39. Chow, W. H., Blaser, M. J., Blot, W. J., Gammon, M. D., Vaughan, T. L., Risch, 
H. A., Perez-Perez, G. I., Schoenberg, J. B., Stanford, J. L., Rotterdam, H., West, 
A. B. and Fraumeni Jr., J. F. An inverse relation between cagA+ strains of 
Helicobacter pylori infection and risk of esophageal and gastric cardia 
adenocarcinoma. Cancer Res. 1998;58:588-590.
40. Correa, P. Diet modification and gastric cancer prevention. JNCI Monogram. 
1992;12:75-78.
41. Crabtree, J. E. Gastric mucosal inflammatory responses to Helicobacter pylori. 
Aliment. Pharmacol. Ther. 1996;10:(Suppl.l):29-37.
204
42. Crabtree, J. E., Wyatt, J. I., Trejdosiewicz, L. K., Peichl, P., Nichols, P.H., 
Ramsay, N., Primrose, J. N. and Lindley, I. J. D. Interleukin-8 expression in 
Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J. 
Clin. Pathol. 1994;47:61-66.
43. Crabtree, J. E. Role of cytokines in pathogenesis of Helicobacter pylori-induced 
mucosal damage. Dig. Dis. Sci. 1998;43:46S-55S.
44. Crabtree, J. E. Virulence factors of H  pylori and their effect on chemokine 
production. In: The Immunobiology of H. pylori’, from pathogenesis to 
prevention. Edited by: Ernst, P. B., Michetti, P. and Smith, P.D. Lippincort- 
Raven Publishers, Philadelphia (1997).
45. Crabtree, J. E. The host inflammatory response to Helicobacter pylori. European 
J. Gastroenterol. Hepatol. 1998;10(Suppl.l):S9-S13.
46. Craig, P. M., Territo, M. C., Karnes, W. E. and Walsh, J. H. Helicobacter pylori 
secretes a chemotactic factor for monocytes and neutrophils. Gut. 1992;33:1020- 
1023.
47. Crowe, S. E., Alvarez, L., Dytoc, M., Hunt, R. H., Muller, M., Sherman, P., 
Patel, J. and Ernst, P. B. Expression of interleukin-8 and CD54 by human gastric 
epithelium after Helicobacter pylori infection in vitro. Gastroenterol. 
1995;108:65-74.
48. D ’Elios, M. M., Manghetti, M., Almerigogna, F., Amedei, A., Costa, F., Burroni,
D., Baldari, C. T., Romagnani, S., Telford, J. L. and DelPrete, G. Different 
cytokine profiles and antigen specificity repertoire in H. pylori -specific T cells 
clones from the antrum of chronic gastritis patients with or without peptic ulcer. 
Eur. J. Immunol. 1997;27:1751-1755.
49. De Maeyer, E. and De Maeyer-Guignard, J. Interferon-y. Curr. Biol. 1992;4:321- 
326.
205
50. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J.M., Oldham, E., Ait-Yahia, S., 
Briere, F., Zlotnik, A., Lebecque, S. and Caux, C. Selective recruitment of 
immature dendritic cells by distinct chemokines expressed in different anatomic 
sites. J. Exp. Med. 1998;188:373-386.
51. Dieu-Nosjean, M. C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J. J., 
Vicari, A., Lebecque, S., Dezutter-Dembuyant, C., Schmitt, D., Zlotnik, A. and 
Caux, C. Macrophage inflammatory protein 3a is expressed at inflamed 
epithelial surfaces and is the most potent chemokine known in attracting 
Langerhans cell precursors. J. Exp. Med. 2000; 192:705-718.
52. Desai, M. A. and Vadgama, P. M. An in vitro study of enhanced H+ diffusion by 
urease action on urea. Implication for Helicobacter /?y/on-associated peptic 
ulceration. Scand. J. Gastroenterol. 1993; 28:915-919.
53. Dixon, M. F. Alimentary system. In: General and Systematic Pathology.
Second Edition. Edited by: J. C. E. Underwood. Churchill Livingstone.
J. C. E. Underwood. Churchill Livingstone. (Edinburgh). 1996; 401-449.
54. Dullens, H. F. J. and De Wit, C. L. Cancer treatment with interleukins 1, 4 and 6 
and combinations of cytokines: a review. In vivo. 1991; 5:567-570.
55. Dunn, B. E., Cohen, H. and Blaser, M. J. Helicobacter pylori. Clinical 
Microbiol. Rev. 1997;10:720-741.
56. Dwinell, M. B., Eckmann, L., Leopard, J. D., Varki, N. M. and Kagnoff, M. F. 
Chemokine receptor expression by human intestinal epithelial cells.
Gastroenterol. 1999;117:359-367.
57. Eales, L. J. Cells and tissues of the immune system. In: Immunology for Life 
Scientists. A basic introduction. John Wiley and Sons. (UK); 1997:1-24.
206
58. Ebert, E. C. Tumour necrosis factor-a enhances intraepithelial lymphocyte 
proliferation and migration. Gut. 1998;42:650-655.
59. Eck, M., Schmausser, B., Scheller, K., Toksoy, A., Kraus, M., Menzel, T. and 
Muller, H. K. CXC chemokines Groa/IL-8 and IP-10/MIG in Helicobacter 
pylori gastritis. Clin. Exp. Immunol. 2000;122:192-199.
60. Eckmann, L., Jung, H. C., Schurer-Maly, C., Panja, A., Morzycka-Wroblewska,
E. and Kagnoff, M. F. Differential cytokine expression by human intestinal 
epithelial cell lines: regulated expression of interleukin-8. Gastroenterol. 
1993;105:1689-1697.
61. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight,
A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., Wells, T. N. 
C., Power, C. A., Sutterwala, S. S., Dorns, R. W., Landau, N. R. and Hoxie, J. A. 
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 1996; 
87:745-756.
62. Ernst, P. B., Crowe, S. E., Reyes, V. E. How does Helicobacter pylori cause 
mucosal damage? The inflammatory response. Gastroenterol. 1997;113:S35- 
S42.
63. Emstoff, M. S., Gooding, W., Nair, S., Bahnson, R. R., Miketik, L., Banner, B., 
Day, R., Whiteside, T., Titusemstoff, L. and Larkwood, J. M. Immunobiological 
effects of treatment with sequential administration of recombinant interferon 
gamma and alpha in patients with metastatic renal cell carcinoma during a phase 
1 trial. Cancer Res. 1992;52:851-856.
64. Fan, X. G., Chua, A., Fan, X. J. and Keeling, P. W. N. Increased gastric 
production of interleukin-8 and tumour necrosis factor in patients with 
Helicobacter pylori infection. J. Clin. Pathol. 1995;48:133-136.
207
65. Farrar, M. A. and Schreiber, R. D. The molecular cell biology of interferon-y and 
its receptor. Annu. Rev. Immunol. 1993;11:571-611.
66. Feldman, R. A., Eccersley, J. P. and Hardie, J. M. Epidemiology of Helicobacter 
pylori’, acquisition, transmission, population prevalence and disease-to-infection 
ratio. Br. Med. Bull. 1998; 54:39-53,
67. Feil, C. and Augustin, H. Endothelial cells differentially express functional CXC- 
chemokine receptor-4 (CXCR4/fusin) under the control of autocrine activity and 
exogenous cytokines. Biochem. Biophys. Res. Commun. 1998;247:38-45.
68. Freeman, W. H. and Bracegirdle, B. An advanced atlas of histology. Heinemann 
Educational books. Oxford University Press (London); (1980): 23.
69. Gale, L. M. and McColl, S. R. Chemokines: extracellular messengers for all 
occasions? BioEssays. 1999;21:17-28.
70. Genta, R. M., Hamner, H. W. and Graham, D. Y. Gastric lymphoid follicles in 
Helicobacter pylori infection: frequency, distribution and response to triple 
therapy. Hum. Pathol. 1993;24:577-583.
71. Genta, R. M., Lew, G. M. and Graham, D. Y. Changes in the gastric mucosa 
following eradication of Helicobacter pylori. Mod. Pathol. 1993;6:281-289.
72. Genta, R. M. and Hamner, H. W. The significance of lymphoid follicles in the 
interpretation of gastric biopsy specimens. Arch. Pathol. Lab. Med. 1994; 118: 
740-743.
73. Gionchetti, P., Vaira, D., Campieri, M., Holton, J., Menegatti, M., Belluzzi, A., 
Bertinelli, E., Ferretti, M., Brignola, C., Miglioli, M. and Barbara, L. Enhanced 
mucosal interleukin-6 and interleukin-8 in Helicobacter pylori-positive dyspeptic 
patients. Am. J. Gastroenterol. 1994;89:883-887.
74. Goebeler, M., Toksoy, A., Spandau, U., Engerhardt, E., Brocker, E. B., and
2 0 8
Gillitzer, R. The CXC chemokine MIG is highly expressed in the papillae of 
psoriatic lesions. J. Pathol. 1998; 184:89-95.
75. Goldsby, R. A., Kindt, T. J., Osborne, B. A. Overview of the immune system. In: 
Kuby Immunology. (4th Edition). W. H. Freeman & Company. (New York); 
2000:3-12.
76. Goodwin, C. S and Armstrong, J. A. Microbiological aspects of Helicobacter 
pylori {Campylobacterpylori). Eur. J. Clin. Microbiol. 1990; 9:1-13.
77. Greaves, D. R., Wang, W., Dairaghi, D. J., Dieu, M. C., de Saint-Vis, B., Franz- 
Bacon, K., Rossi, D., Caux, C., McClanahan, T., Gordon, S., Zlotnik, A. and 
Schall, T. J. CCR6, a CC chemokine receptor that interacts with macrophage 
inflammatory protein-3a and is highly expressed in human dendritic cells. J. 
Exp.Med. 1997;186:837-844.
78. Grimm, M. C., Elsbury, S. K., Pavli, P. and Doe, W. T. Enhanced expression and 
production of monocyte chemoattractant protein 1 in inflammatory bowel disease 
mucosa. J. Leukoc. Biol. 1996;59:804-812.
79. Gunn, M., Ngo, Y., Ansel., K., Ekland, E., Cyster, J. and Williams, L. A B cell- 
homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma 
receptor-1. Nature. 1998;391:799-803.
80. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E. and Stadel, J. M. 
Chemokine receptors in human endothelial cells. Functional expression of 
CXCR4 and its transcriptional regulation by inflammatory cytokines. J.
Biol. Chem. 1998;273:4282-4287.
81. Harris, A. W. and Misiewicz, J. J. Helicobacter pylori. Blackwell Healthcare 
Communications. (1996): 41-52.
209
82. Haeberle, H. A., Kubin, M., Bamford, K. B., Garofalo, R., Graham, D. Y., El- 
Zaatari, F., Karttunen, R., Crowe, S. E., Reyes, V. E. and Graham, D. Y. 
Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed 
Helicobacter pylori in vitro and association of IL-2 production with gamma 
interferon-producing T cells in the human gastric mucosa. Infect, hnmun. 
1997;65:4229-4235.
83. Hayes, I. M., Jordan, N. J., Towers, S., Smith, G., Paterson, J. R., Eamshaw, J. J., 
Roach, A. G., Westwick, J. and Williams, R. J. Human vascular smooth muscle 
cells express receptors for CC chemokines. Arterioscler. Thromb. Vase. Biol. 
1998;18:397-403.
84. Hida, N., Shimoyama Jr., T, Neville, P., Dixon, M. F., Axon, A. T. R., 
Shimoyama Sr., T and Crabtree, J.E . Increased expression of IL-10 and IL-12 
(p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial 
cag status and peptic ulceration. J. Clin. Pathol. 1999;52:658-664.
85. Hieshima, K., Imai, T., Opdenakker, G., Van Damme, J. et al. Molecular cloning 
of a novel human CC chemokine liver and activation regulated chemokine 
(LARC) expressed in liver: chemotactic activity for lymphocytes and gene 
localization on chromosome 2. J. Biol. Chem. 1997;272:5846-5853.
86. Hirai, Y., Hayashi, S., Shimomura, H., Oguma, K. and Yokota, K. Association of 
Helicobacter pylori with gastroduodenal diseases. Jpn. J. Infect. Dis. 
1999;52:183-197.
87. Hjelstrom, P. Lymphoid neogenesis: de novo formation of lymphoid tissue in 
chronic inflammation through expression of homing chemokines. J. Leukoc. 
Biol. 2001;69:331-339.
88. Holzer, P. Gastroduodenal mucosal defence. Curr. Opin. Gastroenterol. 
2000;16:469-478.
210
89. Horuk, R., Chitnis, C. E., Darbonne, V. C., Colby, T. J., Rybicki, A., Hadley, T. 
J. and Miller, L. H. A receptor for the natural malarial parasite. Plasmodium 
vivax: the erythrocyte chemokine receptor. Science. 1993;261:1182-1184.
90. Horuk, R. Molecular properties of the chemokine receptor family. Trends 
Pharmacol. Sci. 1994;15:159-165.
91. Hromas, R., Kim, C. H., Klemsz, M., Krathwohl, M., Fife, M., Cooper, S., 
Schnizlein-Bick, C., Broxmeyer, H. E. Isolation and characterization of Exodus- 
2, a novel CC chemokine with a unique 37 amino and carboxyl- terminal 
extension. J. Immunol. 1997;159:2554-2558.
92. Huang, J., O’Toole, P. W., Doig, P. and Trust, T. J. Stimulation of interleukin-8 
production in epithelial cell lines by Helicobacter pylori. Infect. Immun.1995; 
63:1732-1738.
93. Hunt, R. H. The role of Helicobacter pylori in pathogenesis : the spectrum of 
clinical outcomes. Scand. J. Gastroenterol. 1996;31 (Suppl. 220):3-9.
94. Ibraghimov, A. and Pappo, J. The immune response against H. pylori- a direct 
linkage to the development of gastroduodenal disease. Microbes Infect. 2000; 
2:1073-1077.
95. Imai, T., Yoshida, T., Baba, M., Nishimura, M., Kakizaki, M. and Yoshie, I. 
Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus 
by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 1996; 
271:21514-21521.
96. Ishihara, S., Fukuda, R. and Fukumoto, S. Cytokine gene expression in the 
gastric mucosa: it’s role in chronic gastritis. J. Gastroenterol. 1996;31:485-490.
211
97. Izadpanah, A., Dwinell, M. B., Eckmann, L., Varki, N. M. and Kagnoff, M. F. 
Regulated MIP-3a/CCL20 production by human intestinal epithelium: 
mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest.
Liver Physiol. 2001;280:G710-G719.
98. Jinquan, T., Jacobi, H. H., Madsen, H. O., Glue, C., Skov, P. S., Mailing, H. J. 
and Poulsen, L. K. CXC chemokine receptor 4 expression and stromal cell- 
derived factor l a  induced chemotaxis in CD4+T lymphocytes are regulated by 
EL-4 and IL-10. Immunol. 2000;99:402-410.
99. John, M., Hirst, S. J., Jose, P. J., Robichaud, A., Berkman, N., Witt, C., Twort, C. 
H. C., Barnes, P. J. and Chung, K. F. Human airway smooth muscle cells express 
and release RANTES in response to T helper 1 cytokines. Regulation by T helper 
2 cytokines and corticosteroids. J. Immunol. 1997;158:1841-1847.
100. Joo, S. K., Hyun, C. J., Jung, M. K., In, S. S. and Chung, Y. K. Helicobacter 
pylori-water soluble surface proteins activate human neutrophils and up-regulate 
expression of CXC chemokines. Dig. Dis. Sci. 2000;45:83-
92.
101. Jordan, N. J., Watson, M. L., Williams, R. J., Roach, A. G., Yoshimura, T. and 
Westwick, J. Chemokine production by human vascular smooth muscle cells: 
modulation by IL-13. Br. J. Pharmacol. 1997;122:749-757.
102. Jordan, N. J., Kolios, G., Abbot, S. E., Sinai, M. A., Thompson, D. A., Petraki, 
K. and Westwick, J. Expression of functional CXCR4 chemokine receptors on 
human colonic epithelial cells. J. Clin. Invest. 1999;104:1061-1069.
103. Jourdan, P., Abbal, C., Nora, N., Hori, T., Uchiyama, T., Vendrell, J. P, 
Bousquet, J., Taylor, N., Pene, J. and Yssel, H. Cutting edge: IL-4 induces 
functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 
1998;160:4153-4157.
212
104. Kagnoff, M. F. and Eckmann, L. Epithelial cells as sensors for microbial 
infection. J. Clin. Invest. 1997;100:6-10.
105. Kandel, G. Helicobacter and disease: still more questions than answers. Can. J. 
Surg. 2000;43:339-346.
106. Karakurum, M., Shreeniwas, R., Chen, J., Pinsky, D., Yan, S. D., Anderson, M., 
Synouchi, K., Major, J., Hamilton, T. and Kubabara, K. Hypoxic induction of 
IL-8 gene expression in human endothelial cells. J. Clin. Invest. 1994; 93: 1564- 
1570.
107. Kardamakis, D. Interferons in the treatment of malignancies. In vivo. 1991;5: 
589-598.
108. Karttunen, R., Karttunen, T., Ekre, H. P. T. and MacDonald, T. T. Interferon 
gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter 
pylori positive and negative gastritis. Gut. 1995;36:341-345.
109. Karttunen, R. A., Karttunen, T. J., Yousfi, M. M., El-Zimaity, H. M. T.,
Graham, D. Y. and El-Zaatari, F. A. K. Expression of mRNA for interferon- 
gamma, interleukin-10 and interleukin-12 (p40) in normal gastric mucosa and in 
mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 1997;32:22- 
27.
110. Katagiri, M., Asaka, M., Kobayashi, M., Kudo, M., Kato, M. and Takeda, H. 
Increased cytokine production by gastric mucosa in patients with Helicobacter 
pylori infection. J. Clin. Gastroenterol. 1997;25(Suppl.l):S211-S214.
111. Keane, M. P., Arenberg, D. A., Moore, B. B., Addison, C. L. and Strieter, R. M. 
CXC chemokines and angiogenesis/angiostasis. Proc. Assoc. Am. Physicians. 
1998;110:288-296.
213
112. Kelly, C. P. and Michetti, P. Pathogenesis of Helicobacter pylori infection.
Curr. Opin. Gastroenterol. 1998;14:57-63.
113. Kikuchi, T., Kato, K., Ohara, S., Sekine, H., Arikawa, T., Suzuki, T., Noguchi, 
K., Saito, M., Saito, Y., Nagura, H., Toyota, T. and Shimosegawa, T. The 
relationship between persistent secretion of RANTES and residual infiltration of 
eosinophils and memory T lymphocytes after Helicobacter pylori eradication.
J. Pathol. 2000;192:243-250.
114. Kim, C. H. and Broxmeyer, H. E. Chemokines: signal lamps for trafficking of T 
and B cells for development and effector function. J.Leukoc.Biol.1999; 65:6-15.
115. Koch, A. E., Kunkel, S. L., Harlow, R. A., Johnson, B., Evanoff, H. C., Haines,
G. K., Burdick, M. D., Pope, R. M. and Strieter, R. M. Enhanced production of 
monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 
1992;90:772-779.
116. Kolios, G. and Nakos, A. Cytokines in inflammatory bowel disease. Hellenic 
J. Gastroenterol. 1995;8:117-125.
117. Kolios, G., Robertson, D. A. F., Jordan, N. J., Minty, A., Caput, D., Ferrara, P. 
and Westwick. Interleukin-8 production by the human colon epithelial cell line 
HT-29: modulation by interleukin-13. Br. J. Pharmacol. 1996;119:351-359.
118. Kolios, G., Wright, K. L., Jordan, N. J., Leithead, J. B., Robertson, D. A. F. and 
Westwick, J. CXC and CC chemokine expression and secretion by the human 
colonic epithelial cell line, HT29: differential effect of T lymphocyte-derived 
cytokines. Eur. J. Immunol. 1999;29:530-536.
214
119. Kusugami, K., Ando, T., Ohsuga, M., Imada, A., Shinoda, M., Konagaya, T., 
Ina, K., Kasuga, N., Fukatsu, A., Ichiyama, S., Nada, T. and Ohta, M. J. 
Mucosal chemokine activity in Helicobacter pylori infection. Clin. 
Gastroenterol. 1997;25(Suppl.l):S203-S210.
120. Kusugami, K., Ando, T., Imada, A., Ina, K., Ohsuga, M., Shimizu, T., Sakai, T., 
Konagaya, T. and Kaneko, H. Mucosal macrophage inflammatory protein-
l a  activity in Helicobacter pylori infection. J. Gastroenterol. Hepatol. 1999; 
14:20-26.
121. Lamkhioued, B., Renzi, P. M., Abi Younes, S., Garcia Zepada, E. A., 
Allakhverdi, Z., Ghaffar, O., Rothemberg, M. D., Luster, A. D. and Hamid, Q. 
Increased expression of eotaxin in bronchoalveolar lavage and airways in 
asthmatics contributes to the chemotaxis of eosinophils to the site of 
inflammation. J. Immunol. 1997; 159:4593-4601.
122. Larrick, J. W. and Kunkel, S. L. The role of tumour necrosis factor and 
interleukin-1 in the immunoinflammatory response. Pharm. Research. 
1988;5:129-139.
123. Le, J. and Vilcek, J. Tumour necrosis factor and interleukin-1. Cytokines with 
multiple activities. Lab Invest. 1987;56:234-248.
124. Legler, D. F., Loetscher, M. and Roos, R. S. B cell attracting chemokine-1, a 
human CXC chemokine expressed in lymphoid tissues, selectively attracts B 
lymphocytes viaBLRl/CXCR5. J. Exp. Med. 1998;187:655-660.
125. Lehmann, F. S. and Stalder, G. A. Hypothesis on the role of cytokines in peptic 
ulcer disease. Eur. J. Clin. Invest. 1998;28:511-519.
126. Levi, S., Haddad, G., Ghosh, P., Beardshall, K., Playford, R. and Calam, J. 
Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 
1989;5:1167-1168.
215
127. Legler, D. F., Loetscher, M., Roos, R. S., Clark-Lewis, I., Baggiolini, M. and 
Moser, B. B cell-attracting chemokine 1, a human CXC chemokine expressed in 
lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. 
Med. 1998;187:655-660.
128. Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B. and Farber, J.
CC chemokine receptor 6 is expressed on diverse memory subsets of T cells 
and determines responsiveness to macrophage inflammatory protein 3a. J. 
Immunol. 1999; 162:186-194.
129. Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., 
Baggiolini, M. and Moser, B. Chemokine receptor specific for IP-10 and MIG: 
Structure, function and expression in activated T-lymphocytes. J. Exp. Med. 
1996;184:963-969.
130. Lohoff, M., Rollinghoff, M. and Sommer, F. Helicobacter pylori gastritis: a Thl 
mediated disease? J. Biotechnol. 2000;83:33-36.
131. Luo, Y., Lloyd, C., Gutierrez-Ramos, J. C. and Dorf, M. E. Chemokine 
amplification in mesangial cells. J. Immunol. 1999;163:3985-3992.
132. Luster, A. D. Chemokines-chemotactic cytokines that mediate inflammation. N. 
Engl. J. Med. 1998;338:436-445.
133. Mahalingam, S. and Karupiah, G. Chemokines and chemokine receptors in 
infectious diseases. Immunol. Cell Biol. 1999;77:469-475.
134. Malfertheiner, P. Helicobacter pylori infection in ulcer pathogenesis. Digestion. 
1997;58(Suppl.l): 17-20.
135. Mantovani, A. The chemokine system: redundancy for robust outputs.
Immunol. Today. 1999;20:254-257.
136. Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J.,
216
Galanaud, P. and Emilie, D. Regulation of the production of the RANTES 
chemokine by endothelial cells. Synergistic induction by IFN-y plus TNF-a and 
inhibition by IL-4 and IL-13. J. Immunol. 1995;154:1870-1878.
137. Marshall, B. J. Epidemiology of H. pylori in western countries. In: Hunt, R. H. 
and Tytgat, G. N. J. (ed). Helicobacter py lori: basic mechanisms to clinical 
cure. Lancaster Kluwer. 1994;75-84.
138. Martin-Guerrero, J. M., Hergueta Delgado, P., Carretero, J. J. E., Rivera Hueto,
F. F., Pellicer Bautista, F. J. and Herrerias Gutierrez, J. M. Pathogenic 
implications of interleukin-8 activity and bacterial phenotype in antral gastritis 
associated with Helicobacter pylori. Rev. Esp. Enferm. Dig. 2000;92:309- 
315.
139. Massari, P., Manetti, R., Burroni, D., Nuti, S., Norais, N., Rappuoli, R., Telford, 
J. and Montecucco, C. Binding of the Helicobacter pylori vacuolating cytotoxin 
to target cells. Infect. Immun. 1998;66:3981-3984.
140. Mazzucchelli, L., Blaser, A., Kappeler, A., Scharli, P., Laissue, J. A., 
Baggiolini, M. and Uguccioni, M. BCA-1 is highly expressed in Helicobacter 
pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. 
Clin. Invest. 1999;104:R49-R54.
141. McGee, D. J. and Mobley, H. L. T. Pathogenesis of Helicobacter pylori 
infection. Curr. Opin. Gastroenterol. 2000;16:24-31.
142. Minty, A., Chalon, P., Derocq, J. M., Dupont, X., Guillemot, J., Kaghad, M., 
Labit, C., Leplatois, P., Liauzun, P. and Miloux, B. Interleukin-13 is a new 
human lymphokine regulating inflammatory and immune responses. Nature. 
1993;362:248-250.
217
143. Mitra, P., Shibuta, K., Mathai, J., Shimoda, K., Banner, B. F., Mori, M. and 
Barnard, G. F. CXCR4 mRNA expression in colon, oesophageal and gastric 
cancers and hepatitis C infected liver. Int. J. Oncology. 1999;14:917-925.
144. Molinari, M., salio, M., Norais, N., Rappuoli, R., Lanzavecchia, A. and 
Montecucco, C. Selective inhibition of li-dependent antigen presentation 
By Helicobacter pylori toxin VacA. J. Exp. Med. 1998;187:135-140.
145 Moore, B. B., Arenberg, D. A., Addison, C. L., Keane, M. P. and Strieter, R. M. 
Tumour angiogenesis is regulated by CXC chemokines. J. Lab. Clin. Med. 
1998;132:97-103.
146. Moore, B. B., Keane, M. P., Addison, C. L., Arenberg, D. A. and Strieter, R. M. 
CXC chemokine modulation of angiogenesis: the importance of balance 
between angiogenic and angiostatic members of the family. J. Invest. Med. 
1998;46:113-120.
147. Mori, N., Ueda, A., Geleziunas, R., Wada, A., Hirayama, T., Yoshimura, T. and 
Yamamoto, N. Induction of monocyte chemoattractant protein 1 by 
Helicobacter pylori involves NF-KB. Infect. Immun. 2001;69:1280-1286.
148. Moss, S. F., Legon, S., Davies, J. and Calam, J. Cytokine gene expression in 
Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567-1570.
149. Murdoch, C. CXCR4: chemokine receptor extraordinaire. Immunol. Rev. 
2000;177:175-184.
150. Muzio, M., Sironi, F, Polentarutti, M., Minty, A., Caput, D., Ferrara, P., 
Mantovani, A. and Colotta, F. IL-13 induces the production of IL-1 receptor 
antagonist (IL-lra) and the expression of the mRNA for the intracellular 
(keratinocyte) form of IL-lra in human myelomonocytic cells. Blood. 
1994;83:1738-1743.
151. Nagasawa, H., Kitutani, H. and Kishimoto, T. Molecular cloning and structure
218
of a pre-B-cell growth stimulating factor. Proc. Natl. Acad. Sci. USA. 91:2305- 
2309.
152. Nagasawa, T., Tachibana, K. and Kishimoto, T. A novel CXC chemokine 
PBSF/SDF-1 and its receptor CXCR4: their functions in development, 
hematopoiesis and HIV infection. Semin. Immunol. 1998;10:179-185.
153. Nagasawa, T., Tachibana, K. and Kawabata, K. A CXC chemokine SDF- 
1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv. Immunol. 1999;71: 
211-228.
154. Nakachi, N., Klein, T. W., Friedman, H. and Yamamoto, Y. Helicobacter pylori 
infection of human gastric epithelial cells induces IL-8 and TNF-a, but not 
TGFpi mRNA. FEMS Immunol. Med. Microbiol. 2000;29:23-26.
155. Ngo, V. N., Komer, H., Gunn, M. D., Schmidt, K. N., Riminton, D. S., Cooper, 
M. D., Browning, J. L., Sedgwick, J. D. and Cyster, J. G. Lymphotoxin cc/p and 
tumour necrosis factor are required for stromal cell expression of homing 
chemokines in B and T cell areas of the spleen. J. Exp. Med. 1999; 189:403- 
412.
156. Noach, L. A., Bosma, N. B., Jansen, J., Hoek, F. J., van Deventer, S. J. H. and 
Tytgat, G. N. J. Mucosal tumour necrosis factor-a, interleukin-lp and 
interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. 
Gastroenterol. 1994. 29:425-429.
157. O’Garra, A., McEvoy, L. M. and Zlotnik, A. T-cell subsets: Chemokine 
receptors guide the way. Curr. Biol. 1998;8:R646-R649.
219
158. Ogawa, T., Suda, Y., Kashihara, W., Hayashi, T., Shimoyama, T.,_Kusumoto, S. 
and Tamura, T. Immunological activities of chemically defined lipid A from 
Helicobacter pylori lipopolysaccharide in comparison with Porphyromonas 
gingivalis lipid A and Escherichia coli.-type synthetic lipid A. Vaccine. 
1997;15:1598-1605.
159. Ohsuga, M., Kusugami, K., Ina, K., Ando, T., Yamaguchi, H., Imada, A., 
Nishio, Y., Shimada, M., Tsuzuki, T., Noshiro, M., Konagaya, T. and Kaneko,
H. Comparison between in vivo and in vitro chemokine production in 
Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2000;14(Suppl.l):205-
215.
160. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., 
Orentreich, N. and Sibley, L. K. and Helicobacter pylori infection and the risk 
of gastric carcinoma. New Engl. J. Med. 1991;325:1127-1131.
161. Peek Jr., R. M., Miller, G. G., Tham, K. T., Perez-Perez, G. I., Zhao, X., 
Atherton, J. C. and Blaser, M. J. Heightened inflammatory response and 
cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab.
Invest. 1995;71:760-770.
162. Pelchen-Matthews, A., Signoret, N., Klasse, P. J., Fraile-Ramos, A. and Marsh, 
M. Chemokine receptor trafficking and viral replication. Immunol. Rev. 1999; 
168:33-49.
163. Piotrowski, J., Piotrowski, E., Skrodzka, D ., Slomiany, A. and Slomiany, B. L. 
Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori 
lipopolysaccharide. Scand. J. Gastroenterol. 1997; 32: 203-211.
164. Queiroz, D. M., Mendes, E. N., Rocha, G. A., Oliviera, A. M., Oliviera, C. A., 
Cabral., M. M., Nogueira, A. M. and Souza, A. F. Serological and direct 
diagnosis of Helicobacter pylori in gastric carcinoma: a case control study. J. 
Med. Microbiol. 1999; 48:501-506.
220
165. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., 
Koch, A. E., Moser, B. and Mackay, C. R. The chemokine receptors CXCR3 
and CCR5 mark subsets of T cells associated with certain inflammatory 
reactions. J. Clin. Invest. 1998; 101:746-754.
166. Raport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W. and Charo, I. F. 
Molecular cloning and functional characterization of a novel human CC 
chemokine receptor (CCR5) for RANTES, M IP-lp and M IP-la. J. Biol. Chem. 
1996; 271:17161-17166.
167. Rathanaswami, P., Hachicha, M., Sadick, M., Schall, T. J. and McColl, S. R. 
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. 
Differential regulation of RANTES and interleukin-8 genes by inflammatory 
cytokines. J. Biol. Chem. 1993; 268:8:5834-5839.
168. Reinecker, H. C., Loh, E. Y., Ringler, D. J., Mehta, A., Rombeau, J. L. and 
MacDermott, R. P. Monocyte-chemoattractant protein 1 gene expression in 
intestinal epithelial cells and inflammatory bowel disease mucosa. 
Gastroenterol. 1995;108:40-50.
169. Rieder, G., Einsiedl, W., Hatz, R. A., Waltz, A., Stolte, M. and Endos, G. The 
CXC cytokine ENA-78 correlates strictly with activity of H. pylori-associated 
gastritis. Gut. 1997; 41:A14-A15.
170. Rieder, G., Einsiedl, W., Hatz, R. A., Stolte, M., Enders, G. A. and Waltz, A. 
Comparison of CXC chemokines ENA-78 and interleukin-8 expression in 
Helicobacter pylori-associated gastritis. Infect. Immun. 2001; 69:81-88.
171. Rollins, B. J. Chemokines. Blood. 1997;90:909-928.
172. Robson, R. L., Westwick, J. and Brown, Z. Differential regulation of RANTES 
in response to IL-la and TNF-a in human mesangial cells. J. Am. Soc. Nephrol. 
1995(a);6:851-851.
2 2 1
173. Robson, R. L., Westwick, J. and Brown, Z. Interleukin-1 induced IL-8 and IL-6 
gene expression and production in human mesangial cells is differentially 
regulated by CAMP. Kidney Int. 1995(b);48:1767-1777.
174. Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., 
Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., Baggiolini, 
M., Maggi, E., Romagnani, S. and Serio, M. Cell cycle-dependent expression of 
CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. 
J.Clin.Invest. 2001;107:53-63.
175. Rossi, D. and Zlotnik, A. The biology of chemokines and their receptors. Annu. 
Rev. Immunol. 2000;18:217-242.
176. Rottman, J. B. Key role of chemokines and chemokine receptors in 
inflammation, immunity, neoplasia and infectious disease. Vet. Pathol. 
1999;36:357-367.
177. Rovin, B. H., Yoshimura, T and Tan, L. Cytokine-induced production of 
monocyte chemoattractant protein-1 by cultured human mesangial cells. J. 
Immunol. 1992;148:2148-2153.
178. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., 
Kleinman, H. K., Oppenheim, J. J. and Murphy, W. J. Human endothelial cells 
express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and 
tumour progression. Blood. 2000;96:34-40.
179. Sallusto, F., Lenig, D., Mackay, C. R. and Lanzavecchia, A. Flexible programs 
of chemokine receptor expression on human polarized T helper 1 and 2 
lymphocytes. J. Exp. Med. 1998;187:875-883.
180. Sallusto, F., Lanzavecchia, A. and Mackay, C. R. Chemokines and chemokine 
receptors in T-cell priming and Thl/Th2-mediated responses. Immunol. Today. 
1998;19:568-574.
222
181. Sartor, R. B. Cytokines in intestinal inflammation: pathophysiological and 
clinical considerations. Gastroenterol. 1994;106:533-539.
182. Sato, Y., Sugimura, K., Mochizuki, T., Honma, T., Suriki, H., Tashiro, K., 
Ishizuka, K., Narisawa, R., Ichida, T., Van Thiel, D. H. and Asakura, H. 
Regional differences on production of chemokines in gastric mucosa between 
Helicobacter pylori-positive duodenal ulcer and gastric ulcer. Dig. Dis. Sci. 
1999;44:2390-2396.
183. Sauty, A., Dziejman, M., Taha, R. A., Iarossi, A. S., Neote, K., Garcia-Zapeda, 
E. A., Hamid, Q. and Luster, A. D. The T cell specific CXC chemokines IP-10, 
MIG and I-TAC are expressed by activated human bronchial epithelial cells. J. 
Immunol. 1999;162:3549-3558.
184. Sawai, N., Kita, M., Kodama, T., Tanahashi, T., Yamaoka, Y., Tagawa, Y., 
Iwakura, Y. and Imanishi, J. Role of gamma interferon in Helicobacter pylori- 
induced gastric inflammatory responses in a mouse model. Infect. Immun. 1999; 
67:279-285.
185. Schall, T. J. and Bacon, K. B. Chemokines, leukocyte trafficking and 
inflammation.Curr. Opin. Immunol. 1994; 6:865-873.
186. Schaerli, P., Willimann, K., Lang, A. B., Lipp, M., Loetscher, P. and Moser,
B. CXC chemokine receptor 5 expression defines follicular homing T cells 
with B cell helper function. J. Exp. Med. 2000; 192:1553-1562.
187. Schiller, J. H., Witt, P. L., Storer, B., Alberti, D., Tombes, M. B., Arzoomanian, 
R., Brown, R. R., Proctor, R. A., Vess, S. D. and Spriggs, D. R Clinical and 
biological effects of combination therapy with ylFN and TNF. Cancer. 1992; 
59:562-571.
188. Schrum, S., Probst, P., Fleischer, B. and Zipfel, P. F. Synthesis of the CC- 
chemokines M IP-la, MIP-ip and RANTES is associated with a Type 1 
immune response. J. Immunol. 1996; 157:3598-3604.
223
189. Schutyser, E., Struyf, S., Menten, P. et al. Regulated production and 
molecular diversity of human liver and activation-regulated chemokine 
macrophage inflammatory protein 3a from normal and transformed cells.
J. Immunol. 2000; 165:4470-4477.
190. Scott, P. and Trinchieri, G. The role of natural killer cells in host-parasite 
interactions. Current Opin. Immunol. 1995;7:34-40.
191. Sekiya, T., Miyamasu, M., Imanishi, M., Yamada, H., Nakajima, T., 
Yamaguchi, M., Fujisawa, T., Pawankar, R., Sano, Y., Ohta, K., Ishii, A., 
Morita, Y., Yamamoto, K., Matsushimata, K., Yoshie, O. and Hirai, K. 
Inducible expression of a Th2-type CC chemokine thymus- and activation- 
regulated chemokine by human bronchial epithelial cells. J. Immunol. 
2000;165:2205-2213.
192. Sharma, S. A., Tummuru, M. K. R., Miller, G. G. and Blaser, M. J. Interleukin- 
8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in 
vitro. Infect. Immun. 1995;63:1681-1687.
193. Shi, K., Hayashida, K., Kaneko, M., Hashimoto, J., Tomita, J., Lipsky, P. E., 
Yoshikawa, H. and Ochi, T. Lymphoid chemokine B cell attracting chemokine
1 (CXCL13) is expressed in germinal centre of ectopic lymphoid follicles 
within the synovium of chronic arthritis patients. J. Immunol. 2001; 166:650- 
655.
194. Shibuta, K., Begum, N. A., Mori, M., Shimoda, K., Akiyoshi, T. and Barnard,
G. F. Reduced expression of the CXC chemokine hIRH/SDF-la mRNA in 
hepatoma and digestive tract cancer. Int. J. Cancer. 1997;73:656-662.
195. Shimada, T. and Terano, A. Chemokine expression in Helicobacter pylori- 
infected gastric mucosa. J. Gastroenterol. 1998;33:613-617.
224
196. Shimizu, T., Kusugami, K., Ina, K., Imada, A., Nishio, Y., Hosokawa, T., 
Ohsuga, M., Shimada, M., Noshiro, M., Kaneko, H. and Ando, T. Helicobacter 
pylori-associated gastric ulcer exhibits enhanced mucosal chemokine activity at 
the ulcer site. Digestion. 2000;62:87-94.
197. Shimoyama, T., Everett, S. M., Dixon, M. F . , Axon, A. T. R. and Crabtree, J.
E. Chemokine mRNA expression in gastric mucosa is associated with 
Helicobacter pylori cagA positivity and severity of gastritis. J. Clin. Pathol. 
1998;51:765-770.
198. Singh, R. K. and Fidler, I. J. Lymphokine Cytokine Res. 1993;285-291.
199. Sipponen, P., Kekki, M., Sipponen, P. and Siurala, M. The Sydney system: 
epidemiology and natural history of chronic gastritis. J. Gastroenterol. Hepatol. 
1991;6:244-251.
200. Smoot, D. T., Mobley, H. I., Chippendale, G. R., Lewison, J. F. and Resau, J. H. 
Helicobacter pylori urease activity is toxic to human gastric epithelial cells. 
Infect. Immun. 1990;58:1992-1994.
201. Smoot, D. T. How does Helicobacter pylori cause mucosal damage? Direct 
mechanisms. Gastroenterol. 1997;6(Suppl.l):S31-S34.
202. Sobala, G. M., Crabtree, J. E., Dixon, M. F. et al. Acute Helicobacter pylori 
infection: clinical features, local and systemic immune response, gastric 
mucosal histology and gastric juice ascorbic acid concentration. Gut. 1991; 
32:1415-1418.
203. Sobala, G. M., O’Connor, H. J., Dewar, E. P., King, R. F. G., Axon, A. T. R. 
and Dixon, M. F. Bile reflux and internal metaplasia in gastric mucosa. J. Clin. 
Pathol. 1993;46:235-240.
225
204. Sozzani, S., Allavena, P., Vecchi, A. and Mantovani, A. The role of chemokines 
in the regulation of dendritic cell trafficking. J. Leukoc.Biol. 1999;66:1-9.
205. Stadnyk, A. W. Cytokine production by epithelial cells. FASEB J. 1994;8:1041- 
1047.
206. Staines, N., Brostoff, J. and James, K. Introducing Immunology. Second 
Edition. Mosby, London (1993): 5-29.
207. Standiford, T. J., Kunkel, S. L., Phan, S. H., Rollins, B. J. and Strieter, R. M. 
Alveolar macrophage-derived cytokines induce monocyte chemoattractant 
protein 1 expression from human pulmonary type II-like epithelial cells. J. Biol. 
Chem. 1991;266:9912-9918.
208. Stellato, C., Beck, L. A., Gorgone, G. A., Proud, D., Schall, T. J., Ono, S. J., 
Lichtenstein, L. M. and Schleimer, R. P. Expression of the chemokine RANTES 
by a human bronchial epithelial cell line. Modulation by cytokines and 
glucocorticoids. J. Immunol. 1995;155:410-418.
209. Stemme, S. and Hansson, G. K. Immune mechanisms in atherogenesis. Ann. 
Med. 1994; 26:141-146.
210. Stolte, M. and Eidt, S. Lymphoid follicles in antral mucosa: immune response 
to Campylobacter pylori? J. Clin. Pathol. 1989; 42:1269-1271.
211. Stolte, M., Eidt, S. and Ohnsmann, A. Differences in H. py/on-associated 
gastritis in the antrum and body of the stomach. Z. Gastroenterol. 1990;28:229-
233.
212. Strachan, D. P. Non-gastrointestinal consequences of Helicobacter pylori 
infection. Br. Med. Bull. 1998;54:87-93.
226
213. Strieter, R. M., Polverini, P. J., Arenberg, D. A. and Kunkel, S. L. The role of 
CXC chemokines as regulators of angiogenesis. Shock. 1995;4:155-160.
214. Strieter, R. M. Chemokines: Not just leukocyte chemoattractants in the 
promotion of cancer. Nature Immunol. 2001;2:285-286.
215. Strober, W. Interactions between epithelial cells and immune cells in the 
intestine. Ann. NY Acad Sci. 1998;859:37-45.
216. Suzuki, H., Mori, M., Sakaguchi, A., Suzuki, M., Miura, S. and Ishii, H. 
Enhanced levels of CXC chemokine, human GROa, in Helicobacter pylori- 
associated gastric disease. J. Gastroenterol. Hepatol. 1998;13:516-520.
217. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Nishikawa, S., Kishimoto, T. 
and Nagasawa. T. The chemokine receptor CXCR4 is essential for 
vascularization of the gastrointestinal tract. Nature. 1998;393:591-594.
218. Takagi, A., Kamiya, S., Koga, Y., Ohta, U., Kobayashi, H., Shirai, T.,
Harasawa, S. and Miwa, T. Analysis of interleukin-8 secretion induced by 
Helicobacter pylori from the gastric epithelial cell line MKN45: A mechanism 
independent of the intensity of cytotoxicity. J. Gastroenterol. Hepatol. 1997; 
12:368-372.
219. Tanabe, S., Heesen, M., Yoshizawa, I., Berman, M. A., Luo, Y., Bleul, C. C., 
Springer, T. A., Okuda, K., Gerard, N. and Dorf, M. E. Functional expression of 
the CXC-chemokine -receptor-4/fusin on mouse microglial cells and astrocytes. 
J. Immunol. 1997;159:905-911.
220. Tanaka, Y., Imai, T., Baba, M., Ishikawa, I., Uehira, M., Nomiyama, H. and 
Yoshie, O. Selective expression of liver and activation-regulated chemokine 
(LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 
1999;29:633-642.
221. Tanaka, Y. Integrin activation by chemokines: relevance to inflammatory
227
adhesion cascade during T cell migration. Histol. Histopathol. 2000;5:1169- 
1176.
222. Tashiro, K., Tada, H., Heillker, R., Shirozu, M., Nakano, T. and Honjo, T. 
Signal sequence trap: a cloning strategy for secreted proteins and type I 
membrane protein. Science. 1993;261:600-603.
223. Teran, L. M., Noso, N., Carroll, M., Davies, D. E., Holgate, S. and Scroder, J. 
M. Eosinophil recruitment following allergen challenge is associated with the 
release of the chemokine RANTES into asthmatic airways. J. Immunol. 1996; 
157:1806-1812.
224. Thibodeau, G. A. and Patton, K. T. Anatomy and Physiology. Second Edition. 
Mosby, St. Louis (1993): 624-634.
225. Toi, M., Bicknell, R. and Harris, A. L. Inhibition of colon and breast carcinoma 
cell growth by IL-4. Cancer Res. 1992;S2:275-279.
226. Tortora, G. J. and Grabowski, S. R. Principles of Anatomy and Physiology. 
Ninth Edition. John Wiley and Sons. Inc., New York (2000):832-836.
227. Tummuru, M. K.,Cover, T. L. and Blaser, M. J. Cloning and expression of a 
high-molecular mass major antigen of Helicobacter pylori: evidence of linkage 
to cytotoxin production. Infect. Immun. 1993;61:1799-1809.
228. Tytgat, G. N. J. Ulcers and gastritis. Endoscopy. 2000;32:108-117.
229. Van Coillie, E., Van Damme, J. and Opdenakker, G. The MCP/eotaxin 
subfamily of CC chemokines. Cytokine and Growth Factor Rev. 1999; 
10:61-86.
2 2 8
230. Van Damme, J., Proost, P., Lenaerts, J. P. and Opdennaker, G. Structural and 
functional identification of 2 human tumour-derived monocyte chemotactic 
proteins MCP-2 and MCP-3. J. Exp. Med. 1992;176:59-65.
231. Van Deventer, S. J. H. Chemokine production by intestinal epithelial cells: a 
therapeutic target in inflammatory bowel disease? Aliment. Pharmacol. Ther. 
1997;ll(Suppl.3):l 16-121.
232. Van Deventer, S. J. H. Cytokines and cytokine-based therapies. Curr. Opin. 
Gastroenterol. 1998;14:317-321.
233. Vandenplas, Y. Helicobacter pylori infection. World J. Gastroenterol. 2000;6: 
20-31.
234. Van Doom, L. J., Figueiredo, C., Sanna, R., Plaisier, A., Schneeberger, P., de 
Boer, W. and Quint, W. Clinical relevance of the cagA, Vac A and iceA status 
of Helicobacter pylori. Gastroenterol. 1998; 115:58-66.
235. Wang, J., Huang, M., Lee, P., Komanduri, K., Sharma, S., Chen, G. and 
Dubinett, S. M. IL-8 exhibits non-small cell lung cancer proliferation: a possible 
role for regulation of tumour growth by autocrine and paracrine pathways. J. 
Interferon Cytokine Res. 1996; 16: 53-60.
236. Ward, S. G. and Westwick, J. Chemokines: understanding their role in T 
lymphocyte biology. Biochem. J. 1998; 333:457-470.
237. Warhurst, A. C., Hopkins, S. J. and Warhurst, G. Interferon y induces 
differential upregulation of a and b chemokine secretion in colonic epithelial 
cell lines. Gut. 1998;42:208-213.
238. Watanabe, N., Shimada, T., Ohtsuka, Y., Hiraishi, H. and Terano, A. 
Proinflammatory cytokines and Helicobacter pylori stimulate CC-chemokine 
expression in gastric epithelial cells. J. Physiol. Pharmacol. 1997; 48:405-413.
229
239. Wells, T. N., Proudfoot, A. E. and Power, C. A. Chemokine receptors and their 
role in leukocyte activation. Immunol. Lett. 1999; 65:35-40.
240. Williams, S. R., Yanling, J., Cochran, D., Dorsam, G. and Graves, D. T. 
Regulated expression of monocyte chemoattractant protein 1 in normal human 
osteoblastic cells. Am. J. Physiol. 1992;263:C194-C199.
241. Williams, P. L., Warwick, R., Dyson, M. and Bannister, L. H. The Alimentary 
System In: Gray’s Anatomy. 37th Edn. Churchill Livingstone(1993): 1347-1355.
242. Wilson, M., Seymour, R. and Henderson, B. Bacterial perturbation of cytokine 
networks. Infect. Immun. 1998;66:2401-2409.
243. Wilson, K. T and Fantry, G. T. Pathogenesis of Helicobacter pylori infection. 
Curr. Opin. Gastroenterol. 1999;15:66-71.
244. Yamaoka, Y., Kita, M., Kodama, T., Sawai,N., Kashima, K., Imanishi, J. 
Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori 
infection. Scand. J. Gastroenterol. 1995;30:1153-1159.
245. Yamaoka, Y., Kita, M., Kodama, T., Sawai, N. and Imanishi, J. Helicobacter 
pylori cagA gene and expression of cytokine messenger mRNA in gastric 
mucosa. Gastroenterol. 1996; 110:1744-1752.
246. Yamaoka, Y., Kita, T., Kodama, T., Sawai, N., Kashima, K. and Imanishi, J. 
Induction of various cytokines and development of severe mucosal 
inflammation by cagA gene positive Helicobacter pylori, strains. Gut; 
1997;41:442-451.
247. Yamaoka, Y., Kita, M., Kodama, T., Sawai, N., Tanahashi, T., Kashima, K. and 
Imanishi, J. Chemokines in the gastric mucosa in Helicobacter pylori infection. 
Gut. 1998;42:609-617.
230
248. Yang, S. K, Eckmann, L., Panja, A. and Kagnoff, M. F. Differential and 
regulated expression of CXC, CC and C chemokines by human colon epithelial 
cells. Gastroenterol. 1997;113:1214-1223.
249. Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M. and 
Matsushima, K. Tumour necrosis factor a  and interferon y synergistically 
induce interleukin-8 production in a human gastric cancer cell line through 
acting concurrently on AP-1 and NF-KB-like binding sites of the interleukin-8 
gene. J. Biol. Chem. 1992; 267:22506-22511.
250. Ye, G., Gunasena, H. and Reyes, V. E. The role of the gastric epithelium in 
local T cell activation. The Immunobiology of H. pylori. In: From Pathogenesis 
to Prevention. Ed. Ernst, P. B., Michetti, P. and Smith, P. D. Lippincort-Raven 
Publishers, Philadelphia (1997): 153-166.
251. Yla-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Sarkioja, T., Yoshimura, T., 
Leonard, E. J., Witztum, J. L. and Steinberg, D. Expression of monocyte 
chemoattractant protein-1 in macrophage-rich areas of human and rabbit 
atherosclerotic lesions. Proc. Natl. Acad. Sci. 1991;88:5252-5256.
252. Yoshie, O., Imai, T. and Nomiyama, H. Novel lymphocyte-specific CC 
chemokines and their receptors. J. Leukoc. Biol. 1997;62:634-644.
253. Zack Howard, O. M., Oppenheim, J. J. and Wang, J. M. Chemokines as 
molecular targets for therapeutic intervention. J. Clin. Immunol. 1999; 
19:280-292.
254. Zarilli, R., Ricci, V. and Romano, M. Molecular response of gastric epithelial 
cells to Helicobacter pylori-induced cell damage. Cell. Microbiol. 1999; 1:93-
99.
255. Zlotnik, A., Morales, J. and Hedrick, J. A. Recent advances in chemokines and 
chemokine receptors. Crit. Rev. Immunol. 1999;19:1-47.
231
256. Zlotnik, A. and Yoshie, O. Chemokines: a new classification system and their 
role in immunity. Immunity. 2000;2:121-127.
257. Zurawski, G. and de Vries, J. E. Interleukin 13, an interleukin 4-like cytokine 
that acts on monocytes and B cells, but not on T cells. Immunol.Today. 
1994;15:19-26.
